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Abstract 
Salt formation provides a means of altering the 
physicochemical and resultant biological 
characteristics of a drug entity without modifying its 
molecular structure. Many published reviews have 
indicated the importance of the selection of the most 
appropriate salt form. This work is an investigation 
into the salt formation of two heterocyclic drugs. 
This is done by the physicochemical ·and the 
crystallographic studies of 19 high resolution single 
crystal diffraction studies. 
The particular targets of the work are the selection of 
the most appropriate salt forms, investigations into 
the tautomerism and polymorphism (or pseudo-
polymorphism) and an understanding of the interactions 
most likely between these heterocyclic drugs and their 
specific receptor sites. 
Section 1 describes the effect of protonation on the 
absor~tion of drugs, the rationale for using various 
salt forms and the resultant effect this has on a 
number of physicochemical properties of the parent 
compound. 
Section 2 is a description of the experimental 
techniques used in the physicochemical investigations 
and in crystal structure determination. 
In Sections 3 and 7, the preparation and character-
isation of the salts and modifications of the two 
heterocyclic drugs, GU and IM is described. 
In Sections 4 and 8, the physicochemical investigations 
into the hygroscopicity and solid-state stabilities of 
the salts of GU and IM is described. Van't Hoff 
solubility studies are used to determine the enthalpies 
of solution and where appropriate the relative thermo-
dynamic stabilities of the various phases produced. 
The structures of 19 of the salts or modifications of 
GU and IM, together with their packing and hydrogen 
bonding interactions is described in Sections 5 and 9. 
Sections 6 and 10 describe the ionisation properties of 
these molecules. Both the guanidine and imidazole 
moieties of GU and IM, respectively, .are tautomeric, 
the particular form(s) found in these investigations 
and the effect of protonation is discussed. 
The conformations of these structures are discussed and 
the effect of protonation, especially on the puckering 
of the piperazine ring, is described. 
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1. Introduction 
All drugs have to cross cell membranes to be absorbed, 
distributed and eliminated from the body. The cell 
membrane is thought to be a bimolecular lipid layer 
associated with protein. The hydrophobic ends of the 
lipid molecules are orientated towards the centre of 
the bilayer and molecules crossing the membrane must 
first dissolve in the lipid. There are small pores 1n 
the membrane through which small water soluble 
molecules may diffuse through, eg Methanol. 
There is also believed to be carr1er mediated t~ansport 
across the bilayer, but this is only generally impor-
tant for drugs resembling some natural substances 1 • 
An indication of whether or not a drug will be 
transported across lipid membranes is given by its 
ability to partition effectively from an aqueous 
solution into a non-aqueous, organic solution. This is 
known as the partition coefficient and is usually 
determ~ned by measuring the partitioning behaviour of a 
drug between an aqueous buffered solution and an 
immiscible organic solvent, such as octanol or 
chloroform at a constant temperature. The partition 
coefficient (P) is defined as the ratio of the 
concentrations of the same molecular species between 
two immiscible liquid phases at equilibrium, normally 
defined as: P = [B] org 
[B] aq 
For compounds that are not charged, this in vitro condition 
also applies to partitioning within biological systems. 
Information on partitioning behaviour can be used to 
predict to what extent a drug might be metabolised, 
since it is lipid soluble drugs that are liable to 
undergo extensive metabolism1 • 
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This simplistic view of partitioning relates to drugs 
existing as a single molecular species in solution. 
Most drugs are organic molecules with one or more 
substituents on them, which confer acidic, basic or 
amphoteric properties. They exist in solution in 
equilibrium mixtures among forms of varying degrees of 
protonation. The terms acidic and basic are used for 
drugs whose uncharged forms have acidic or basic 
properties respectively: 
Acidic Drug HA + H20 ~ H3o+ + A-
Ka = ..f..!LO+] [A-] 
[HA] 
Basic Drug HB+ + H20 ~ H3o+ + B 
Ka = ..f..!LO+] [ B] 
[HB+] 
Molecules which possess an electrostatic charge are 
more polar and tend to be hydrophillic. Uncharged 
molecules tend to be hydrophobic (or lipophilic) . The 
degree of protonation of a drug is, therefore, very 
important as it dictates the amount of uncharged, lipid 
soluble drug available for dissolution in the lipid 
bilayer. 
The uncharged form is assumed to be sufficiently 
lipophilic to transverse the membrane; if it is not, 
theory predicts that there is no absorption 
irrespective of pH. 
The fraction of charged drug at the absorption site 1s 
controlled by both the pH and the pKa, where pKa = 
-log (Ka), of the drug, according to the Henderson-
Hasselbach equation2 • Thus, for bases 
pH = pKa + log (uncharged species concentration) 
charged species concentration 
The pKa(s) is characteristic of a drug and is the pH at 
which equimolar concentrations of the uncharged and 
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charged drug exist. For those drugs that can exist as 
more than one species, at physiological pH, the degree 
of protonation must be considered when extrapolating m 
vitro partitioning behaviour to in vivo distribution of drugs 
into and across biological membranes. For compounds 
that protonate, the following relationship can be made: 
For Bases [ BH+] aq Ka C> [ B] aq __ P_C>[B] org 
where Ka is the dissociation constant and P is the 
partition coefficient. The greater the degree of 
protonation, the lower the effective partition 
coefficient, commonly known as the distribution 
coefficient (D) given by: 
D = --.....J.(...;;;;B;....~)...J:)org_-­
( B ] aq + [ BH+ ] aq 
Therefore, D is pH dependent and can be calculated from 
the pKa and P and any pH value: 
log D = log P- log [1 + antilog (pKa- pH)] 
The pH range 1.0 to 8.0 encompasses the changes in pH 
seen in the gastrointestinal tract and at other 
absorption sites. This leads to several consequences. 
First, very weak acids, such as Phenytoin and many 
barbiturates, whose pKa values are in excess of 7.5, 
are essentially unaffected by pH and for these acids 
absorption is independent of pH. Secondly, for acids 
with pKa values in the range 2.5 to 7.5, the fraction 
of uncharged species changes dramatically with pH and 
for these compounds a change in the rate of absorption 
with pH is expected and has been observed. Thirdly, 
absorption of very strong acids (pKa less than 2.5) is 
slow, even under acidic conditions. 
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A similar analysis indicates that only in very weak 
bases, eg Caffeine (pKa 0.5), is absorption independent 
of pH. At the low pH of gastric fluid, most bases 
exist almost exclusively in the cationic form and for 
these, gastric absorption should be low. Absorption of 
these bases should be more rapid from an alkaline 
environment. 
Despite its general appeal, this theory fails to 
explain certain observations. A variety of quaternary 
ammonium compounds (charged at all values of pH), 
elicit systemic effects when given orally. Animal 
studies also indicate penetration of the charged form 
of many acids and bases through the intestinal 
epithelium, though more slowly than the uncharged form. 
Whether these protonated species transverse the 
membrane through aqueous pores, through ion specific 
channels or by carrier mediated transport processes, is 
not fully understood. 
In accordance with predictions of the pH partition 
theory, weak acids are absorbed more rapidly from the 
stomach when the pH of the contents is closer to 1 than 
to 8 and the converse holds for weak bases. Absorption 
of acids, however, is always much faster from the more 
alkaline small intestine (pH 5-7) than from the 
stomach4 • 
These apparently conflicting observations can be 
reconciled if one considers comparative surface area. 
The total absorptive area of the small intestine has 
been calculated to be about 200 m2 , with a blood flow 
of 1 litre. min-I, corresponding estimates for the 
stomach are 1 m2 and 0. 15 litre. min-I. These increases 
in surface area and blood flow more than compensate for 
the decreased fraction of uncharged drug in the small 
intestine. Indeed, the absorption of all compounds 
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acidic, neutral or basic is faster from the small 
intestine. 
Absorption following administration of a solid dose 
form is a two step procedure: 
Solid 
Drug 
dissolutioo Drug in c:ntsy into the body 
-----~ ~ Solution 
Absorbed 
Drug 
There are two rate-limiting variables affecting 
absorption, (i) transmembrane rate-limited absorption 
and (ii) dissolution rate-limited absorption. 
In the former case, the drug is very soluble, eg 
Neomycin and the rate of dissolution >> rate of 
absorption. In the latter case, the drug is poorly 
soluble, absorption cannot proceed any faster than the 
dissolution rate. In this case, changes in dissolution 
profoundly affect the rate and sometimes the extent of 
drug absorption. 
As a general rule, salts of drugs exhibit higher 
dissolution rates than the corresponding conjugate acid 
or base, at equivalent pH, even if the aqueous 
solubility is comparable. The explanation of this is 
given by Nernst and Brunner5 in their diffusion layer 
model of dissolution: 
dw = 
dt 
where w is the amount of solute dissolved at time t, 
dwfdt is the rate of mass transfer per unit time, D is 
the diffusion coefficient of the solute, S is the 
surface area of the dissolving solute, c is the 
concentration of the drug in the bulk solution and C5 
is the concentration of the drug in the diffusion 
layer, h is the thickness of the diffusion layer. 
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The driving force of the above process is the 
difference between cs and c. If the drug is not 
readily absorbed, then c rapidly increases to the same 
level as cs and the rate of dissolution is reduced. 
Absorption is then said to be transmembrane rate-
limited. If the absorption rate is rapid then cs >> c 
and the process of absorption is said to be dissolution 
rate-limited. However, in either case an increase in 
cs increases the dissolution rate. Salts increase the 
value of cs by acting as their own buffers, altering 
the pH of the diffusion layer and maximising the 
solubility of the drug6 • The salt form of a drug 
generally has a higher aqueous solubility than the 
corresponding uncharged form due to strong ion-dipole 
interactions with water. 
Miller and Holland7 stated that different salts of the 
same drug rarely differ pharmacologically, the 
differences are usually based on the physical 
properties. The salt form is known to influence a 
number of physicochemical properties of the parent 
compound including dissolution rate, solubility, 
stability, melting point and hygroscopicity. These 
properties in turn affect the processing properties and 
bioavailability of the drug. Consequently, the 
pharmaceutical industry has systematically engaged in 
studies of the physicochemical properties of the 
uncharged drug and its salts, to determine the most 
suitable form for drug formulation. 
Juncher eta,, demonstrated that the plasma levels of 
Penicillin V, obtained on administration of three 
different salts and the free acid, were in the same 
order as their in vitro dissolution rates. Nelson et af 
showed that the in vitro dissolution rate of sodium 
Tolbutamide was 5000x more rapid than the free acid and 
when plasma levels were compared, these findings were 
correlated. 
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Occasionally, some studies show that salt formation can 
actually decrease the dissolution rate of the drug and 
its subsequent absorption. This was found for 
aluminium acetylsalicylate10 , sodium Warfarin 11 and 
Benzphetamine pamoate12 • This reduction in dissolution 
rate was apparently the result of precipitation of an 
insoluble film on the surface of the tablets, reducing 
the effective surface area and retarding deaggregation 
of the particles. 
Solubility is also a factor affecting the stability and 
the formulation of the drug. The solubility of the 
compound is dependent upon the physical and chemical 
properties of the solute. For instance, within a 
series of compounds, a lowered melting point would 
indicate a decrease in lattice energy and would 
possibly be reflected in an increase in solubility. 
Investigations into the formation of salts of 
Triamteren indicated that the organic acid salts were 
more soluble than the corresponding mineral acid salts. 
In a similar study, the aqueous solubility of a series 
of 35 salts of the antibacterial Chlorohexidine were 
investigated14 • The inorganic salts were poorly 
soluble. Increasing the hydroxylation (particularly 
with the sugar acids) of the organic counter ion 
markedly increasing aqueous solubility. 
Several reports showed that the structure of the anion 
influences the aqueous solubility of the resultant 
salts. Investigations into the properties of the salts 
of the weak bases Erythromycin15 and Lincomycin 16 
demonstrated that the aqueous solubility was dependent 
on the size of alkyl substituents of the anion. 
For certain products, such as sustained release dose 
forms, for suspensions and for taste masking; a 
reduction in the aqueous solubility is desired. This 
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may be attained by use of an appropriate salt form. 
Many problems concerned with the formulation and 
subsequent stability of topical and oral formulations, 
containing Bacitracin were overcome by the use of the 
zinc salt17 • A substantial advantage over the parent 
compound is its relative insolubility and consequent 
lack of taste. A similar approach was used for 
Propoxyphene18 ; the napsylate is practically water 
insoluble as compared to the highly water soluble, 
bitter tasting chloride and can thus be formulated into 
flavoured, aqueous suspensions. The taste of these 
suspensions can be markedly improved by the addition of 
sodium or calcium napsylate, as a common ion to depress 
solubility further. 
Another approach is to select a salt form that will 
pharmacologically antagonise an unfavourable property 
(such as taste) of the parent compound. Salts of N-
cyclohexylsulphonic acid (cyclamates), have a 
characteristic sweet taste which can be used to 
antagonise bitter tasting drugs. The cyclamates of 
DextrG>methorphan and Chlorpheniramine19•20 exhibit 
greatly improved bitterness thresholds and enhanced 
solubility properties, compared to commonly occurring 
salts. 
Systematic investigations of the thermal and photolytic 
stabilities of the investigative drug candidate and its 
salts provide essential input towards the choice of the 
most suitable derivative and dosage form. 
Different salt forms impart differing stability 
characteristics to the parent drug. An orally 
administered drug must be stable in acidic 
environments, as generally it must pass intact through 
the stomach if it is to be absorbed. Erythromycin 
estolate21 (lauryl sulphate) has lower solubility and is 
thus more stable than the free base form. Therefore, 
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it retains its potency even when exposed to acidic 
environments for extended periods of time, it can thus 
be eo-administered with food without any decrease in 
drug plasma levels. 
Amorphous calcium Novobiocin is ta~teless, yet stable 
and biologically active in an aqueous suspension. The 
sodium salt is chemically unstable, while the free acid 
is not absorbed. The amorphous calcium salt does, 
however, slowly convert into the non-absorbed, 
crystalline phase as it is a metastable form22 • 
Penicillin G is a therapeutically important drug which 
is very unstable, with a half-life of <2 weeks at 4°Cn. 
Suspensions of the sparingly soluble amine salts, eg 
procaine, benzathine and hydrabamine salts, improve the 
stability sufficiently to allow the product(s) to be 
marketed. 
Differences in hygroscopicity of salts will also 
influence the stability of drugs on storage. This is 
particularly relevant for drugs, such as Penicillin, 
which readily undergo hydrolysis. Several studies on 
the effects of moisture on salts of Penicillin have 
demonstrated this fact~~. Potassium Penicillin G is 
much less hygroscopic than the sodium salt and has 
become the preferred marketed form in the dry state. 
For salts of weak bases, the moisture associated with 
the drug can be very acidic and can potentially cause 
severe hydrolytic degradation. The stability of the 
thiamine salts are related to their hygroscopicity, 
solubility and resultant pH~n~. 
Walking etaP9 prepared a series of aryl sulphonic acid 
salts of Xilobam to protect the easily hydrolysed base. 
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Polar salts have a propensity to be hygroscopic, 
sometimes in the extreme, through favourable hydrogen 
bonding interactions with available atmospheric 
moisture. Thus, the very factors that promote high 
solubility can result in excessive problems of 
hygroscopicity and preclude their isolation and use in 
certain dosage forms. An excellent example is the 
gluconate salt of Chlorohexidine14 , which although 
demonstrated the highest attainable solubility, was 
unuseable due to its low melting point and high 
hygroscopicity. 
A clear compromise of properties for the salt form is 
thus required, but the difficulty remains of assessing 
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methoxyphenyl]-1-piperazine carboxamidine (GU) 
GU was synthesised as the hydrate by J C Pascal 1 of Syntex 
in 1986, as a potential antiarrhythmic agent with class I 
and class III activities as proposed by Vaughan Williams 2 • 
Its Syntex code is RS-87337-000 and it lS referred to 
generically here as GU. 
A drawing of the molecular structure, 
numbering system used during the 
together with the 
crystallographic 
investigations, is given as Figure 2.1.1. In each ring, the 
last digit of the name corresponds to the chemical ring 
position. The hydrate is a white crystalline powder, 
melting at 132.0-134.0°C, with decomposition. Its acid/base 
properties are further discussed in Section 6.1. 
2.1.2 1-[[2-(4-Methylphenyl)-4-Methyl)-3H-imidazol-4-
yl-methyl)-5-diphenylmethyl piperazine (IM) 
Although Elguero et al 3 suggest that the numbering of the 
imidazole r1ng system should begin with the pyrrole 
nitrogen, IUPAC still accepts the alternative system of 
nominating the pyrrole nitrogen by use of lH or 3H. The 
latter system was adopted for the present investigations. 
The alternative numbering system, v~z 1-([2-(4-
methylphenyl)-5-methyl]-lH-imidazol-4-yl-methyl]-4-diphenyl 
methyl piperazine was adopted for the patent application4 • 
IM was synthesised by J C Pascal of Syntex in 1989 as the 
anhydrous free base (-000). It is a novel compound with 
sodium/calcium ion channel modulating properties, with the 
potential to prevent neuronal cell death 1n ischaemic 
cerebral tissue. It is being developed for the treatment of 
acute focal cerebral ischaemia (stroke) . 
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It is referred to generically here as IM. 
A drawing of the molecular structure, together with the 
numbering used during the crystallographic investigations, 
is given as Figure 2.1.1. 
The free base can exist as one of two polymorphs dependent 
upon the nature of the crystallisation solvent used in the 
final step of the synthesis. Crystallisation from water, 
produces the metastable lower melting (186°-187°C), Phase 
B polymorph. Crystallisation from dimethylformamide, 
produces the stable, higher melting (236°-238°C), Phase A 
polymorph. 
Heating of the Phase B polymorph past its melting point, 
results in a solid-state phase transition and the 
production of the more stable Phase A (see Figure 2.1.2). 
The monomesylate salt is a white crystalline powder, 
melting at 203.6-204.0°C. 
Similarly, the trichloride salt 1s a white crystalline 
powder, melting at 210-213°C, with decomposition. 
Its acid/base properties are further discussed 1n Section 
10.1. 
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Figure 2.1.1 Structure and Numbering System used in Crystallographic Investigations of 
a) GU b) IM 
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2.1.3 Other Materials 
A range of organic and inorganic acids were used 1n the 
preparation of a variety of salts of GU and IM. Physico-
chemical properties5 of these acids are summarised in Table 
2. 1. 3. 
A wide range of solvents were used. All were of AR or HPLC 
grade, as appropriate. HPLC grade reagents were supplied by 
Rathburn Chemicals, Walkerburn, Scotland. 
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HCI (Ca 31 %w/w) 
CH3S03H (99%w/w) 
HN03 (Ca 70%w/w) 
H3P04 (Ca 85%w/w) 





F = Fisons 
A= Aldrich 
B = BDH 
F 
A 
192.13 153 F 
90.08 1IO A 
116.07 286-7(d) B 
116.07 130.5 B 
104.06 130-5(d) B 
90.04 104-6 A 












2.2 Characterisation of Salts 
Each of the individualy prepared salts or solvated forms 
of the basic drug entity, were characterised using a 
variety of instrumental techniques. 
2.2.1 Elemental Analysis 
Samples were analysed by Butterworth Laboratories, 54-56 
Waldegrave Road, Teddington, Middlesex, England. 
Duplicate carbon, hydrogen and nitrogen values (%w/w) 
were determined simultaneously, by standard procedures, 
using Perkin Elmer Elemental Analyzers, Model A or C. 
Found values were compared with the calculated values and 
are tabulated, in Sections 3.2 and 7.2 respectively, for 
the various compounds of GU and IM. 
2.2.2 Karl Fischer Water Content 
Samples (ea 200mg) were dissolved in modified Karl 
Fischer reagent (Fisons, Loughborough, England) and 
titrated, in duplicate, using a pre-calibrated Metrohm 
Karl Fischer Automat E-547 Unit. Found values of percent 
water are compared with calculated values and are 
tabulated, in Sections 3.2 and 7.2 respectively, for the 
various compounds of GU and IM. 
2.2.3 Nuclear Magnetic Resonance Spectroscopy (NMR) 
Salts of GU were prepared in d 6-dimethyl sulphoxide and 
those of IM in d 4 methanol. The resulting solutions were 
run on a Bruker WP-200SY, 200MHz NMR spectrometer. 
2.2.4 Basic Equivalence Factor 
The amount of base (Basic Equivalence Factor) in each of 
the samples was determined, using the appropriate HPLC 
-22-
method. 
Found values of Base Equivalence Factor are compared with 
calculated values, and are tabulated in Sections 3.2 and 
7.2 respectively, for the various compounds of GU and IM. 
2.2.5 Differential Scanning Calorimetry (DSC) 
DSC heating curves were obtained on a Perkin Elmer DSC-4, 
using samples sizes of ea 2-3mg, heating rates of 
20° min- 1 and a sensitivity range of 5 meal. s-1 • 
(=ea 21mJ.s- 1 ) 
2.2.6 Melting Point (mp) 
Capillary melting points were performed using a 
Gallenkamp Melting Point Apparatus, the heating rate 
being adjusted to 1. 0° min-1 when the sample reached 10-
200 below the anticipated melting point. 
2.2.7 Infrared Soectroscopy (IR) 
Samples were prepared as potassium bromide discs and run 
on a Philips PU 9516 Infrared Spectrophotometer, with air 
as the reference and over the range 4000 to 650 cm- 1 • 
2.3 Chromatography 
The general chromatographic procedure requires that a 
solute undergo distribution between two phases, one of 
them fixed (stationa~ phase), the other moving (mobile 
phase) . It is the mobile phase that transfers the solute 
through the medium until it emerges, separated from other 
solutes. Generally, the solute is transported through the 
separation medium by means of a flowing stream, either 
liquid (HPLC) or gaseous (GLC), known as the eluant. The 
statonary phase may act through adsorption as is the case 
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with activated alumina, silica gel and ion-exchange 
resins, or it may act by dissolving the solute thus 
partitioning the latter between the stationary and mobile 
phases. In the latter process, a liquid coating held on 
an inert support serves as the stationary phase. 
Partitioning is the predominant mechanism of separation 
in gas-liquid chromatography, paper chromatography and in 
forms of column chromatography designated as liquid-
liquid chromatography. In practice, separations 
frequently result from a combination of partition and 
adsorption effects. 
2.3.1 Liquid Chromatography (HPLC) 
This method is sometimes referred to as HPLC (high 
performance liquid chromatography) . The liquid 
chromatograph consists of a pumping system, analyte 
(solute) injection device, chromatographic column, 
detector and electronic integration system. The high 
pressure pumping module delivers the mobile phase from a 
degassed solvent reservoir to the column, via an 
automated injection system, utilising a Rheodyne loop. 
The columns used for analytical separations have small 
internal diameters (ea 2-Smm) and can be obtained in a 
variety of lengths (ea 100-300mm) and are made from 
stainless steel. Unless otherwise specified in the 
individual method, the column is maintained at ambient 
temperatures. Column technology is based on the use of 
small particle size packings (typically 3-10~), that 
allow fast equilibrium between mobile and stationary 
phases. The use of small particle size stationary phases, 
thus requires the use of a high pressure pumping system, 
capable of exerting pressures in the region of 200 bar 
(2900 psi), to achieve the pre-requisite flow rates of 
several ml per minute. The stationary phase can be either 
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a liquid or polymer, either coated or chemically bonded 
to the surface of the support in a thin film that reduces 
mass transfer resistance, so that a fast equilibrium can 
be attained. In partition liquid chromatography, mobile 
and stationary phases of different polarity are used. If 
the mobile phase is polar and the stationary phase lS 
non-polar, as lS the case with chemically bonded, 
octadecyl silyl stationary phases (ODS) , this is referred 
to as reverse-phase chromatrography. 
Problems of peak as~~metry, encountered with polar drugs, 
such as alcohols and amines, may be overcome by the use 
of mobile phase additives for in-situ selectivity 
modification. In this process a mobile phase additive is 
selectively attracted to the stationary phase and forms a 
parallel layer. The solutes then partition between the 
mobile phase and the solvated stationary phase surface. 
Many additives can be used to affect selectivity and 
improve the chromatography, they are added as minor 
components of the mobile phase. For example alkylamines, 
such as triethylamine, are added to reduce peak tailing 
and are often referred to as amine modifiers 6 • 7 • 
Since analyte (solute) loadings on the column are low, 
sensitive detectors are required. The most commonly used 
detectors are the variable wavelength ultra-violet 
spectrometer, the differential refractometer and the 
fluorometer; less commonly used are various electro-
chemical devices and the mass spectrometer. In general, 
the signal from the detector is amplified, before being 
fed to an electronic integration system for the automatic 
measurement of chromatogram peak areas. Both peak height 
and peak area (peak response, Ru) can be related to the 
sample concentration. The detector response may be 
calibrated by relating peak responses to a known 
concentration of reference standard (R
5
), using either an 
external or internal standardisation procedure. Only the 
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former approach was used in this work. 
one drawback of the method of external calibration is 
that accuracy and precision are dependent upon the 
reproducibility of analyte injection. In all cases the 
residual standard deviation was always <1%, for the 
reported data. 
2.3.2 Liquid chromatography methodology for Salts and 
Modifications of GU and IM 
The apparatus used included a six figure, pre-calibrated 
electronic Cahn micro-balance (Model 4700) and a Liquid 
Chromatograph comprising of a Kontron 420 high pressure 
pump module, a Kontron MSI 660 auto-injector, a LDC 
spectromonitor 3100, variable wavelength UV detector and 
an HP 3392A electronic integrator. 
The reference standards were samples of GU or IM, or 
salts of the above, with a determined purity of 98-102%. 
The mobile phase for GU determination was a solution 
containing 0.025 mol of triethylamine dihydrogen 
orthophosphate per litre of 38% v/v acetonitrile/water. 
For IM determinations, the solution contained 0.04 mol of 
ammonium acetate and 0.036 mol of triethylamine acetate 
per litre of 60% v/v acetonitrile/water. The diluent for 
GU samples was the same as the mobile phase, whilst that 
for IM omitted the triethylamine acetate. Solutions were 
equilibrated at room temperature and vacuum degassed. 
The chromatographic operating conditions are summarised 
in Table 2.3.3. Duplicate injections of the appropriate 
reference standard were performed, until satisfactory 
precision was obtained (typically <1% residual standard 
deviation). Duplicate injections of the sample solutions, 
bracketted at regular intervals, with reference standard 
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injections, were performed. The value of GU or IM in the 
samples solution was calculated using the mean peak 
response of the reference standard, before and after the 
sample solution of interest. Assuming the following 
convention: 
Rs: Peak response for GU or IM in reference standard 
Ru: Peak response for GU or IM in sample 
Ws: weight (mg) of GU or IM in reference standard 
W : weight (mg) of GU or IM in sample 
Then, Ru x Ws = mg recovered from sample (Wu) 
Rs 
% label (purity) = Wu x 100 
w 
The specificity and statistical validation of these 
methods have been demonstrated8 • 9 • 
Table 2.3.3 Chromatographic Procedures 
Parameter 
Reference standard 
and sample solution 
Column Length 
Column Internal Diameter 




























2.4 Crystal Structure Determination 
2.4.1 Introduction 
A crystalline solid is one whose atoms are disposed in a 
regular three dimensional array. The atoms in this array 
are not static; each atom possesses thermal energy and 
vibrates about its mean position. 
For a perfect single crystal, the regular arrangement of 
atoms in the crystal can be completely described by 
defining the unit cell, together with its symmetry 
operations and the positions in the cell of one 
'asymmetric unit' of atoms. The asymmetric unit is often 
a single molecule or the group of molecules and ions 
making up the formula of the compound being studied. 
Each unit cell has three reference axes, with directions 
being dependent on the symmetry, termed x,y and z. These 
reference axes are by convention right handed, the unit 
cell edges parallel to x,y and z are respectively a,b and 
c and the interaxial angles a, p and y. 
When elements in the unit cell have identical environ-
ments except for the orientation of that environ-
ment, they are described as symmetry related. The 
symmetry operators of a finite body must pass through a 
point (the centre of the body}, such a combination of 
symmetry operators are known as a point group. 
Crystallographers use the Hermann-Mauguin system to 
describe point group symmetries. In this system an n-fold 
rotation axis is represented simply by the number n and a 
n-fold rotary inversion axis by n, the only exception 
being that 2 is written as m (mirror plane} . A two-fold 
rotation axis indicates that rotation through 180° i.e. 
360°/2, restores the original environment. 
There are ten crystallographic point group symmetry 
operators which are defined as 1,2,3,4,6,1,m,3,4,6. 
The symbol for a point group is obtained by combining the 
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symbols for the symmetry operators in a prescribed 
sequence. The combination of a rotation ax1s and a 
perpendicular mirror plane is indicated by a slanted line 
after the number (n) e.g., 2/m. 
It is conventional to group the crystallographic point 
groups into crystal systems, all having some elements of 
symmetry in common. The three crystal systems accounting 
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There are additional Bravais lattices that are obtained 
by adding face-centring (designated F if all faces are 
centred and A,B or C, if only one pair of faces centred) 
and body centring (I), of certain of the seven space 
lattices. The distinguishable lattices for the most 
common crystal systems are listed below: 
Triclinic P 
Monoclinic P C 
Orthorhombic PC F I 
C in monoclinic can alternatively be A or I; C in orthorhombic can be A or B and P designates 
primitive. 
Addition of translational symmetry elements, screw axes 
and glide planes, to these Bravais lattices gives the 230 
crystallographic space groups. Some of these additional 
symmetry elements, also cause systematic absences in the 
diffraction pattern. As an example, for a two-fold screw 
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axis parallel to a, h in the h 0 0 reflections can only 
be even and for a glide plane perpendicular to a with b/2 
translations (ab glide), kin the 0 k 1 reflections can 
only be even (the Miller indices, h,k and 1 are defined 
in the next section) . 
2.4.2 X-Rays and X-Ray Diffraction 
Studies of the internal structure of crystals depend upon 
the use of a penetrating radiation that will enter the 
crystal and will display interference effects, as a 
result of scattering from the ordered arrays of the 
crystal lattice. X-rays have the necessary penetrating 
power and show interference effects since they have 
wavelengths in the angstrom range (10-8cm). Diffraction 
effects occur when the crystal interferes with the X-
rays, so that some of the scattered radiation is shifted 
out of phase with respect to other waves. If the crystal 
lattice did not have a spacing which was the same order 
of magnitude as the wavelengths of the X-rays, simple 
reflection and scattering of the X-rays would occur. The 
reflection is not in fact simple and is greatly disturbed 
by interference effects and results in both destructive 
(X-rays out of phase with one another) and constructive 
interference. The latter occurs whenever the phase of the 
beams scattered from successive layers 1s shifted by an 
integral multiple of wavelengths. This is the basis for 
Bragg's Diffraction Law where 
n A = 2d(hkl) Sine where n = 1,2,3 ...... . 
and shows that for a given value of the X-ray wavelength 
(A), measurement of e (angle between incident X-ray beam 
and lattice), gives information on the spacing between 
the lattice planes (d), where h, k and 1 are Miller 
Indices and indicate order with respect to x, y and z. 
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Rearrangement of the Bragg expression to 
A = 2d(hkl) Sin 8 
n 
shows that the high order reflections from planes with a 
spacing d, can be treated as if they were due to first 
order reflections from planes with spacing d/n. Thus each 
reflection can be labelled using the Miller Indices (hkl) 
and a spacing d(hkl) can be associated with the 
reflection. Similar indexing of the reflections in the 
other layer lines is performed and all of the data is 
evaluated to deduce the internal structure of the 
crystal. The phenomenon of X-ray diffraction by crystals 
may be considered in terms of theory, analogous to 
diffraction by gratings and extended to 3-dimensions (von 
Laue) or in terms of reflections from planes through 
points in the crystal lattice (Bragg) . These two treat-
ments are equivalent. 
The maximum number of reflections that can be measured 
for a crystal is _ 32nV/3 A3n, where n=l for a primitive 
cell, 2 for body or single face centring and 4 for full 
face centring. The integrated diffraction intensity data 
may require correction for 1 geometric factors, 
absorption and other effects. Atoms that have an 
absorption edge close to the incident radiation 
frequency, introduce an additional phase change, which is 
referred to as Anomalous Scattering. For such atoms the 
simple scattering factor (F) which is calculated on the 
basis that the electrons in the atom can be treated as 
free electrons, has to be modified to take into account 
the interaction of the incident X-rays with the bound 
electrons, it is this interaction that produces the 
absorption edge. 
The crystal may also introduce partial polarisation into 
the unpolarised X-ray beam, as the crystal does not 
reflect waves vibrating in all directions with equal 
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efficiency. This causes a reduction in the intensity of 
the diffracted beam by a factor of [(l+cos228)/2]. This 
results in the greatest reductions in intensities for 
28=90° and the least reductions for 28=0° or 180°. The 
intensities for low or high angle data are enhanced 
relative to those at intermediate levels. 
Checks are also required for drift and bad reflections. 
In addition the amount of time the reciprocal lattice 
points spend in the reflecting position, the Lorentz 
Effect, enhances the intensities of high angle 
relections. 
2.4.3 Determination of the Lattice Type and Unit 
Cell Dimensions 
The analysis of a crystal structure consists of three 
general stages, the first of which is the experimental 
determination of the lattice type, and includes the 
determination of the unit cell dimensions. 
Two types of experimental data can be derived from 
measurements of the diffraction pattern~ 
Firstly the angle or direction of scattering (28) which 
can be used to measure size and shape of the unit cell. 
Plus the intensities of the diffracted beam, which give 
data on the positions of the atoms within the unit cell 
and eventually related information (such as vibration 
parameters, fractional occupancies and electron 
distribution) . 
2.4.4 Selection and Orientation of a Crystal 
The crystal must of necessity be single, to maintain 
structural uniformity, not cracked or twinned and of an 
appropriate size (ideally 0.5 to O.OSmm). 
The crystal is examined in plane polarised light; for all 
non-cubic crystals, there will only be certain 
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orientations of the crystal which do not alter the plane 
of polarisation. Thus, if a crystal is examined between 
crossed polars, sharp 'extinction' directions are 
observed, while multiple crystals display extinction from 
different parts of the crystal, in different positions. 
The crystal is mounted about a suitable axis (usually 
parallel to a prominent edge) and an oscillation 
photograph taken. This ensure correct alignment and 
centring of the crystal about sensible axes and gives an 
indication of overall crystal quality. Poorly diffracting 
crystals may be rejected at this stage. Further 
photographs can be used to determine approximate unit 
cell dimensions, general symmetry elements and systematic 
absences. Certain space groups can be uniquely identified 
at this stage; the use of photographic methods provides 
good ancillary data and is a useful screening tool for 
the rejection of sub-standard crystals. 
2.4.5 Cell Dimensions and Density 
The crystal is then transferred to an automated 2- or 4-
circle diffractometer for accurate unit cell dimensions. 
These are determined from accurately measured 28 values, 
as the 28 values are a function only of cell dimensions 
and wavelength of radiation used. 
Given the unit cell volume (V) and the molecular weight 
(M), the number of molecules (Z) in the unit cell can be 
established from a knowledge of the density of the 
crystals, obtained by classical flotation methods. z must 
have an integer value. The mass (in g) of the unit cell 
contents is MZ/N, where M is in daltons and N is 
Avogadro's Number (6.02 x 10 23 mol- 1 ). If the unit cell 
volume is given in A3 , then the density (p) (g cm- 3 ) is 
p = MZ x 0.1659 
V 
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conversely, the theoretical density can be determined by 
substituting different integer values of Z into the above 
equation, until physically sensible density values are 
achieved e.g. p = 1.2-1.5 g.cm- 3 • These can be then 
compared with the measured or expected density values and 
discrepancies investigated. For instance, a low 
theoretical density could be indicative of an under-
estimation of the theoretical molecular mass caused by 
the presence of unsuspected solvation or hydration. 
2.4.6 The Deduction of a Trial Structure 
The second stage in crystal structure analysis is the 
deduction of a suggested atomic arrangement. The 
intensities of the diffraction maxima corresponding to 
this arrangement can then be calculated and compared with 
the observed intensities. For the structure, the identity 
of the atoms present are known, but the positions are 
not; for the diffraction pattern, the structure 
amplitudes are known, but the phases and signs are not. 
The intensity of the diffracted beam is dependent on a 
number of factors, the amplitude and phase of the 
scattered wave and this in turn is determined by the 
arrangement of the atoms, relative to the plane in 
question. This may be expressed mathmatically for 
centrosymrnetric crystals, by the Structure Factor (Fhkl) 
Fhkl = LN fr cos 2n (hxr+kyr+lzr) Tr 
r=l 
where fr is the scattering factor for the th atom. 
27t(hxr+kyr+Qzr) is the relative phase for the th atom. 
xr, yr and zr are the atomic fractional coordinates for the th atom. 
Tr is the temperature factor term, which is equivalent to exp ( -2Br Sin20/ A?) with Br the isotropic 
temperature factor. 
and N is number of atoms in half the unit cell. 
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conversely, given a knowledge of the amplitude and phases 
of the scattered waves in reciprocal space, the electron 
density (p) at any point (x,y,z) in the unit cell of a 
centrosymmetric crystal may be determined 
p (x,y,z) = L L L Fhkl cos 2n (hx+ky+lz) 
h k I 
The expansion of the electron density distribution, 
p(x,y,z) as a sum of the component density waves is 
fundamental for the X-ray analysis of complex crystals. 
since the intensities can be measured, the relative 
magnitude of the Fourier coefficients, the structure 
amplitudes IF(h,k,l) I can be obtained. However, to 
reconstruct the electron density distribution by adding 
the component waves, the sign of each F must be known. 
For non-centrosymmetric crystals, it is required that the 
amplitudes and their relative phases a(hkl) are known. 
The latter'""{ not experimentally attainable. In the 
absence of phase or sign information, it is not known 
whether each component density wave starts at the origin 
with a maximum, minimum or some intermediate value. This 
is the fundamental problem of X-ray analysis - the phase 
problem. 
The phase problem is overcome by the deduction of a trial 
structure, by one of several methods. The intensities of 
the diffracted maxima corresponding to this postulated 
arrangement, can then be calculated (Fcalc) and compared 
with the observed values (Fobs). The two basic approaches 
are Patterson and Direct Methods. Patterson methods are 
mainly applicable to structures containing heavy atoms or 
fragments of known structures. 
Direct Methods are a series of analytical techniques 
which may be utilised to derive an approximate set of 
phases from which can be calculated a trial electron 
density map. Direct Methods utilises the fac~ that 
structural information is contained in the intensities of 
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the reflections, that electron density in a real 
structure cannot be negative and the origin can be 
fixed. 
In practice Direct Methods are carried out on Normalised 
structure Factors (E): th\~takes into account the fall 
off in the individual scattering factors (f) with 
increased scattering angle (28) . E represents the ratio 
ofF to {F}, where {F} is the r.m.s value of IFI in the 
given range, sinG/ A. Once a table of E values has been 
produced, only about the strongest 10% are considered. 
Then a triple product sign relationship is applied, viz 
s(h,k,l).s(h',k',l').s(h-h', k-k', 1-1') ~ +1 
where s is the sign and h,k,l, are all strong reflections. 
Here a group of three reflections, all having related 
indices are selected and since each of the three 
reflections in a triple phase product has a high E value, 
the product of their signs are probably positive. 
An electron density map (E-map) is then generated using 
Fourier methods, based on the highest figure of merit. 
These are numerical quantities used for indicating 
comparative effectiveness, in this context it is used to 
indicate an estimate of the average precision in the 
selection of the phase angles. 
The E-map is then interpreted, attempting to elucidate 
trial structures that make chemical sense. Sometimes, 
only part of the structure is revealed in an interpret-
able fashion and the rest is located by iterative 
procedures. 
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2.4.7 Refinement of a Trial Structure 
After approximate positions have been determined for 
most, if not all of the atoms; refinement of the 
structure can proceed. In this procedure the atomic 
parameters are varied in a systematic fashion, so as to 
give the best possible agreement of the observed 
structures factor amplitudes with those calculated for 
the proposed structure. There are two refinement 
techniques, one involving Fourier syntheses and the other 
a Least Squares process. The former is normally only used 
to complete a partial structure. 
The Least Squares procedure utilises the fact that there 
are many more observations than parameters to be 
determined, in any crystal structure analysis. Minimising 
the sum of the squares of the discrepancies between the 
!Fobs!, or 1Fobsl 2, and those calculated for the trial 
structure, IFcalcl,produces the best parameters for the 
model structure. 
The discrepancy index (R) 1s a measure of the correctness 
of a given structure determination. The smaller the value 
of R, the better the fit between calculated and observed 
data. 
R = Ln W (Yi obs - Yi calc) 2 
i=l 
where W is the weighting factor and is in principle 
inversely proportioned to cr2 for each measurement. 
The parameters that are normally refined are: 
1) Overall scale factor, which relates IFobsl to 
IFCalcl 
2) Atom scattering factor (f), which is related to the 
atomic number and is normally assumed to be constant. 
3) Positional parameters for each atom, with three 
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parameters per atom, relating to the x,y and z 
coordinates. 
4) Site Occupancy, which for most structures equals one, 
but may be less if disorder is encountered. 
5) Temperature Factors, which show how atoms vibrate and 
may be treated as isotropic or anisotropic. 
In the former, atoms are treated as spheres and a single 
temperature factor for each atom is required. In the 
latter, where atoms are treated as e]ipsoids, six 
parameters are required to determine electron density. 
For a typical structure, the total number of parameters 
(M} ·to be considered is: 
M = 1 + 3n + ni + 6na 
(Scale+ Number of+ Isotropic +Anisotropic) 
A~ms A~ms A~ms 
Relevant chemical knowledge, relating to the geometry of 
rigid and semi-rigid groups may be employed. For example 
the geometry of methyl, methylene, methine and aromatic 
groups are well established and the hydrogens can be 
constrained to idealised positions. 
To complete the structure the hydrogens are located and 
placed into the trial structure. 
2.4.8 The Correctness of a·structure 
The following criteria should all be applied 
1) The agreement of individual structure factor 
amplitudes with those calculated for the refined model 
should be consistent with the estimated precision of the 
experimental measurements. The R factor must be low. 
2) A difference map, phased with final parameters for the 
refined structure, should reveal no fluctuations in 
electron density, greater than those expected based on 
the estimated precision. 
3) The refinement must have converged. 
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4) The model must make chemical sense, with sensible 
values for bond lengths, bond angles, torsion angles, 
thermal motion and molecular geometry interactions. 
2.4.9 Standard Procedures 
The following Standard Procedures were used in all 
structures, unless otherwise stated in the appropriate 
Section. 
No absorption corrections were applied, scattering 
factors and anomalous corrections from International 
Tables for X-Ray Crystallography10 • Structure solution by 
Direct Methods (SHELX84 or SHELX86 1 L 12 ), most non-hydrogen 
atoms being located in the first E-map, and the rest in 
the first difference Fourier synthesis. 
Non-hydrogen atoms refined anisotropically, hydrogen 
atoms bonded to carbon included in calculated positions 
and allowed to ride (C-H 1.08A, geometry constrained to 
trigonal or tetrahedral as appropriate. Methyl groups 
were initially placed, where possible, in a fully 
staggered conformation and sometimes allowed to rotate as 
a fixed group) . Positions of other hydrogen atoms were 
refined. All hydrogens were assigned a fixed isotropic 
thermal parameter (U) of 0.05A2 • Full matrix least-
squares refinement (SHELX76 13 ), was employed. 
Derived bonds, angles and torsion angles obtained using 
CALC14 • Perspective drawings of single molecules of GU, 
projected into the plane of the guanidine group [C(l), 
N(2), N(3) and N(ll)]; together with anions and related 
solvent molecules (if appropriate), were determined using 
PLUT015 • 
For IM, the drawings were projected into the plane of the 
piperazine ring, [N(7), C(9) and C(ll)]. 
Molecular packing diagrams were viewed down an 
appropriate crystallographic axis and the unit cell was 
superimposed onto the diagrams, for the sake of clarity. 
Fractional Coordinates are given in Appendix A for GU 
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structures and Appendix B for IM structures. 
2.5 Water Adsorption/Desorption Isotherms 
The water adsorption (hygroscopicity) and desorption 
(efflorescence) isotherms of the various salts, were 
determined gravimetrically. 
Samples (ea 500mg) were gently ground and pre-dried in a 
vacuum desiccator, placed in glass weighing crucible(s) 
of dimensions, d=40mm h=35mm and accurately weighed. 
The samples were weighed using a Sartorius 2004 MP, 
electronic, 5 figure, pre-calibrated balance. Based on a 
500mg sample size, each weighing should be accurate to 
+/- 0.002% w/w. 
The samples were exposed to different relative humidity 
(RH) environments in equilibrated hygrostats, using 
saturated salt solutions to maintain the appropriate 
humidity16 • The various relative humidity environments 
are details below: 
25°C/87% RH (saturated sodium carbonate 10H20) 
25ocns% RH (saturated sodium chloride) 
25°C/52% RH (saturated magnesium nitrate) 
25°C/20% RH (saturated potassium acetate) 
The crucibles were weighed on a periodic basis, over a 
six day-period. The % w/w weight gain (loss) at each time 
point was then calculated. 
The efflorescence properties of the various salts were 
studied by transferring crucibles from one environment to 
the next lowest environment ie 87% RH to 75% RH. The 
samples were again weighed on a periodic basis, over a 
seven day period. The % w/w weight gain (loss) at each 
time point was then determined. 
Water adsorption/desorption isotherms were then 
constructed for all samples. 
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2.6 Stability Studies 
Raw material stability studies were carried out on 
samples of all of the isolated modifications and salts of 
GU and IM. The samples were gently ground and pre-dried 
in a vacuum desiccator. The samples (ea SOOmg) were 
placed in small glass containers, which were stoppered 
for thermal studies and open for the humidity studies. 
Samples used for light investigations were placed in 
sealable, clear plastic envelopes. Samples were stored 






6 25°C/87% RH (RH) 
7 South Facing Window Light (Lt) 
8 Ultra-Violet Light (366nm, Hu) 
The samples were assayed in duplicate, by the appropriate 
HPLC methodology, on a regular basis. Since the relative 
stability of the samples were unknown, initially; 
analyses were carried out after 1,2,3,4,12 and 26 weeks. 
This sampling interval was later adjusted to, once every 
4 weeks, for 24 weeks. 
The mean, % label recovery of all samples, at the 
individual storage conditions and appropriate time points 
were then plotted as a function of time. 
2.7 Van't Hoff Solubility Studies 
Van't Hoff 17 demonstrated that the natural logarithm of 
the molar solubility (ln C5 ) varies as a function of the 
reciprocal of absolute temperature {T) according to the 
equation: 
d { 1 n CsL = -~Hs 
d (1/T} R 
-41-
....... Van't Hoff Isochore 
Where R is the Universal Gas Constant and LlH_ is the enthalpy of solution. 
This equation can be used to determine the enthalpy of 
solution (~Hs) from the slope of the Van't Hoff plot. 
Van't Hoff solubility studies were carried out on all 
salts and modifications of GU and IM. The samples were 
gently ground and pre-dried in a vacuum desiccator and 
placed in small, screw topped glass containers with 
rubber septa and a capacity of ea 4ml. The appropriate 
solvent was added slowly, at the appropriate temperature. 
The containers were sealed and mixed for several minutes, 
additional solute was added until a solid residue was 
always present. The containers were then placed in an 
orbital tube rotator at 25 rpm for 72 hours at the 
appropriate temperature, additional solute being added if 
total dissolution occurred. Solubilities were determined 
at 4, 24, 40 and 48°C. Water was the solvent of choice 
for all GU samples and ethanol for all IM samples. Water 
was used initially for the IM samples, but the free base 
modifications were too insoluble (~ lOOng.ml- 1 ) and the 
protonated samples were too soluble (> lOmg.ml- 1 ), for 
this to be a practical proposition. 
At the end of the study, aliquots of the supernatant were 
filtered through a Millipore Mille~-H 0.45~ filter unit 
into a pre-tared volumetric flask then diluted and 
assayed using the relevant HPLC methodology, versus a 
free base standard. The solubilities thus determined are 
expressed in terms of the free base and Van't Hoff plots 
were constructed for all samples. 
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SECTION 3 : PREPARATION AND 
CHARACTERISATION OF SALTS AND 
MODIFICATIONS OF GU 
-45-
3.1 Introduction 
In this section, the codes used for the salts and 
modifications of GU that were prepared and subsequently 
characterised, are as follows. 
The first two letters, GU, refer to the guanidine 
moiety, which is a principal salt forming group in the 
molecule. The next letter(s), indicate the protonation 
state of the compound; FB - Free Base, M = Monoproton-
ated, H = Hemiprotonated, s = Sesquiprotonated, 
D = Diprotonated and T = Triprotonated. 
This is followed, in the case of the protonated 
compounds, by the code designating the anion; 
FUM - Fumarate, CIT - Citrate, ACE - Acetate, 
HCL - Chloride, ASC - Ascorbate, MAL - Maleate, 
MALN - Malonate, MES = Mesylate, NIT - Nitrate, 
SULF - Sulphate and PHOS = Phosphate. 
Finally, the presence of solvation (or hydration) is 
indic~ted by; HY = Hydrate, ET = Ethanol, 
IP = Isopropanol, SIB = S-Isobutanol, 
RIB = R-Isobutanol and IPE = Isopentanol. 
Some examples are: 
GUFBSIB = S-isobutanol solvate of the free base 
GUHFUMET = ethanol solvate of the hemifumarate salt 
GUMMALNIP = isopropanol solvate of the monomalonate 
salt 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SECTION 4: PHYSICOCHEMICAL INVESTIGATIONS 
INTO SALTS AND MODIFICATIONS OF GU 
4 . 1 . 
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Hygroscopicity/Efflorescence Studies on Salts 
and Modifications of GU 
All modifications of the free base were non-hygroscopic 
under all humidity conditions studied, taking up less 
than 1% w/w of water. The data are summarised in Figures 
4.1.1. to 4.1.4. The samples exhibit Type II adsorption 
characteristics as classified by Brunauer1 • This occurs 
in physical adsorption on nonporous or microporous 
adsorbent, allowing a multilayer of adsorbate to be bound 
to the surface. An inflection point is indicative of the 
first monolayer formation. The moisture adsorption-
desorption isotherms show the typically closed hysteresis 
loopL 2 which are indicative of the materials having 
capillary pores. The data are summarised in Figure 
4.1.14. 
Of the salts studied only the dicarboxcylic acid salts, 
GUHFUMET and GUMMALNIP and the monochloride salt, 
GUMHCLHYIP were hygroscopic. GUHFUMET, rapidly adsorbs 
water under all storage conditions and achieves 
equilibrium moisture contents after only 24 hours (Figure 
4.1.5.), the values equating to between 1.81 (20% RH) 
and 2.57 (87% RH) moles of water. GUHFUMET exhibits Type 
I 1 adsorption characteristics. These occur in 
chemisorption processes and are limited to a few 
monolayers of adsorbate. The amsymptote is approached 
when the water molecules occupy all of the available 
sorption sites. Again the moisture adsorption-desorption 
isotherms show a closed hysteresis loop (Figure 4.1.15.). 
GUMHCLHYIP is only hygroscopic at elevated humidities. 
After 24 hours at 87%RH the sample has adsorbed 10.09% 
w/w (=3.19 moles) of water, but rapidly loses much of 
this before equilibrating to 6.10% w/w (=1.93 moles) of 
water. It equilibrates to a similar level, 6.50% w/w 
(=2.05 moles) when stored at 75% RH (Figure 4.1.6.). 
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GUMHCLHYIP exhibits Type IV1 adsorption characteristics, 
these occur on porous surfaces and the inflection point 
indicates the position of the first monolayer. The 
moisture adsorption-desorption isotherms show the closed 
hysteresis loop (Figure 4.1.16.). 
GUMMALNIP is deliquescent at 87% RH, it rapidly 
equilibrates to a level of 6.49% wjw (=2.01 moles) of 
water and then gradually deliquesces over the next few 
days (Figure 4.1.7.). GUMMALNIP is non-hygroscopic when 
stored at between 20% to 75% RH. It exhibits Type II 
adsorption characteristics and a closed hysteresis loop 
(Figure 4.1.15.). 
All of the remaining salts are non-hygroscopic (Figures 
4.1.8. - 4.1.13.) the majority exhibit Type II adsorption 
characteristics, the exceptions being GUMACEHY (Type IV, 
Figure 4 .1. 8.) and GUMASCHY. (Type III, Figure 4. 1. 9.) . 
Type III adsorption occurs when the heat of adsorption is 
less than the adsorbate's heat of liquefaction. Thus, 
additional adsorption is facilitated because the 
adsorbate's interaction with the monolayer is greater 
than its interaction with the adsorbent surface. 
Only GUMMALIB and GUSULF, exhibit an open hysteresis loop 
for the adsorption-desorption isotherms (Figure 4.1.15 
and 4.1.17)· This indicates that these materials have the 
so-called 'ink-bottle' or narrow neck pores1•2 • 
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Figure 4. 1. 1 Hygroscopicity I Efflorescence Studies on GUFBHY 
Hygroscopicity Studies Efflorescence Studies 
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Figure 4.1.2 Hygroscopicity I Efflorescence Studies on GUFBIP 
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Figure 4.1.3 Hygroscopicity I Efflorescence Studies on GUFBIB 
Hygroscopicity Studies Efflorescence Studies 











0.1 10 100 
Time (Hours) 
Identifier Condition 
1 87% RH 
2 75% RH 
3 52% RH 
4 20% RH 
1000 

















87% RH - 75% RH 
75% RH - 52% RH 
52% RH - 20% RH 
Figure 4.1.4 Hygroscopicity I Efflorescence Studies on GUFBIPE 
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Figure 4.1.5 Hygroscopicity I Efflorescence Studies on GUHFUMET 
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Figure 4.1.6 Hygroscopicity I Efflorescence Studies on GUMHCLHYIP 
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Figure 4.1. 7 Hygroscopicity I Efflorescence Studies on GUMMALNIP 
Hygroscopicity Studies Efflorescence Studies 
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Figure 4.1. 8 Hygroscopicity I Efflorescence Studies on GUMACEHY 
Hygroscopicity Studies Efflorescence Studies 
-9-1 ---2 -a ---e--4 




0.1 10 100 1000 
Time (Hours) 
Identifier Condition 
1 87% RH 
2 75% RH 
3 52% RH 
4 20% RH 
~A _._8 --c 













87% RH - 75% RH 
75% RH - 52% RH 
52% RH - 20% RH 
-63-
figure 4.1.9 Hy~roscopicity I Efflorescence Studies on GUMASCHY 
Hygroscopicity Studies Efflorescence Studies 
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Figure 4.1.11 Hygroscopicity I Efflorescence Studies on GUSULF 
Hygroscopicity Studies Efflorescence Studies 
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Figure 4.1.12 Hygroscopicity I Efflorescence Studies on GUDHCLHY 
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Figure 4.1.13 Hygroscopicity I Efflorescence Studies on GUDMES 
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0.1 10 100 
Time {Hours) 
Identifier Condition 
1 87% RH 
2 75% RH 
3 52% RH 
4 20% RH 
1000 
















87% RH - 75% RH 
75% RH - 52% RH 
52% RH - 20% RH 
-66-




87'-RH 76'-RH 6~ 20t.RH 
"4 w/w 0.46 
Mol•• !I 0 0.11 
0.36 0.24 0.11 
O.OG 0.06 0.03 
EFFLORESCENCE 
76-..RH 62"l.RH 2~H 
0.3G 0.25 0.13 
O.OG 0.06 0.03 
- ADaotlPTIOM -f- o<aoArTIOtC 
HYGROSCOPICITY 
87'-RH 715-..RH 62"l.RH 20"4RH 
"4 w/w 0.73 






76-..RH 6~ 20"4RH 
o.68 o • .c8 0.38 
0.18 0.13 0.11 
HYGROSCOPIClTY 
87"4AH 76'-RH 62"4RH 20-..RH 
"4 w/w O.G1 0.83 0.65 0.40 
M olea !1 0 0.27 0.25 0.20 0.12 
KYGROSOOPICITY 
87'-RH 76-..RH 62"l.RH 20"4RH 
"4 w/w O.G2 0.80 0.72 0.4 1 
Mo&ee !1 0 0.2G 0.26 0.23 0.13 
EFFLORESCENCE 
76-..RH 62-..RH 2~H 
0.61 0.67 0.3G 
0.18 0.17 0.12 
EFFL.OR£SCENCE 
78-..RH 62-..RH 2:0SRH 
0.87 0.81 0.61 
0.21 0.111 0.18 
Figure 4.1.15 
-67-






87~H 715~ 152't.RH 20T.RH 
8.10 8.70 8.23 . 8.63 
Uolea!f 0 2..157 2.44 • 2.30 1..81 
EFFLORESCENCE 
715~H 15nRH 20T.RH 
8.82 8.40 8.158 
2.151 2.35 1..80 
- N:Jeo..PT10tl -+- K.ORPTIOM 




87~H 715~ 62't.RH 20T.RH 
"'.,,., 0.28 







87~H 76'1.RH 62'1.RH 20T.RH 
"- w/w 8.33 0.88 0.84 0.88 
"'~!« 0 1.87 0..30 0.28 0.21 
EFFLOREsct:NCE 






715~H 6~H 20"-RH 
15.71 0.48 . 0..32 
1.77 0.115 0.10 
Figure 4.1.16 
-68-
Adsorption I Desorption Isotherms of Monoprotonated Salts of GU 
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Adsorption I Desorptiop Isotherms of Diprotonated Salts of GU 
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4.2 Stability Studies on Salts and Modifications of GU 
4.2.1 Appearance of Stability Samples for Salts and 
Modifications of GU 
The appearance of the salts and modifications of GU, at 
the end of the stability studies are given in Table 
4.2.1. 
Table 4.2.1 Appearance of Salts and Modifications of GU at the end of the Stability Studies. under 
the various conditions studied 
Condition/ Appearance Salt/ 





NC NC P(l) P(2) M,B 
F(l) P(l) P(2) P(3) M,B 
F(l) F(2) F(4) Br(4) M,B 









GUHFUMET NC NC NC F(l) M,Br(l) A,F(l) F(l) Br(l) 
GUMMALIB NC NC F(l) F(3) M,Br(3) NC F(4) P(l) 
GUMMALNIP NC F(l) F(3) Br(2) M,B 





GUMASCHY NC NC F(l) F(3) M,Br(3) A,NC F(l) F(3) 




NC NC F(1) F(2) F(4) 
NC NC F( 1) F(2) F(5) 
NC NC NC F(l) F(3) 
The key to the abbreviations are: 
NC No change in colour 
A Aggregates 
M Melted 
F Fawn B Black 
Br Brown P Purple 






Intensities of the colours have been subjectively 
estimated on a rank order between 1 (least colouration) 
and 5 (most colouration) and are given in brackets after 
the abbreviation. The marked colour changes should not be 
taken as indicative of extensive chemical degradation, 
although this was certainly observed for some of the 
samples studied. Both oxidation (to the highly coloured 
quinone derivative) and photolysis (which is often a 
precursor to oxidation in the initiation phase, and is 
usually mediated by free radicals to produce dark-
coloured products) may result in colouration of the 
samples, with only small levels of degradation being 
present. 3 
Despite a slight darkening in colour, all samples stored 
between 25° and sooc and at elevated humidities, 
demonstrated excellent stability, with no loss in potency 
over the course of the studies. 
4 . 2 . 2· Solid-State Reaction Kinetics 
The subject of the kinetics of solid-state reactions of 
drugs and indeed of solid-state reactions in general is 
not well understood. Solid-state reactions show complex 
rate behaviour that is not easily modelled and unlike 
solution reactions cannot be easily fitted to a single 
kinetic equation. 4 
The kinetics of the solid-state decomposition reactions 
of drugs have been extensively studied; the objective of 
most of these studies was to obtain an equation that 
provided an adequate fit for plots of rate vs. time, to 
make shelf-life predictions. However the majority of 
these studies were not aimed at elucidating the molecular 
details of the reaction under investigation. Solid-state 
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reactivity is largely controlled by molecular 
conformation and crystal packing in the particular 
structure that is involved5 • 
In certain cases, the extent of decomposition varies in a 
sigmoid fashion, the reaction showing an initial rapid 
change followed by a gradual slowing down (topochemical) 
or an initial lag phase followed by a rapid change 
(nucleation) . 
Topochemical Kinetics 
In topochemical or contracting geometry decomposition the 
solid-state reaction is assumed to be controlled by the 
advancement of phase boundaries from the outside of the 
crystal inwards. A series of equations have been derived 
dependent on whether the advancement of the phase 
boundary is in 1, 2 or 3 dimensions6•7 • 
If the crystal is assumed to react along one direction 
only, then the rate is a function of time and a zero 
order rate equation will apply: 
1 - a = kt ........................ ( 1) 
If the reaction is assumed to proceed from the surface of 
a circular disk (or cylinder) inwardly, then equation (2) 
will apply: 
1- {l-a}~= kt ..................... (2) 
And, if the reaction proceeds from the surface of a 
sphere inwardly in three dimensions, then equation (3) 
will apply: 
1 - ( 1-cr) ~~a = kt ..................... ( 3) 
In all case er is the relative amount of decomposition, t 
is time and k is the rate constant. 
Nucleation Kinetics 
Nucleation decomposition assumes control by the growth 
and formation of active nuclei at the surface and inside 
of the crystals. The formation of decomposition products 
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initiates strains ln the crystal structure which are 
relieved by crack propagation. Decomposition then 
continues on these new surfaces and the chain reaction 
continues. 
This situation can be described using the Prout-Tompkins8 
equation: 
ln {1/1 -a) = kt ..................... (4) 
This equation has been successfully applied to several 
inorganic solid-state reactions, including those of 
mercury fulminate, lead oxalate and nickel formate. The 
role of crystal defects is also far more important than 
was first realised. The real solid has surfaces, grain 
boundaries, dislocations, impurities, occluded solvent 
etc. Molecules at or close to these defects have a higher 
potential energy than those in the bulk crystal and 
consequently may be more reactive. In many such reactions 
the diffusion of a reactant or product is rate 
controlling and diffusion is only possible by virtue of 
these lattice defects 6• 7 • 
Diffusion Kinetics 
If the rate of reaction lS controlled by a 1 dimensional 
processes then equation (5) will apply: 
a,2 = kt ......................... ( 5) 
and if the reaction is assumed to be controlled by 
diffusion from a spherical particle then the Jander 
equation may be applied: 
[1 - (1-a)"] 2 = kt ...................... (6) 
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Solid-State reactions of salts and modifications of GU 
In an effort to understand the kinetic processes involved 
in the solid-state stability studies; equations (1) - (6) 
were applied to the relevant data. Linear regression 
analyses using a least squares fit program were performed 
and the correlation coefficients (R2 ) are tabulated in 
Table 4.2.2. This approach was first used to investigate 
the dehydration of Cytosine monohydrate by Perrier9 • 
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0.801 0.706 0.999 
0.680 0.709 0.773 
0.690 0.675 0.900 
0.949 0.906 0.957 






0.739 0.798 0.854 0.956 
0.850 0.820 0.786 0.861 
0.835 0.824 0.795 0.866 
0.701 0.811 0.911 
0.786 0.774 0.833 
0.691 0.740 0.572 
0.878 0.940 0.683 
0.739 0.727 0.800 
0.931 0.910 0.934 
0.860 0.843 0.925 
0.084 0.076 0.122 
0.580 0.554 0.686 
0.684 0.745 0.925 
0.963 0.873 0.874 













0.869 0.724 0.655 0.497 0.971 0.756 
0.980 0.985 0.964 0.864 0.658 0.967 
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The stability data are summarised in Figures 4.2.1 to 
4.2.13 and the degradation profiles are summarised 1n 
Tables 4.2.3 to 4.2.5. 
The stability of the various modifications of the free 
base at 70°C appears to be dependent upon the volatility 
of the solvent and not the melting point of the sample. 
There is initially a small increase in potency for the 
alcohol solvates, the size of this increase being 
dependent on the volatility of the solvent (GUFBIP, 
104.2%; GUFBIB, 104.0% and GUFBIPE, 102.7%). This is 
followed by a reasonably linear decrease in potency as a 
function of time (Figures 4.2.2 - 4.2.4). 
The kinetics are either pseudo zero order ot due to 1D 
advancement of a phase boundary. 
The solvates all show a complex degradation profile with 
several (ea 10) more polar and three less polar, 
degradation products. The hydrate is very stable over the 
whole study period, exhibiting only a small drop 1n 
potency (95% label), accompanied by several more polar 
degradation products (Figure 4.2.1). 
The free base, 100°C samples all show similar 
decomposition profiles (Figure 4.2.14). There 1s no 
increase in potency after 4 weeks as the rate of 
decomposition is greater than the rate of de-solvation 
for all of the samples. The hydrate (GUFBHY) had in fact 
~ 
melted after only 1 weeks storage (in line with the other 
samples), even though it was stored at some 30°C below 
its melting point. The DSC heating curve (Figure 4.2.17) 
helps to explain this, by showing a very broad melting 
endotherm between 101.0 and 137.8°C, followed by 
decomposition. There is no separate dehydration 
endotherrn. Thus storage at 100°C leads to loss of water 
and premature melting. The kinetics best fit a 1D 
diffusion model for GUFBHY and GUFBIP, but none of the 
models studied gave a good correlation for the data. The 
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degradation profiles (Table 4.2.3) are again very 
complex, but appear similar to the 70°C profiles. 
With the exception of GUFBIP (84.6%), light stability 1s 
good. Although the volatility of the isopropanol solvent 
appears to be the favoured explanation for the reduced 
light stability, it should be noted that the photolytic 
degradation profile (Table 4.2.4 and Figure 4.2.15) 1s 
not identical with the thermal degradation profile. The 
kinetics are confusing and gave acceptable correlations 
for all of the models studied. 
The stability of the free base samples are reduced when 
stored under UV light, as compared with window light. The 
degradation profiles (Table 4.2.5 and Figure 4.2.16) are 
similar, GUFBIP is again the least stable modification 
and GUFBHY, the most stable. The kinetic profiles for 
GUFBIP gave acceptable correlations, whilst those for 
GUFBIB and GUFBIPE gave poor correlations, for the models 
studied. 
The stability of the dicarboxcylate salts of GU are again 
not solely dependent on the values of their melting 
points. The fumarate (GUHFUMET) has the highest melting 
point, while the maleate and malonate salts have similar 
melting points, but vastly different thermal stabilities. 
The maleate (GUMMALIB, Figure 4.2.5) 1s the most stable 
of the three salts, even when stored at 100°C. It 
initially shows an almost quantitative desolvation at 
100°C, resulting in the loss of the isobutanol solvent 
and a resulting increase in potency (111.8% = 97.6% loss 
of isobutanol). This is followed by a gradual loss in 
potency to 106.0%, with the concurrent increase in the 
degradation product at RRt 0.68 to a final level of ~6% 
(Table 4.2.3). The fumarate (GUHFUMET, Figure 4.2.4) has 
a half-life of about 25 weeks, when stored at 100°C. 
There is a marked change in the rate of the reaction 
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after 12 weeks, possibly as a result of a phase change, 
although this could not be confirmed due to the high 
levels of degradation present (Table 4.2.3). The kinetic 
data gave good correlation for three of the models 
studied, the 3D diffusion, nucleation and a 2D 
topochemical model. The malonate salt (GUMMALNIP, Figure 
4.2.6) is the least stable of the dicarboxcylate salts, 
having a half-life of 4 weeks at 100°C. Part of the 
explanation may again be the volatility of the 
isopropanol solvent. The degradation profile (Table 
4.2.3) is again very complex and the data gave poor 
correlations in all of the kinetic models studied. All of 
the salts demonstrated good light stability with 
quantitative recoveries and low levels of degradation 
(Table 4.2.4). The stability under UV light was identical 
for GUMMALIB, but was reduced for GUHFUMET (93.7%) and 
GUMMALNIP (83.6%). The degradation profiles were similar 
for all three dicarboxcylate salts (Table 4.2.5). 
The monoacetate (GUMACEHY) and monoascorbate (GUMASCHY) 
salts show excellent light and thermal stability up to 
70°C tFigures 4.2.8 and 4.2.9, respectively). On storage 
at 100°C, both salts exhibited premature melting. This 
was caused by loss of the water of crystallisation 
followed by melting of the anhydrate form. Similar 
behaviour was previously observed for GUFBHY. The 
anhydrate forms rapidly degrade with half-lives of 28 and 
7 days respectively, for GUMACE and GUMASC. The 
degradation profiles are summarised in Table 4.2.3. As 
there are two reactions occurring, desolvation and 
decomposition, it is not surprising that the kinetic 
models gave poor correlations. 
Although melting point is in general an important 
parameter in assessing salt stability, for the mono and 
diprotonated chlorides the presence of solvent again 
appears to be more critical. The hydrated dichloride, 
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GUDHCLHY has a high melting point (263.2 - 265.4°C) and 
it demonstrates excellent stability (Figure 4.2.12). The 
hydrated, isopropanol solvate of the monochloride 
GUMHCLHYIP, also has a high melting point (235.5 -
237.5°C), but the presence of volatile isopropanol 
solvent reduces the light and thermal stability at 100°C, 
quite markedly (Figure 4.2.10). The data for the 
monochloride salt can be fitted to several kinetic 
models. For the 100°C data a pseudo zero order or 1D 
phase advancement model gives the best correlations. For 
the light data all models except the nucleation and 1D 
diffusion model, gave good correlations. Conversely for 
the UV light data, the nucleation and 1D diffusion models 
gave the best correlations. 
For the mesylate (GUDMES, Figure 4.2.11) and the hydrated 
sulphate (GUSULFHY, Figure 4.2.13), although the geometry 
of the anions are similar the presence of solvent appears 
to be the critical factor. GUDMES shows excellent 
stability at all conditions and likewise GUSULFHY shows 
good stability at all but the 100°C station. Here, as has 
previously been observed, dehydration followed by 
degradation of the anhydrate, results in a half-life of 
only 12 weeks at 100°C. A 1D diffusion model gave the 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4. 2. 1 Stability Data for GUFBHY 
- 26"C -+- 40"C ...._ IO"C -G- 70"C 
-* 100"C + 26"C/I7'-"H -Ar WIHOOW l.IOHT --H- UV l.IOHT 







0 12 16 20 24 26 
Tllol( (WEEKS) 
TIME POINT CONDITION ('% label) 
(Weeks) 25 40 50 70 100 RH lt Hv 
99.0 100.2 98.9 100.0 84.4 99.8 99.4 99.2 
2 99.1 98.2 100.2 101.4 64.7 99.7 100.4 99.2 
3 100.4 101.5 101.1 99.6 54.4 101.2 99.0 99.5 
4 100.1 100.7 100.2 100.6 45.4 100.4 100.3 99.2 
12 100.4 100.6 101.6 100.0 3.0 99.8 99.2 98.8 
26 99.9 99.5 100.4 95.0 0.0 100.4 98.7 97.7 
Figure-4.2.2 Stability Data for GUFBIP 
- 26"C -+- 40"C -¥- IO"C -6- 70"C 
"'*- 100"C + 26.C/a7'-RH -Ar WINDOW LIGHT -H- UV LIOHT 







0 t2 t6 20 24 
Tllol( IW((ICSI 
TIME POINT CONDITION (% label) 
(Weeks) 25 40 50 70 100 RH lt Hll 
4 98.9 98.9 98.9 104.2 45.4 102.8 96.6 92.5 
10 100.2 100.2 100.2 92.8 H.4 102.9 93.5 90.1 
12 99.4 99.4 99.4 85.8 10.2 100.0 91.2 86.3 
15 99.2 100.7 101.2 79.1 6.7 99.8 89.6 86.0 
21 99.4 99.4 99.4 67.0 3.0 99.4 87.1 82.1 
25 100.5 100.5 100.5 60.5 2.9 101.0 84.6 81.5 
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Figure 4.2.3 Stability Data for GUFBIB 
-- 26"C 
4<- 1oo·c 













-+- •o·c """*- 60"C -& 70"C 
+ 26"C/e7,RH -b- WINDOW liOHT -K- UV liOHT 
12 16 20 
TII.IE (WEEKS) 
CONDITION ('% Label) 
40 50 70 100 RH Lt 
100.0 101.3 104.0 40.2 100.6 100.3 
98.9 99.2 95.8 24.1 99.8 100.4 
99.6 99.6 86.8 12.1 99.2 101.2 
100.0 100.2 81.8 8.1 99.7 101.0 
99.4 98.8 75.0 3.8 100.0 101.7 
100.4 99.6 65.2 1.9 98.9 101.2 
Figure 4.2.4 Stability Data for GUFBIPE 
-u·c 
"*- 100"C 
















-+- •o·c -4- ao·c -e- To·c 
+ 2f"C/81~H -l!r WINDOW l.IOHT -H- UV \.IQHT 
12 16 20 
TII.IE (W(EII:I) 
CONDITION ('lo Label} 
40 50 70 100 RH Lt 
99.7 100.2 102.7 38.6 100.4 100.2 
99.0 99.4 95.6 22.8 98.4 100.4 
101.0 100.5 93.5 8.0 100.2 100.4 
99.0 98.8 87.4 5.0 99.2 99.0 
100.8 99.2 85.2 3.4 98.7 99.5 



















Figure 4.2.7 Stability Data for GUMMALNIP 
- 26"C -+- 40"C ..._ to·c -G- 70"C 
-*" 100"C + 26"C/17UK -6- WINDOW LIOKT -H- UV LIQHT 








0 u 10 20 24 
TU.CE (WEEICSI 
TIMEPOINT COt\:tiTION (, label) 
(Weeks) 25 40 50 70 100 RH lt Hv 
4 100.0 100.8 101.6 100.6 53.6 100.8 99.2 
95.6 
8 100.8 100.8 100.7 99.1 14.0 100.0 99.7 
95.2 
12 101.0 101.0 100.6 95.5 2.1 101.2 98.8 
89.6 
16 100.2 100.4 100.0 92.7 2.2 99.4 96.8 
88.8 
22 100.3 100.6 100.6 89.1 0.0 100.3 98.4 
83.0 
24 100.0 100.-4 99.2 90.0 0.0 101.2 97.8 
83.6 
Figure·4.2.8 Stability Data for GUMACEHY 
- u·c -+- •o·c -*- to·c -G- 10"C 
-*" 100"C + 2t"C/I11.AH -A- WINDOW l.IQHT -H- UV l.IOHT 








0 12 10 20 
24 
Tlloe( (W((ICSI 
TIMEPOINT CONDITION (, Label) 
(Weeks} 25 40 50 70 100 RH lt Hv 
4 100.5 100.2 100.2 100.2 51.8 99.8 95.6 
95.2 
8 100.3 100.2 100.8 103.4 22.4 100.3 95.9 
93.6 
12 99.7 100.0 100.1 99.8 6.2 100.2 96.4 
96.0 
16 99.4 100.8 99.5 99.7 2.8 99.1 97.0 
94.4 
22 100.0 100.0 100.4 102.4 0.0 102.0 96.5 
95.5 
b 
2<4 100.0 100.4 99.2 100.2 0.0 99.8 97.1 
92.6 
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Figure 4.2.9 Stability Data for GUMASCHY 
- 21"C --+- co·c ..._ ao·c -G- JO"C 
-*" tOO"C + 211"C/17~H -6- WINDOW LIGHT -B- UV LIGHT 







0 t2 te 20 24 211 
Tll.l( (W££11:&1 
TIMEPOINT C0NOITION (" LabeO 
(Weeks) 25 40 60 70 100 RH u Hv 
100.0 101.0 100.2 99.9 62.8 100.2 99.6 99.8 
2 100.8 100.4 101.2 100.6 38.0 1002. 100.3 99.7 
3 100.8 98.8 100.5 100.6 27.6 100.8 100.6 99.6 
4 99.6 100.5 100.4 100.9 20.4 100.6 100.0 100.2 
12 99.3 99.1 99.3 99.3 3.0 99.6 100.8 97.8 
26 100.0 99.6 99 ... 99.7 2.9 99.6 98.7 97.2 
Figure·4.2.10 Stability Data for GUMHCLHYIP 
- 26"C --+- co·c _... IO"C -t1- 70"C 
""*- 100"C + 211"CII7'-RH -A- WINDOW liOHT -B- UV UOHT 







t2 111 20 24 21 
TII.C£ IWEEKSI 
TIMEPOINT CONDITION (" Label) 
(Weeks) 25 40 60 70 100 RH u Hv 
.. 99.9 100.0 100.6 100.6 102.9 99.2 98.6 99.2 
10 100.6 100.3 100.2 100.6 93.6 98.8 96.2 93.0 
12 99.4 101A 102.4 100.4 91.6 97.2 94.9 91.1 
15 100.4 99.5 101.8 100.5 88.7 98.4 94.2 90.7 
21 98.5 99.0 98.2 98.6 83.0 100.4 90.8 89.6 
25 98.2 100.2 100.2 98.2 81.8 100.2 88.2 87.0 
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Fii!Ure 4.2.11 Stability Data for GUDMES 
- 21·c 
"'"*" 10o·c 













+ •o·c ..._ eo·c -e- Jo·c 
+ ze·c"r"'RH -A- WINDOW LIGHT -B- UV LIOHT 
• 12 10 20 24 2e 
TI"'E CWE£11:1) 
CONDITION (-so Label) 
40 50 70 100 RH Lt 
97.9 98.3 100.0 98.0 98.1 98.8 
100.3 100.8 98.4 98.2 98.8 99.3 





4 99.9 100.5 100.6 100.4 100.6 101.2 102.4 101.5 
12 101.0 99.4 100.5 99.6 98.0 100.0 100.3 98.8 
26 99.9 98.3 99.5 98.2 97.0 99.2 99.8 98.4 
Figure 4.2.12 Stability Data for GUDHCLHY 
- 21·c + •o·c ..._ to·c -e- ro·c 
-K- 10o·c + u·C/17'-RH --A- WINDOW LIGHT -H- UV LIOHT 








t2 Ul 20 24 21 
TI"'E (W££11:31 
TIME POINT CONDITION (" Label) 
(Weeks) 25 40 50 70 100 RH Lt Hv 
100.4 99.6 99.5 98.8 103.0 99.3 100.0 99.3 
2 100.0 101.3 102.1 101.4 102.1 100.2 100.5 99.6 
3 99.8 100.2 98.8 100.6 102.2 99.8 99.7 99.4 
4 99.6 99.6 100.2 100.7 100.8 97.8 100.8 100.4 
13 100.2 100.8 99.4 99.2 98.9 98.8 98.3 99.2 
28 100.0 100.4 100.2 100.1 94.4 99.1 101.4 99.5 
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Figure 4.2.13 Stability Data for GUSULFHY 
- 26"C -t- 40"C -*" IO'C -9- 70'C 
-M- .oo·c + 21'C/Ut.RH -6- WINDOW LIGHT -H- UV LIGHT 








0 12 " 20 24 21 TU.CE (WEEKSI 
Tt:.~EPOINT CONDITION ("'o Label) 
(Weeks} 25 40 50 70 100 RH Lt Hv 
99.8 99.9 99.6 100.0 97.7 98.8 100.0 100.2 
2 99.6 100.7 100.4 101.8 91.7 97.8 99.9 99.9 
3 100.1 101.0 101.2 101.4 79.2 99.6 100.2 99.8 
4 100.7 100.5 102.4 101.6 74.8 98.-4 101.0 99.7 
12 100.0 101.2 101.2 101.7 49.8 99.0 100.2 99.9 
26 100.0 101.2 101.5 100.3 35.8 97.1 99.0 97.4 
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Figure 4.2.14 Comparison of thermal Stability (lOOOC) of Salts and Modifications of GU 
-- GUFBHY -f- OUFBIP ""*- GUFBIB -8- OUFBIPE 











, lABEl STRENGTH 
0 












- QUOHCLHY + GUOMES + OUSULF 
28 
28 
ol_------~-------J--------L-------~----~-J20--------2~4------~2~e---12 18 0 
TIME (WEEKS) 
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Figure 4.2.15 Comparison of window light Stability of Salts and Modifications of GU 
~ OUFBHY -4- OUFBIP """*- OUFBIB -8- OUFBIPE 






0 e 12 18 20 24 28 
TIME (WEEKS) 
OUHFUMET -+- GUMMALIB """*- QUMMALNIP 
-a- GUMASCHY "'* OUMACEHY + QUMHCLHYIP 








0 e 12 1e 20 24 28 
TIME (WEEKS) 
-OUDHCLHY -f- OUDMES ""*-GUSULF 








0 12 18 20 24 28 
TIME (WEEKS) 
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Figure 4.2.16 Comparison of UV Light Stability of Salts and Modifications of GU 
- OUFBHY -f- OUFBIP + OUFBIB -8- OUFBIPE 







0 8 12 10 20 24 28 
TIME (WEEKS) 
GUHFUMET -+- GUMMALIB +- GUIAIAALNIP 
-a- GUMACEHY ""*"" GUMASCHY + GUIAHCLHYIP 








0 8 12 18 20 24 28 
TIME (WEEKS) 
--GUDHCLHY -f-GUDMES +auSULF 








0 8 12 10 20 24 28 
TIME (WEEKS) 
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WTa 3.50 mg 
SCAN RATEa 10.00 dog/m1n 
PEAK FROH: 101 
TO: 137.77 
ONSET I 11 2. 7 2 
(AL/GRAH, 37. 38 
~ 00 ~~~~o.-oo----------w~.oo----------~~--oo---------~~~~oo----------1~~-.-oo---------~-~-~-oo------~ 
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4.3 Van't Hoff Solubility Investigations on Salts and 
Modifications of GU 
The data and Van't Hoff Solubility plots are summarised 
in Figures 4.3.1 and 4.3.2, respectively, for the mono 
and diprotonated salts of GU. Due to the low aqueous 
solubility (<0.001mg.ml-1 ) of the free base solvates, 
Van't Hoff solubility investigations could not be carried 
out for them. 
Linear regression analyses (using least squares fit) were 
performed on the data, the correlation coefficients (R2 ) 
were good, only GUMACEHY gave an R2 value of <0.9 
(0.845). 
These data together with the heat of solution (~Hs) 
values are given in Table 4.3.1. 
Table 4.3.1 Summary of linear regression and Heats of Solution (~Hs) data for salts of GU 
Salts of Linear Regression Analyses ~Hs 
GU R2 a b KJ.Mol- 1 
GUMACEHY 0.845 -8.343 1068.7 - 8.89 
GUMASCHY 0.914 4.530 -2180.0 18.13 
GUMMALIB 0.999 2.286 -2123.9 17.66 
GUMHCLHYIP 0.996 -0.943 -1318.5 10.96 
GUSULF 0.999 3.058 -2707.1 22.51 
GUDMES 0.982 -11.278 2763.6 -22.98 
GUSPHOS 0.990 2.555 -2410.7 20.04 
GUDNIT 0.986 2.230 -2225.8 18.51 
GUDHCLHY 0.934 -2.283 - 859.0 7.14 
a = intercept, b = slope of graph 
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Only two of the salts studied gave an inverse 
relationship between natural logarithm of molar 
concentration (ln Cs) and the inverse of absolute 
temperature (T- 1 ). The monoacetate (GUMACEHY, ~Hs = -8.89 
KJ.mol- 1 ) and the dimesylate (GUDMES, ~Hs =-22.98 
KJ.mol- 1 ) salts, both demonstrated exothermic heat of 
solution which implies an extensive solute - solvent 
interaction10 • 
This behaviour is ln contrast to that observed for most 
drugs 10 ' 11 , where a rise in temperature results ln a 
corresponding increase in drug solubility and results in 
an endothermic heat of solution. 
Cyclosporin A12 was recently reported to exhibit an 
exothermic heat of solution. This work was in accord with 
the previous investigations of Loosli et a1 13 , who 
suggested that at higher temperatures the intramolecular 
hydrogen bonds are stronger and the molecule adopts a 
conformation corresponding to an isolated, rather than a 
solvated molecule. As the temperature decreases the 
intramolecular hydrogen bonds weaken and the solubility 
increases. 
Both the dimesylate (GUDMES) and the monoacetate 
(GUMACEHY) salts show evidence of intramolecular 
associations in solid phase. GUDMES exhibits a unique 
intramolecular hydrogen bond between the piperazine 
nitrogen, N(14) and the methoxy oxygen, 0 (32). 
(see Table 5.7) 
Although GUMACEHY is not capable of exhibiting this type 
of intramolecular association, due to its protonation 
state (only the diprotonated salts possess a proton on 
the piperazine nitrogen, N(14)); it can achieve a 
similar bonding arrangement, by using a water molecule as 
a key intermediate. The water molecule exhibits a 
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bifurcated hydrogen bond to the piperazine nitrogen, 
N(14) and to the methoxy oxygen, 0 (32) of the same 
molecule (see Table 5.4}. 
The remainder of the salts all gave positive 
relationships and endothermic heat of solution. 
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3.2 3.4 3.11 
) 
I() lnverae of Abaolute Temperature 
SALT 3.61 3.36 3.H~ 
GUMACEHY -4.63 -4.84 -6.00 
GUMASCHY -3.24 -2.g4 -2.64 
GUMMALIB -6.38 -4.84 -4.61 
GUMHCLHYIP -6.71 -6.37 -6.12 
3.1 







Figure 4.3.2. Van't Hoff solubility Plots for Diprotonated Salts of GU 
OUOHCI.HY + OUOWEI + OUIUI.f 










3.2 3.4 3.1 3.1 
1/T a 10.·3 Ke-1 
l 10 lnwr .. of Abaolute Temperature ( K"') 
SALT 3.81 3.38 3.H~ 3.088 
OUSULF -6.72 -6.02 -6.69 NA 
OUOMES -1.3~ -1.90 -2.62 NA 
OUSPHOS -8.17 -6.~8 -6.17 NA 
OUONIT -6.80 -6.17 -~.86 -~.69 
OUOHCLHY -6.~ 1 -6.11 -6.<>e NA 
-98-
4.4 Physicochemical Properties of Salts and 
Modifications of GU 
Salt formation provides a means of altering the 
physicochemical and resultant biological characteristics 
of a drug entity without modifying its molecular 
structure14 • Many published reviews 14 • 15 • 16 have indicated 
the importance of the selection of the most appropriate 
salt form. In making this selection, the variables under 
consideration are yield, rate and quality of the 
crystallisation process, availability and cost of the 
process, solubility, hygroscopicity, stability of the 
salt form and the toxicological effects of chronic and 
acute dosing of the drug and its conjugate acid. 
These requirements are in many ways conflicting and salt 
selection tends to be a semi-empirical process. 
The most important considerations for salt formation are 
the relative pka of the basic drug (HB+) and of the acid 
of the proposed counterion (HA) . Salt formation requires 
that the equilibrium lie well to the right 
Since log k for this reaction is, pka (HB+) - pka 1HA), 
it is essential that the pka (HB+) > pka (HA) . A 
secondary consideration is that of relative toxicity of 
the conjugate acid. A compilation of salts used in 
pharmaceutical products marketed in the US up to 1974 is 
given in Table 4.4.1. 
The physicochemical properties of the salts and 
modifications of GU studied are summarised in Table 
4.4.2. Clearly the very low aqueous solubility and 
intrinsic toxicity of the solvate alcohols, will restrict 
the use of the modifications of the free base of GU. 
The deliquescent nature of GUMMALNIP and GUMACEIP would 
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prevent the use of these monoprotonated salts, whilst the 
moderate hygroscopicity of GUMHCLHYIP could lead to 
processing difficulties during solid oral dose form 
development. 
Due to the strength of hydrochloric acid (pka < 0), the 
resulting aqueous solutions tend to be very acidic (< pH 
217 ) • This can limit the utility of chloride salts in 
certain parenteral dosage forms and lead to processing or 
packaging incompatibilities. 
In addition, although the aqueous solubilities of the 
monoprotonated (GUMHCLHYIP) and diprotonated (GUDHCLHY) 
salts are adequate, 1.8 and 2.4 mg.ml- 1 , respectively; 
the solubility in gastric fluid is likely to be much 
reduced. This is based on the effect of the common 
chloride ion on the equilibrium product in gastric fluid: 
BH+ <aq> + Cl- <aq> 
This reduction in solubility can result in the 
dissoiution rate of the chloride salt(s) falling below 
that of the free base form18 • 19 • 
The moderate hygroscopicity, allied to the low aqueous 
solubility would preclude the use of the fumarate 
(GUHFUMET) salt. 
The monocitrate (GUMCITIP) salt could not be readily 
crystallised, and in addition its low aqueous solubility 
would again preclude its use. 
The intrinsic toxicity of the alcohol solvates of the 
monomaleate (GUMMALIP and GUMMALIB) would present 
problems. In addition although GUMMALIB demonstrated 
excellent stability and moderate aqueous solubility 
(3.lmg.ml-1 ), the low melting point (117.9-120.5°C) might 
present problems with processing. Low melting point drugs 
generally exhibit plastic deformations20 , which can lead 
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to aggregation of the bulk drug, significantly affecting 
its flow and compression properties. The melting point 
also influences the compatibility of the drug with 
formulation excipients21 , as it affects the eutectic 
melting point and can produce melting during tabletting, 
due to the frictional forces encountered. 
All of the diprotonated salts studied, gave high melting 
points, good yields, were non-hygroscopic and 
demonstrated excellent stability. The solubility of the 
GUSULFHY was insufficient for further development; 
however the remainder all gave adequate and in the case 
of the mesylate (GUDMES) excellent solubility. 
Since these salts are all formed from mineral acids, the 
resulting aqueous solutions tend to be very acidic and as 
mentioned previously, this can limit their use in 
parenteral dosage forms. These problems are not 
insurmountable, in that the dosage form can be buffered 
to an appropriate pH (3.5-4.0) and the consequent 
reduction in solubility compensated for by the addition 
of appropriate eo-solvents. 
However the two most promising salts are the 
monoascorbate (GUMASCHY) and monoacetate (GUMACEHY) 
salts. Both are non-hygroscopic, have moderate melting 
points and demonstrate good stability. Both the acetate 
(pka 4.76) and ascorbate (pka 4.21) salts produce aqueous 
solutions of acceptable pH. 
The ascorbate has superior aqueous solubility 
(20.9mg.ml- 1 , cf 3.8mg.ml-1 for GUMACEHY) and in addition 
the ascorbate's anti-oxidant and low toxicity22 
properties, greatly facilitated its selection as the salt 
of choice. However it is not easily synthesised 
(see Table 3.1) or isolated. 
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Therefore based on the cost, non-hygroscopicity and good 
stability, the free base hydrate (GUFBHY) was selected 
for development. The ascorbate salt was subsequently 
prepared, in situ during formulation, by the addition of 
equimolar quantities of the base and ascorbic acid. 
One striking feature of these salt selection 
investigations are the propensity of the salts and 
modifications of GU to form solvates (pseudopolymorphs). 
Perhaps this is not too surprising given the widespread 
nature of the phenomenon of polymorphism and solvation. 
Indeed Dunitz 5 speculated that almost all compounds are 
polymorphic, if the right conditions for crystallisation, 
are produced. 
-102-
Table 4.4. 1 FDA APPROVED COMMERCIALLY MARKETED SALTS 
Anion Percene Anion Percent 
Acetate 1.26 Iodide 2.02 
Benzenesul fonate 0.25 Isethionatei 0.88 
Benzoate 0.51 Lactate 0.76 
Bicarbonate 0.43 Lactobionate 0.13 
Bitartrate 0.63 Malate 0.13 
Bromide 6.58 Maleate 3.03 
Calcium edetate 0.25 Mandelate 0.38 
Camsylateb 0.25 Mesylate 2.90 
Carbonate 0.38 Methyl bromide 0.76 
Chloride 47.56 Methylnitrate 0.38 
Citrate 3.03 Mucate 0.13 
Edetate 0.25 Napsylate 0.25 
Edisylatec 0.38 Nitrate 0.64 
Estolated 0.13 Pamoate 1.01 
(Embonate) 
Esylatee 0.13 Pantothenate 0.25 
Fumarate 0.25 Phophate/ 3.16 
diphosphate 
Gluceptater 0.18 Polygalacturonate 0.13 
Gluconate 0.51 Salicylate 0.88 
Glutamate 0.25 Stearate 0.25 
Glycollylarsnilate' 0.13 Subacetate 0.38 
Hexylresorcinate 0.13 Succinate 0.38 
Hydrabamineh 0.25 Sulphate 7.46 
Hydroxynaph- Tannate 0.88 
thoate 0.25 Tartrate 3.54 
Teoclatei 0.13 
T riethiodine 0.13 
Cation Percenr Cation Percent 
Organic: Metallic: 
Benzathinek 0.66 Aluminium 0.66 
Chloroprocaine 0.33 Calcium 10.49 
Choline 0.33 Lithium 1.64 
Diethanolarnine 0.98 Magnesium 1.31 
Ethylenediamine 0.66 Potassium 10.82 
Meglumine1 2.29 Sodium 61.97 
Procaine 0.66 Zinc 2.95 
• Percent is based on total number of anionic or cationic salts in use through 1974. 
bCamphorsulphonate. cl ,2- Ethanedisulphenate. dLaurylsulphate. CEthanesulphonate. 
'Glucoheptonate. lp-Glycollamidophenylarsonate. hN,N' Di(dehydroabietyl)ethylenediamine;. 2-
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Colourless rods from 50% aqueous acetone, 0.34 x 0.19 x 
0.10 mm. 
C18H20Cl 2N40 2 .H20, M= 413.3, monoclinic, P2 1 /c (No.14), 
a= 9.055(3), b = 9.078(8), c = 23.945(8)A, 
~ = 93.72(2) 0 , V= 1964.2A3 , z = 4, V/Z = 491 A3 • 
Lattice parameters refined from setting angles for 18 
reflections with e between 8.8 and 11.0°. 
De= 1.40 g cm-3 , Jl = 3.55 cm- 1 , F(OOO) = 864, T=290K. 
Data Collection and Processing 
Stoe STADI-2 diffractometer, MoKa, A=0.71073A. 2584 
independent data (2 < e < 25°, -10 ~ h ~ 10, 0 ~ k ~ 9, 
0 ~ 1 ~ 28) yielding 1536 data with I ~2.5a (I). No 
measurable crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX84). 
m-1 = a2 (F) + o . o o o 2 3 F2 , R = o . o 4 7 , wR = o . o 4 6, 
S = 1.14 based on 262 parameters. Maximum shift/esd on 
last cycle = 0.06. Maximum and minimum ripple in 
difference electron density map : 0.33 and -0.38 e.A-3 • 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 5.10.1-5.10.3. The molecular 
perspective and molecular packing diagrams (as viewed 
along the b-axis) are shown in Figure 5.1. It is 
dominated by hydrogen bonding and ring stacking. 
The water molecule is central to the hydrogen bonding, 
being joined to three different drug molecules. One of 
its donor bonds appears to be bifurcated, the hydrogen 
atom being equally directed towards N(14) and 0(32) of 
the same molecule. These distances are summarised in 
Table 5.1, together with some of the close inter-
-110-
molecular contacts. The main hydrophobic interactions 
involve atoms of the methoxy phenyl ring 3 interacting 
with the piperazine ring of the molecules related to it 
by the inversion centres at ~' 1, 0 and o, 1, o. 
Table 5.1 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry D-H H ... A D ... A 
N(2)-H(2A) .... 0(34) -x,2-y,-z 1.00(5) 2.12(5) 3.1 02(6) 
N(2)-H(28) (none) 0.83(5) 
0(34)-H(34) ... 0(1W) -x,2-y,-z 0.95(5) 1.67(5) 2.605(5) 
0(1 W)-H(1 W) ... N(14) -x, 1-y,-z 0.74(6) 2.49(6) 3.193(5) 
0(32) -x, 1-y,-z 2.65(6) 3.094(5) 
0(1 W)-H(2W) ... N(3) 1 +x,y,z 0.89(5) 1.99(5) 2.863(6) 
b) C ... C Contacts Shorter than 3. 75A 
C(16) ...... C(35) -1-x,2-y,-z 3.523(7) 
C(16) ...... C(34) -1-x,2-y,-z 3.529(7) 
C(12) ...... C(12) -x, 1-y,-z 3.537(7) 
C(15) ...... C(35) -1-x,2-y,-z 3.623(7) 
C(1 ) ....... C(35) x,-1 +y,z 3.627(7) 
C(12) ...... C(34) -x,2-y,-z 3.681 (7) 
C(15) ...... C(36) -1-x,2-y,-z 3.687(7) 
C(13) ...... C(35) -x,2-y,-z 3. 713(7) 
C(13) ...... C(34) -x,2-y,-z 3.736(7) 
c) C ... N Contacts Shorter than 3. 75A 
C(12) ...... N(2) -x, 1-y,-z 3.547(6) 
C(3M) ...... N(2) -x,1-y,-z 3. 725(7) 
c) C ... O Contacts Shorter than 3. 75A 
C(16) ...... 0(1 W) -1 +x,y,z 3.298(6) 
C(24) ...... 0(34) x,1 %-y,% +z 3.375(6) 
C(34) ...... 0(1 W) -x,2-y,-z 3.400(6) 
C(35) ...... 0(1 W) -x,2-y,-z 3.537(6) 
C(12) ...... 0(1 W) -x,1-y,-z 3.571 (6) 
Figure 5.1 
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Molecular Perspective and Molecular Packing Diagrams (viewed along 
the b-axis) of GUFBHY 
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5.2 GUFBIP, GUFBIB and GUFBRIB 
5.2.1 GUFBIP 
Crystal Data 
Colourless plates from isopropanol, 0.32 x 0.20 x 
0.04 mm. 
cl8H2oC12N402. 2C3Hg0 I M = 515. 5 I triclinic I P1 (No. 2) I 
a= 10.256 (7}, b = 11.755 (6), c = 12.644 (8} A, 
a = 110.02 (4), {3 = 94.20 (4), 'Y = 104.30 (3) 0 , 
V = 13 6 6 . 9 A3 I z = 2 I V I z = 6 8 3 A3 . 
Lattice parameters refined from accurately measured 28 
values (18.4 - 21.4°) for 27 reflections 
De = 1 . 2 5 g cm-3, p. = 2 . 7 0 cm-1 , F ( 0 0 o) = 54 8 , 
T = 193K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer with Oxford Cryosystem 
attachment, MoKa, A= 0.71073 A. 3568 independent data 
(2 < e < 22°, -10 ~ h ~ 10, -12 ~ k ~ 12, 0 ~ 1 ~ 13} 
yielding 1744 data with I~ 3a (I). No measurable 
cryst?l decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86}. 
t>-1 = a 2 (F) + 0.00023F2, R = 0.049, wR = 0.054, 
S = 1.15 based on 340 parameters. Maximum shift/esd on 
last cycle= 0.07. Maximum and minimum ripple in 
difference electron density map : 0.24 and -0.24 e.A-3. 
5.2.2 GUFBIB 
Colourless plates from isobutanol, 0.4 x 0.5 x 0.08 mm. 
cl8H2oC12N402.2C4HtoO, M= 543.5, triclinic, Pi (No.2) I 
a= 10.328 (2), b = 11.767 (2}, c = 12.884 (3} A, 
a= 107.51 (1) 1 {3 = 96.37 (2), 'Y = 103.45 (1)
0
, 
V = 1424.4A3, z = 2, V/Z = 712 A?. 
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Lattice parameters refined from accurately measured 2e 
values (15.0 - 21.2°) for 31 reflections. 
D c = 1 . 2 7 g . cm- 3 , Jl = 2 . 6 2 cm -l , F ( 0 0 0 ) = 5 8 0 , 
T = 193 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer with Oxford Cryosystem 
attachment, MoKa, A = 0.71073 A. 3588 independent data 
(2 < e < 22°, -10 ~ h ~ 10, -12 ~ k ~ 12, 0 ~ 1 ~ 13) 
yielding 2008 data with I~ 3a (I) .. No measurable 
crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86). 
ur 1 = cr2 ( F ) + o . o o o 5 9 F2 , R = o . o 57 , wR = o . o 6 8 , 
S = 1.23 based on 328 parameters. Maximum shift/esd on 
last cycle = 0.09. Maximum and minimum ripple in 
difference electron density map : 0.40 and -0.30 e.A- 3 • 
Substantial disorder was apparent in solvent molecules. 
In molecule 1, two positions were refined isotropically 
with half site occupancy for the terminal methyl group, 
C(4A') and C(4A"). In molecule 2, it was necessary to 
consider two alternative chains and four atoms with 
half site occupancy. The two carbon chains consist of 
C(1B')-C(2B)-C(3B')-C(4B') and C(1B")-C(2B)-C(3B")-
C(4B"), where C(1B") and C(3B') effectively occupy the 
same position. In this molecule only 0(2B) was refined 
anisotropically. 
5.2.3 GUFBRIB 
Colourless plates from R isobutanol, 0.4 x 0.5 x 
0.08 mm. 
C18H20Cl 2N40 2 .2C4H100, M= 543.5, triclinic, P1 (No.1), 
a= 10.42 (2), b = 11.90 (1), c = 13.06 (2) A., 
a= 107.0 (1) 1 ~ = 96.6 (1) 1 'Y = 103.9 (1) 0 1 
V= 1473.76 A3 , Z = 2, V/Z = 737 A3 • 
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Lattice parameters refined from accurately measured 2e 
values (20.2 - 21.0) for 15 reflections. 
De = 1 . 2 2 g . cm- 3 , T = 1 9 3 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer with Oxford Cryosystem 
attachment, MoKa, A = 0.71073 A. Crystal not good 
enough to collect data. 
Structure Discussions 
The three compounds are essentially isomorphous, the 
cell volumes of GUFBIB and GUFBRIB being extended 
(mainly by elongation of c) by 57A3 and 107A3 
respectively, in order to accommodate four extra CH2 
groups in the solvent molecules. The cell volume of 
GUFBRIB is larger than its achiral analogue, GUFBIB, 
due to increased disorder and reduced packing 
efficiency in the non-centrosymmetric cell. 
Selected bond lengths, angles and torsion angles are 
given 1n Tables 5.10.1-5.10.3. 
The molecular perspective diagrams of GUFBIP and 
GUFBIB, together with the molecular packing diagram of 
GFUBIP are shown in Figure 5.2.1. One of the solvent 
molecules forms a unique donor hydrogen bond with N(3) 
in both GUFBIP and GUFBIB, while the other is 
bifurcated, giving closest contact with 0(32) and 
slightly more distant contact with N(14) of the same 
molecule; a contact of the same type was found in 
GUFBHY. These contacts are shown in Figure 5.2.2 and 
the distances are summarised in Table 5.2, together 

















































































































































































































































































































































































































































































































































































































































































































































Molecular Perspective Diagrams of GUFBIP and GUFBIB and 
Molecular Packing Diagram (viewed along the b-axis) of GUFBIP 
Figure 5.2.2 
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Perspective View of the Molecule of GUFBIP together with Associated 





Small hexagonal plates from ethanol, 0.23 x 0.13 x 
0.05 mm. 
2 (C1aH21Cl2N402)+.C4H2o/-.C2H60, M= 476.2, monoclinic, 
P2 1/n (alternative setting of P2 1/c, No.14), 
a= 14.449 (19), b = 11.240 (9), c = 16.239 (16) A, 
~ = 111.09 {8} 0 , V= 2460.7 A3 , Z = 4, V/Z = 615 A3 • 
Lattice parameters refined from setting angles for 20 
reflections with 2e between 30 and 35°. 
De = 1. 2 8 g cm- 3 , Jl = 2 6. 8 0 cm-1, F ( 0 0 0) = 10 9 6, 
T = 290 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer, CuKa, A = 1.54178 A. 2742 
independent data (2 <9 < 60°, 0 ~ h ~ 16, 0 ~ k ~ 12, -
8 ~ 1 ~ 18) yielding 1294 data with I ~ 2.5cr (I). No 
measurable crystal decay or movement. 
Structure Solution and Refinement 
Soluti?n by direct methods (SHELX 86). 
ur 1 = cr2 ( F) + o . o o o 4 o F2 , R = o . o 6 5 , wR = o . o 6 7 , 
S = 1.337 based on 312 parameters. Maximum shift/esd 
in the last cycle was 0.177, this was associated with a 
badly disordered ethanol fragment. Maximum and minimum 
ripple in difference electron density map : 0.29 and 
-0.31 e.A- 3 • 
Substantial disorder was apparent in solvent molecules 
and it was necessary to consider two alternative alkyl 
chains and four atoms with partial site occupancy 
(C(1S) :0.386/C{2S) :0.724 and C(3S) :0.712/C(4S) :0.467). 
In this molecule, only 0(1S) was refined 
anisotropically and no hydrogens were located. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
-119-
given in Tables 5.10.1-5.10.3. The molecular 
perspective diagram and the molecular packing (as 
viewed along the b-axis) are shown in Figure 5.3. It 
is dominated by hydrogen bonding and ring stacking and 
comprises of parallel interleaved sheets of 
methoxyphenyl ring systems forming parallel bilayers. 
The dichlorophenyl rings sit on the edge of the bilayer 
with one chlorine projecting into the layer and one 
outwith. The anions straddle the resulting channel 
between the parallel bilayers with the double bond 
being located on a special position, the remainder of 
the channel being occupied by water and disordered 
ethanol molecules (the latter were omitted from the 
packing diagram for clarity). The hydrogen bonding and 
other close intermolecular contacts are summarised in 
Table 5.3. The phenolic oxygen, 0(34) forms a 
bifurcated hydrogen bond with the fumarate oxygens, 
giving closest contact with 0(1C) and slightly more 
distant contact with 0(2C) of the same molecule. A 
similar bifurcated hydrogen bond is formed between the 
guanidino nitrogen, N(3) and the fumarate oxygen, 0(2C) 
and the phenolic oxygen, 0(34); giving closest contact 
to the former and longer contact with the latter atoms 
of the same molecule. 
Table 5.3 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
0(34)-H(34) ... 0(1C) x,y,z 0.76 1.91(10) 2.670(11) 
0(2C) x,y,z 0.76 2.79(1 0) 3.300(11) 
0(1 C)-H(2A) ... N(2)* %-x,-% +y, 1 %-z 1.22 1. 77(8) 2.977(11) 
N(2)-H(2B) .... 0(1 S) % + X, % -y ,-% + Z 0.97 1.94(9) 2.905(11) 
0(1 S)-H .... 0(2C) x,y,z 2. 733(11) 
N(3)-H(3) ..... 0(2C) -x, 1-y, 1-z 1.34 1.51(13) 2.799(11) 
0(34) -x, 1-y, 1-z 1.34 2.66(13) 3.205(11) 
* salt H-bond 
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b) C ... C Contacts Shorter than 3. 75A 
C(2C) ...... C(1 C) -x, 1-y,2-z 2.47(2) 
C(3M) ...... C(1 S) % +x,1 %-y,-% +z 3.19(4) 
C(1 ) ....... C(4S) -x,1-y,1-z 3.40(3) 
C(23) ...... C(2S) % +x, %-y,-% +z 3.55(3) 
C(22) ...... C(2S) % + X, % -y I-% + z 3.57{3) 
C(24) ...... C(32) -% +x, %-y,-% +z 3.62(2) 
C(23) ...... C(4S) %+x,%-y,-%+z 3.67(3) 
C(24) ...... C(1 S) -% +x, %-y,-% +z 3.68(4) 
C(16) ...... C(34) -x,1-y,1-z 3.69(2) 
C(1 ) ....... C(2S) -x, 1-y, 1-z 3.70(3) 
C(25) ...... C(1 S) % +x, %-y,-% +z 3.71 (4) 
C(26) ...... C(3M) x,-1 +y,z 3.72(2) 
C(23) ...... C(13) % +x, %-y,% +z 3.72(2) 
c) C ... N Contact Shorter than 3. 75A 
C(4S) ...... N(2) -x, 1-y, 1-z 3.48(3) 
C(3M) ...... N(2) x,1+y,z 3.58(1) 
C(3S) ...... N(3) -x,1-y,1-z 3.66(2) 
C(2S) ...... N(11) -x, 1-y, 1-z 3.68(2) 
C(4S) ...... N(11) -x, 1-y, 1-z 3.70(3) 
. 
d) C ... O Contacts Shorter than 3.75A 
C(1 C) ...... 0(1 Cl -x, 1-y,2-z 2.96(2) 
C(1 S) ...... 0(32) -% +x,1 %-y,% +z 3.02(4) 
C(13) ...... 0(34) %-x,-% +y,1 %-z 3.14(2) 
C(21 ) ...... 0(34) -x,1-y,1-z 3.31(1) 
C(2C) ...... 0(34) x,y,z 3.33(2) 
C(16) ...... 0(2C) -x,1-y,1-z 3.34(1) 
C(1 C) ...... 0(1 S) x,y,z 3.34(2) 
C(2S) ...... 0(2C) x,y,z 3.38(2) 
C(12) ...... 0(1 C) %-x,-% + y, 1 %-z 3.37(1) 
C(3S) ...... 0(2C) x,y,z 3.41 (2) 
C(1 C) ...... 0(2C) -x,1-y,2-z 3.45(2) 
Figure 5.3 
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Molecular Perspective and Packing Diagrams (viewed along the b-axis) 
ofGUHFUMET 
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5 . 4 GUMACEHY 
crystal Data 
Colourless plates from 95% aqueous ethanol, 0.20 x 0.15 
x 0.03 mm. 
C18H21 Cl2N40 2+.c2H3o2-.H20, M= 455.3, monoclinic, P2 1fc 
(No.14), a= 8.918 (1), b = 11.322 (2), c = 22.362 (3) 
A I {3 = 9 3 . 8 2 ( 1) 0 I V = 2 2 52 . 7 A3 I z = 4 I V I z = 56 3 A3 • 
Lattice parameters refined from accurately measured 28 
values (24.8 - 31.6°) for 24 reflections. 
De = 1 . 3 9 5 g cm-3 , p. = 2 . 7 8 cm-1 , F ( 0 0 0) = 9 8 4 , 
T = 290 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer, MoKa, A= 0.71069 A. 3119 
independent data (2 < e <25°, -10 ~ h ~ 10, -13 ~ k ~ 
13, -8 ~ 1 ~ 26) yielding 2026 data with I ~ 2.5a (I). 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86). 
t>-1 = a2 (F) + 0.000116F2 , R = 0.0505, wR = 0.0505, 
S = 1~128 based on 301 parameters. Maximum shiftjesd 
in the last cycle = -0.053. Maximum and minimum ripple 
in difference electron density map : 0.23 and -0.24 
A-3 e. . 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 5.10.1-5.10.3. The molecular 
perspective and packing diagrams (as viewed along the 
b-axis) are shown in Figure 5.4. GUMACEHY shows major 
conformational differences from the majority of GU 
structures. Instead of the extended conformation, it 
demonstrates a folded conformation, mainly involving 
rotations about the single non-ring bonds at N(3) and 
N(11), as evidenced by the torsion angle, N(11)-C(1)-
N(3)-C(21) = 37.05(7) 0 • 
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The water molecule is central to the hydrogen bonding, 
being joined to three different drug molecules. 
As with previous structures, one of its donor bonds 
appears to be bifurcated, giving closest contact with 
N(14) and a long contact with 0(32) of the same 
molecule. The strength of these bifurcated hydrogen 
bonds, is the inverse of that observed with the 
isomorphous alcohol solvates, GUFBIP and GUFBIB. These 
distances are summarised in Table 5.4, together with 
some close intermolecular contacts. 
Table 5.4 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
N(2)-H(2B). .. 0(1W) 1-x,% +y, %-z 0.86 2.00(5) 2.855(6) 
0(1 W)-H(1 W) ... N(14) x,y,z 0.98 1.94(5) 2.811(5) 
0(32) x,y,z 0.98 2.98(5) 3.330(5) 
0(1 W)-H(2W) ... 0(34) 1 +x,y,z 0.82 1 .97(5) 2.786(5) 
0(34)-H(34) ... 0(1S) 1 +x,y,z 0.85 1.77(5) 2.613(5) 
0(1 S)-H(2A) ... N(2)* x,-1+y,z 0.96 1.95(5) 2.901 (6) 
N(3)-H(3) ..... 0(2S) x,-1 +y,z 0.92 1.88(5) 2.742(5) 
* salt H-bond 
b) C ... C Contacts Shorter than 3.75A 
C(3M) ...... C(1 S) x,y,z 3.486(9) 
C(24). ..... C(3M) 1-x, 1-y, 1-z 3.490(9) 
C(24) ...... C(1 S) -x,-y, 1-z 3.574(7) 
C(24) ...... C(1 S) -x,1-y,1-z 3.603(7) 
C(25). ..... C(21) -x,-y, 1-z 3.633(7) 
C(3M) ...... C(25) x,y,z 3.674(9) 
C(22). ..... C(25) -x,-y, 1-z 3.676(7) 
C(24). ..... C(21) -x,-y, 1-z 3.676(7) 
C(25). ..... C(3M) 1-x, 1-y, 1-z 3.681 (9) 
C(23). .. ; .. C(26) -x,-y, 1-z 3.712(7) 
c) C ... N Contacts Shorter than 3. 75A 
C(1 S) ...... N(11) 
C(1 S) ...... N(3) 
x,1+y,z 
x, 1 +y,z 
d) C ... O Contacts Shorter than 3. 75A 
C(13) ...... 0(1 W) x,y,z 
C(13) ...... 0(1 W) 1-x,-% +y, %-z 
C(12) ...... 0(1 W) 1-x,-% +y,%-z 
C(12) ...... 0(1W) x,y,z 
C(15) ...... 0(2S) 1-x, 1-y, 1-z 
C(16) ...... 0(2S) 1-x,1-y,1-z 
C(1 5) ...... 0(1 W) x,y,z 
C(2S) ...... 0(34) -1 + x,y,z 
C(1 5) ...... 0(34) -1 + x,y,z 
C(34) ...... 0(1 S) 1 + x,y,z 
C(1 ) ....... 0(25) x,-1 +y,z 
C(24) ...... 0(1 S) -x,1-y,1-z 
C(13) ...... 0(34) 2-x,-% + y,0.5-z 
C(26) ...... 0(2S) x,-1 +y,z 


























Colourless, misshapen, triangular plates from water, 
0.25 x 0.25 x 0.1 mm. 
C18H21Cl2N40 2 +. C6H90 6-. H20, M = 591. 5, triclinic, P1 (No. 1) , 
a= 7.748 (5), b = 9.347 (4), c = 19.419 (7) A, a= 
86.19 (4) I {3 = 86.84 (6) I 'Y = 65.61 (5) 0 1 
V = 12 7 9 . 3 A3 I z = 2 I V I z = 6 4 0 A3 • 
Lattice parameters refined from accurately measured 28 
values (16.7 - 31.1°) for 15 reflections. 
De = 1.535 g cm~, ~= 2.64 c~1 , F(OOO) = 616.0, 
T = 290 K. 
Data Collection and Processing 
Enraf-Nonius CAD-4 diffractometer, MoKa, A= 0.71073 A. 
4513 independent data (2 < e < 25°, -9 ~ h ~ 9, 
-11 ~ k ~ 11, 0 ~ 1 S 16) yielding 2837 data with I ~ 
2.5a (I). No measurable crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX84). 
fa>-1 = a 2 (F) + 0.000584F2 , R = 0.045, wR = 0.0440, 
s = 1.117 based on 250 parameters. Maximum shiftjesd 
0.84. Maximum and minimum ripple in difference 
electron density map : 0.29 and -0.28 e.A-3 • Due to the 
presence of two crystallographically independent 
molecules within the unit cell, the molecule was 
refined in three separate parts (cation 1, cation 2 and 
all anions plus water molecules) each part refined in 
separate consecutive cycles. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 5.10.1-5.10.3. The molecular 
perspective diagrams of the two crystallographically 
independent molecules within the unit cell are shown in 
Figure 5.5.1. Due to the presence of the chiral anion 
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the structure must be non-centrosymmetric (with space 
group P1), however, the N(Z) test indicates a high 
pseudo-centrosymmetric character: 
z HKL Centro Non-Centro 
0.1 24.60 24.81 9.52 
0.2 34.04 34.53 18.13 
0.3 39.73 41.87 25.92 
0.4 45.53 47.38 32.97 
0.5 50.74 52.05 39.35 
0.6 56.06 56.14 45.12 
0.7 59.79 59.72 50.34 
0.8 62.50 62.89 55.07 
o.q 65.27 65.72 59.34 
1.0 67.82 68.33 63.21 
A pseudo-centre of inversion was determined between 
each pair of atoms and meaned over the whole structure 
(x = 0.7539, y = 0.8747 and z = 1.4009); the deviation 
of the atom pairs from the pseudo-centre of inversion 
(A) was then determined and is tabulated 1n Table 
5.5.1. 
Table 5.5.1 Deviation of Centroid of Atom Pairs from Pseudo-Centre of Inversion in A 
Pseudo centre of Inversion at: 
0.75390 0.87474 1.40093 
C21 C61 0.0827 -0.0729 -0.0443 
C22 C62 0.0679 -0.0499 -0.0710 
C23 C63 0.0456 -0.0479 -0.0374 
CL23 CL63 0.0607 -0.0379 -0.0453 
C24 C64 0.0584 0.0012 -0.0370 
C25 C65 0.0463 -0.0364 -0.0469 
CL25 CL65 0.0308 -0.0312 -0.0459 
C26 C66 0.0307 -0.0093 -0.0426 
N3 N3· 0.0361 -0.0565 -0.0264 
C1 C1· -0.0306 -0.0845 -0.0302 
N2 N2· -0.0661 -0.1629 0.0970 
N11 N51 -0.0301 -0.0116 -0.0757 
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C12 C52 0.0264 0.0018 -0.1344 
C13 C53 -0.0721 0.0786 -0.0747 
C15 C55 -0.0246 -0.0378 0.0144 
C16 C56 0.0409 -0.0130 -0.0264 
N14 N54 0.0071 0.0106 0.0058 
C31 C71 -0.0476 0.0417 0.0373 
C32 C72 0.0561 0.0112 0.0165 
032 072 0.0545 0.0778 0.0082 
C3M C7M 0.1131 0.1420 -0.0041 
C33 C73 -0.0255 0.0355 0.1021 
C34 C74 -0.1030 0.0522 0.1313 
034 074 -0.0940 0.0321 0.1764 
C35 C75 -0.1378 0.0905 0.0949 
C36 C76 -0.1249 0.0791 0.0530 
ESDS of Centre 0.00863 0.00684 0.00391 
In order to accomodate the chiral anions the 
conformations of the cations are significantly altered 
(see Figure 5.5.1) 1 mainly involving rotations about 
the single non-ring bonds at N ( 3) , N ( 11) and N ( 14) , 
also previously observed with GUMACEHY. 
The cations, as a result, pack in a very efficient 
manner, with the dichlorophenyl rings twisted ea 80° 
out of the plane of the remainder of the molecule. 
These rings stack up in interleaved layers; with 
considerable dipolar interaction between ring systems, 
on adjacent sides of the resulting hydrophobic channel. 
This is particularly well illustrated when viewed along 
the a-axjs (Figure 5.5.2). 
The molecular packing as viewed along the b-axis, lS 
shown in Figure 5.5.2, also serves to illustrate the 
hydrophobic and hydrophilic channels. The latter 
channel is occupied by the more polar functionalities 
of the cation; the guanidinium and methoxy groups, 
protruding into the channel, with the anions and water 
molecules occupying the remaining volume. 
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The 1H NMR of GUMASCHY (see Table 5.5.2) suggests that 
the ascorbate anion is present as the resonance hybrid 
of the two forms a and b. 
Where R = CH(OH)C~OH 
Thus, it is possible for the anion to form salts using 
either 0(41/81) or 0(43/83) as the donating oxygen. 
Interestingly, in the crystal structure each of the 
independent anions utilises a different acidic oxygen 
atom to form a salt with the cation. The hydrogen 
bonding scheme in Figure 5.5.4, shows that an1on I 
utilises 0(43) for salt formation, whereas an1on II 
utilises 0(81) for salt formation. 
The molecular packing is dominated by hydrogen bonding 
with the two independent water molecules being central 
to the whole scheme~ Each being joined to three 
different drug molecules. 
One of the donor bonds from N(2') appears to be 
bifurcated, the hydrogen atom being equally directed 
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towards 0(80) and 0(2W); similarly, the donor bond from 
0(85) is bifurcated giving closest contact with 0(41) 
and a long contact with 0(40) of the same molecule. 
These distances are summarised in Table 5.5.3, together 
with some of the close intermolecular contacts. 
Table 5.5.3 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
0(34)-H(34) ... 0(43) -1+X,1+y,1+Z 0.88 1.95(8) 2.646(7) 
N(3)-H(3) ....... 0(43) 1+X,y,1+Z 0.77 2.61 (9) 3.167(8) 
0( 43)-H(2A)* .. N(2) 1+X,y,1+Z 0.88 1.71 (8) 2.766(8) 
N(2)-H(2B) ..... 0(1W) 1+X,y,1+Z 1.15 2.08(8) 3.017(9) 
0(1W)-H(1WZ) .. 0(83) x,y,z 0.74 2.639(9) 
0(45)-H(45) .... 0(83) 1+x,y,z 0.87 1.91 (9) 2.742(8) 
0(42)-H(42) ... 0(1W) 1+x,-1+y,z 1.11 1.86(8) 2.792(9) 
0(1 W)-H(1 W1 ) ... 0(46) x,y,z 0.63 2.29(9) 
2.891 (9) 
0(46)-H(46) ... 0(32) x,y,1+z 1.25 1.57(7) 2.741 (7) 
0(82)-H(~2) ... 0(2W) -1+x,y,z 0.50 2.45(13) 2.688(11) 
0(2W)-H(2W1 ) ... 0(86) x,-1+y,z 0.64 2.11 (9) 
2.742(8) 
0(86)-H(86) ... 0(46) x,1+y,z 0.94 1.88(8) 2.751 (8) 
0(7 4)-H(7 4) ... 0(81) 1+x,-1+y,z 1.23 1.41 (7) 2.647 
(7)N(3')-H(3) ...... 0(81) -1+x,y,z 0.96 2.00(7) 2.972(8) 
0(81)-H(2B')*. N(2') -1+x,y,z 0.95 2.52(8) 3.024(9) 
N(2')-H(2A') .. 0(80) -1+x,y,z 0.74 2.28(8) 2.890(8) 
0(2W) -1+x,-1+y,z 0.74 2.03(8) 2.936(9) 
0(2W)-H(2W2) ... 0(41) x,-1 +y,z 0.64 2.669(8) 
0(85)-H(85) ... 0(41) 1+x,y,z 1.09 1.84(8) 2.815(8) 
0(40) 1+x,y,z 1.09 2.49(8) 3.339(8) 
* salt H-bond 
b) C ... C Contacts Shorter than 3.75A. 
C23 .......... C65 2+x,y,z 3.471 (1 0) 
C24 .......... C63 2+x,y,z 3.472(1 0) 
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C62 .......... C75 -1 +X, 1 +y,z 3.499(1 0) 
C24 .......... C63 2+x,y,z 3.511 (1 0) 
C23 .......... C64 2+x,y,z 3.522(1 0) 
C62 .......... C74 -1+X,1+y,z 3.534(1 0) 
C22 .......... C35 1+X,-1 +Y,Z 3.540(9) 
C15 .......... C34 1+x,y,z 3.587(9) 
C41 .......... C85 1+x,y,z 3.602(11) 
C24 .......... C64 2+x,y,z 3.604(11) 
C16 .......... C34 1+x,y,z 3.609(9) 
C56 .......... C74 -1+x,y,z 3.61 0(1 0) 
C3M .......... C42 x,1+y,1+z 3.649(11) 
C33 .......... C42 -1+X, 1+y, 1+Z 3.649(1 0) 
C7M .......... C81 x,-1 +y,z 3.653(11) 
C24 .......... C62 2+x,y,z 3.655(1 0) 
C33 .......... C43 -1+X, 1+y, 1+Z 3.659(11) 
C22 .......... C34 1+x,-1+y,z 3.666(9) 
C12 .......... C45 x,y, 1+z 3.667(1 0) 
C22 .......... C64 2+x,y,z 3.669(1 0) 
c) C ... N Contacts Shorter than 3. 75A 
C(81) ........ N(2') 1+x,y,z 3.354(1 0) 
C( 43) ....... _.N(2) -1 +X,y,-1 +Z 3.415(10) 
C(44) ........ N(2) -1+X,y,-1+Z 3.540(1 0) 
C(71 ) ........ N(2') 1+x,y,z 3.640(9) 
C(45) ........ N(14) x,y,-1+z 3.714(8) 
d) C ... O Contacts Shorter than 3.75A 
C(16) ........ 0(42) X, 1+y, 1+Z 3.017(9) 
C(85) ........ 0( 41) -1+x,y,z 3.064{9) 
C(46) ........ 0(86) x,1+y,z 3.175(1 0) 
C(3M) ........ 0(46) x,y, 1+z 3.239(1 0) 
C(3M) ........ 0(45) -1+X,1+y, 1+Z 3.254(1 0) 
C(56) ........ 0(82) x,-1 +y,z 3.262(11) 
C(24) ........ 0(74) x, 1+y,z 3.279(9) 
C(15) ........ 0(42) X, 1+y, 1+Z 3.303(9) 
C(15) ........ 0(34) 1+x,y,z 3.314(8) 
C(46) ........ 0(83) 1+x,y,z 3.319(1 0) 
C(86) ........ 0(72) x,y,z 





Figure 5.5.1 Molecular Perspective Diagrams of GUMASCHY (Molecules 1 and 2) 
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Figure 5.5.2 Molecular Packing Diagrams (viewed along the a- and b-axes) of 
GUMASCHY 
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(6) Multiplicity (M) Integral Assignment 
2.84 m,b 4 NCH2 
3.41 d superimposed on 2 C(46)H2-0H 
3.48 m,b 4 NCH2 
3.65 d,d superimposed on 1 C(45)fi-OH 
3.70 s 3 OCH3 
4.54 d 1 040-C( 41 Hi 
6.27 dd H(35) 
6.38 d H(33) 
6.72 d H(36) 
6.80 d 2 H(22)/H(26) 
7.01 H(24) 
9.00 s,b 0!:! 
3-7 s,v,b -5 NH2 , OH x 3 
m • multiplet, d • doublet, s • singlet, t • triplet, dd • double doublet, b • broad, 
vb • very broad 
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Figure 5.5.3 Hydrogen Bonding Scheme for GUMASCHY 
017Ll---OI81l---NI2'l / ' ' /0!821 
'o!2WI NO{' ofoo1 
01/ ~O!Lll------ · -01851-- ·- ·-- -O!LOI 
/011.61 · N!2J--· --Q(L.])---OIJLI 
omJ ~01/ ~NIJJ 
0 ) 
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5. 6 GUMHCLHYIP 
Crystal Data 
Colourless plates from isopropanol, 0.42 x 0.21 x 
0.07 mm. 
C18H21Cl 2N40 2+.cl-.H20.2C3H80, M= 569.9, triclinic, P1 
(No.2), a= 9.690 (1), b = 12.352 (2), c = 13.562 (2) 
A, a= 103.83 (1), p = 90.02 (6), y = 108.54 (1) 0 , 
V= 1489.2 A3 , z = 2, V/Z = 745 A3 • 
Lattice parameters refined from accurately measured 2e 
values (30-35°) for 28 reflections. 
De = 1. 2 7 g cm- 3 , Jl = 2 9. 8 cm- 1 , F ( 0 0 0) = 6 0 4, 
T = 290 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer, CuKa, A = 1.54183 A. 4233 
independent data (3 < e < 60°, -10 ~ h ~ 10, 
-13 ~ k ~ 12, 0 ~ 1 ~ 15) yielding 2402 data with I ~ 
2.5cr (I). No measurable crystal decay and a maximum 
drift correction of 1.10 applied. 
Structure Solution and Refinement 
Solution by direct methods (SHELX86). 
ur 1 = cr2 (F) + o . o o o 4 9 F2 , R = o . o 81 , wR = o . o 9 9 , 
S = 1.33 based on 355 parameters. Maximum shift/esd in 
the last cycle = 0.20. Maximum and minimum ripple in 
difference electron density map : 0.58 and -0.52 e.A- 3 • 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given 1n Tables 5.10.1-5.10.3. The molecular 
perspective and packing diagrams as viewed along the b-
axis is shown 1n Figure 5.6. It 1s dominated by 
hydrogen bonding and ring stacking. These distances 
are summarised in Table 5.6. 
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Table 5.6 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 











Cl(1 )# 1-x,-y,-z 
0(2S) x,y,z 
Cl(1) x,-1 +y,z 
Cl(1) -x,-y,-z 
N(14) -x,-y ,-z 
0(32) -x,-y,-z 
Cl(1) -x,-y ,-z 
0(1W) 1 + x,y,z 
b) C ... C Contacts Shorter than 3.75A 
C(15) ...... C(35) 2-x,2-y,1-z 
C(12) ...... C(12) 1-x, 1-y, 1-z 
C(15) ...... C(34) 2-x,2-y,1-z 
C(1 S) ...... C(4S) 2-x, 1-y,-z 
C(16) ...... C(34) 2-x,2-y,1-z 
C(13) ...... C(22) 1-x, 1-y, 1-z 
C(3S) ...... C(6S) 1-x, 1-y,-z 
c) C ... N Contacts Shorter than 3. 75A 
C(1 S) ...... N(3) x,y,z 
d) C ... O Contacts Shorter than 3.75A 
C(26) ...... 0(1W) x,y,z 
C(22) ...... 0(5S) x,y,z 
C(4S) ...... 0(1 W) 1 + x,y,z 
C(12) ...... 0(2S) x,y,z 
C(5S) ...... 0(1 W) 1 + x,y,z 
C(21 ) ...... 0(5S) x,y,z 
C(1 ) ....... 0(2S) x,y,z 
C(26) ...... 0(2S) x,y,z 
D-H H ... A D ... A 
1.00(5) + 1.88(5) 2.863( 1 0) 
1.00(5) + 2.29(5) 
1.00(6)* 1.81 (6) 
1.00(6) + 2.20(6) 




























Molecular Perspective and Molecular Packing Diagrams (viewed along 
the b-axis) of GUMHCLHYIP 
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5. 7 GUDMES 
Crystal Data 
Colourless plates from 16% aqueous isopropanol, 0.36 x 
0.24 x 0.12 mm. 
C18H22Cl2N4o/+. 2CH3so3-, M= 587.5, triclinic, P1 (No.2), 
a = 14.034 ( 5) 1 b = 8.315 ( 3) 1 c = 12.222 ( 6) A, 
a = 102.52 ( 7) 1 {3 = 109.95 ( 8) 1 'Y = 91.17 ( 6) O 1 
V = 1301.8 A3 I z = 2 I V/Z = 651 A3 • 
Lattice parameters refined from accurately measured 28 
values (9.4-25.1°) for 10 reflections. 
De = 1 . 4 9 8 g cm-3 , p. = 4 · 5" cm-1 , F ( 0 0 0) = 612 . o , 
T = 290 K. 
Data Collection and Processing 
Stoe STADI-4 diffractometer, MoKa, A=0.71069A. 3395 
independent data {2 < e < 25°, -15 ~ h ~ 15, -8 ~ k ~ 
8, 0 ~ 1 ~ 12) yielding 1810 data with I~ 2.5a (I). 
Structure Solution and Refinement 
Solution by direct methods {SHELX86). 
fa>-1 = a'! {F) + 0.000296F2 , R = 0.0525, wR = 0.0494, 
S = 1.252 based on 349 parameters. Maximum shiftfesd 
in the last cycle = 0.076. Maximum and minimum ripple 
in difference electron density map : 0.38 and -0.32 
e.A-3 • The chlorines {Cl{23) and Cl{25)) and one of the 
mesylate oxygens {0{3S)) showed evidence of some 
thermal disorder. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tabl~s 5.10.1-5.10.3. The molecular 
perspective and packing diagrams as viewed along the b-
axis are shown in Figure 5.7. It is dominated by 
hydrogen bonding and ring stacking. The ring systems 
stack up in interleaved pairs, alternating between 
dichlorophenyl and methoxyphenyl pairs. There is a 
unique intra-molecular hydrogen bond formed between the 
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piperazine nitrogen, N(14) and the methoxy oxygen, 
0(32). These distances are summarised in Table 5.7, 
together with some of the close intermolecular 
contacts. 
Table 5.7 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
0(1 S)-H(2A) ... N(2)* x, 1 +y, 1 +z 0.82 2.03(8) 2.827(9) 
N(2)-H(2B) .... 0(34) x,y, 1 +z 0.97 1 .93(7) 2.855(9) 
0(34)-H(34) ... 0(2S) x,y,z 0.80 1.83(8) 2.626(7) 
0(4S)-H(14) ... N(14)* x, 1 +y,z 0.90 1.91 (7) 2. 747(8) 
N(14)-H(14) ... 0(32)# x,y,z 0.90 2.33(7) 2.650(8) 
N(3)-H(3) ..... 0(55) x,y,z 0.71 2.08(8) 2.777(8) 
* salt H-bonds 
# intra-molecular H-bond 
b) C ... C Contacts Shorter than 3. 75A 
C(23) ..... C(35) x,y, 1 + z 3.452(11) 
C(24) ..... C(35) x,y, 1 +z 3.453(12) 
C(23) ..... C(23) -x,1-y,2-z 3.567(13) 
C(24) ..... C(36) x,y, 1 +z 3.638(12) 
C(23) ..... C(24) -x,1-y,2-z 3.641 (13) 
C(22) ..... C(24) -x, 1-y,2-z 3.717(12) 
C(35) ..... C(3M) x,1 +y,z 3.725(11) 
C(25) ..... C(34) x,y, 1 + z 3. 752(12) 
C(36) ..... C(3M) x, 1 +y,z 3. 752(12) 
c) C ... N Contacts Shorter than 3. 75A 
C(34) ..... N(2) x,y,-1 +z 3.684(1 0) 
d) C ... O Contacts Shorter than 3. 75A 
C(12) ...... 0(5S) x,y,z 3.137(9) 
C(12) ..... 0(4S) x,1+y,z 3.165(9) 
C(16) ..... 0(1 S) X, 1 + y, 1 + Z 3.188(8) 
C(13) ..... 0(6S) -x, 1-y, 1-z 3.189(1 0) 
Figure 5.7 
-142-
Molecular Perspective and Molecular Packing Diagrams (viewed down 
the b-axis) of GUDMES 
-143-
5 . 8 GUDHCLHY 
Crystal Data 
Colourless plates from methanol, 0.38 x 0.12 x 0.08 mm. 
C18H22Cl 2N40/+.2cl-.H20, M= 486.2, monoclinic, P2 1 /c 
(N0.14) 1 a = 8. 782 (1) 1 b = 16.638 (3) 1 C = 15.432 (3) 
A, p = 97.03 (2) 0 , V= 2237.9 A?, z = 4, V/Z = 560 A3 • 
Lattice parameters refined from accurately measured 2e 
values (20-30°) for 25 reflections. 
De= 1.44 g cm- 3 , J.l = 5.56 cm-1 , F(OOO) = 1008, 
T = 290 K. 
Data Collection and Pr0cessing 
Stoe STADI-4 diffractometer, MoKa, A = 0.71073 A. 3058 
independent data ( 3 < 2e < 45° 1 -9 ~ h ~ 91 0 ~ k ~ 
17, 0 ~ 1 ~ 16) yielding 1232 data with I~ 2.5a (I). 
No measurable crystal decay and a maximum drift 
correction of 1.01 applied. 
Structure Solution and Refinement 
Solution by direct methods (SHELX86) . 
ur 1 = a2 (F) + o . o o o 16F2 I R = o . o 52 I wR = o . o 59, 
S = 1.16 based on 283 parameters. Maximum shift/esd in 
the last cycle = 0.01. Maximum and minimum ripple in 
difference electron density map : 0.31 and -0.26 e.A- 3 • 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 5.10.1-5.10.3. A major conformational 
difference occurs in GUDHCLHY relative to most of the 
protonated and free base structures. The C(1)-N(11) 
bond is short and it may no longer be described as 
being equ~torial to the piperazine ring, the two 
exocyclic torsion angles having a mean absolute value 
of 118.4°. This indicates an increase in the double 
bond character of the bond and the change in 
conformation is clear in Figure 5.8. 
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The molecular packing as viewed along the b-axis is 
also shown in Figure 5.8. It is dominated by hydrogen 
bonding and ring stacking. These distances are 
summarised in Table 5.8. Unlike GUDMES, there is no 
internal hydrogen bond between the piperazine nitrogen 
N{l4) and the methoxy oxygen, 0{32). 
Table 5.8 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 
N(2)-H(2A) ... Cl(1) 1 +X, 1 %-y, 1 % + Z 
N(3)-H(3) .... Cl(1 )* ·1 + x,y,z 
N(14)-H(14) .. Cl(2) * 1 +x,y,z 
0(34)-H(34) .. 0(1W) x, %-y,z-% 
0(1 W)-H(1 W) .. Cl(1) -x, 1-y,-z 
0( 1 W)-[H(2W)]. Cl(2) x, %-y,% +z 
N(14)-H(14) ... 0(32) x,y,z 
* salt H-bonds 
b) C ... C Contacts Shorter than 3. 75A 
C(16) ...... C(35) -1-x,1-y,-z 
c) C ... N Contacts Shorter than 3.75A 
C(33) ...... N(2) 
C(34) ...... N(2) 
1 + X, 1 % -y I % + z 
1 +X, 1 %-y,% + Z 
d) C ... O Contacts Shorter than 3. 75A 
C(34) ...... 0(1 S) 
C(35) ...... 0(1 S) 
C(3M) ...... 0(1 S) 
C(13) ...... 0(1 S) 
x, %-y,-% +z 
x, %-y,-% +z 
-x,1-y,1-z 
-1 +x, %-y,-%-z 
0-H H ... A 
1.31 (8) 1.88(8) 
0.92(9) 2.22(9) 
1 .39(8) 1 .65(8) 
0.93(9) 1.82(10) 



















Molecular Perspective and Molecular Packing Diagrams (viewed along 
the b-axis) of GUDHCLHY 
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5. 9 GUDSULF 
Crystal Data 
Small colourless plates from 50% w/v aqeuous 
isopropanol, 0.2 x 0.1 x 0.01 mm. 
c18H22Cl2N4o/+. S042- I M = 493.2 I monoclinic I space group 
not identified, a= 14.29 (2), b = 8.35(2), 
c = 20.08 (4) A, p = 97.44 (15) 0 , V= 2376.4 A3 , z = 4, 
V /Z = 594 A3 • 
Lattice parameters refined from setting angles for 7 
reflections with e between 3.9 and 6.2°. 
De = 1 . 3 8 g. cm- 3 • 
Data Collection and Processing 
Stoe STADI-4 diffractometer with Oxford Cryosystem 
attachment, MoKa, A= 0.71073 A. Crystal not good 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GU is a N,N' disubstituted amidine, (in pursuance of Jen 
et al 1 , the term amidine is used here to include the 
system -N-C(X)=N, in which X=C,N,O and S). More 
specifically GU may be viewed as a N,N' disubstituted 
guanidine. GU is capable of existing as a monoanion (pKa 
11.5), neutral species (pKa 8.6), monocation (pKa 4.1) 
and dication. Under strongly acidic conditions it is 
potentially capable of existing as a trication. Only the 
neutral and cationic species were studied during these 
investigations. In solution GU can exist as an 
equilibrium mixture of all of these species; in practice 
the relative proportions, depends both on the ionisation 
constants and the pH of the media considered. The sites 
and order of protonation are shown in Figure 6.1.1. 
All attempts to produce the trication failed and the 
reasons for this are worthy of further discussion. 
Guanidine is a symmetrical amidine and has many unique 
chemical properties. 
The neutral species is the strongest organic base known 
(pka 13.6) approaching the hydroxide ion in its proton 
affinity2 • The monocation is one of the most stable 
carbonium ions ever isolated, being stable to boiling 
water. Pauling3 used valence bond theory to explain this 
great stability, calculating the resonance energy of the 
guanidine free base as -197 kJ.mol-1 and indicating that 
the monocation had a resonance energy of between 163-172 
kJ.mol- 1 (cf benzene 126-146 kJ.mol-1 ) ie a resonance 
stabilisation energy of 25-34 kJ.mol-1 • 
In terms of the Huckel 4 molecular orbital theory the 
calculated delocalisation energy (DE) for the guanidinium 
ion is 1.60P (-110.5 kJ.mol- 1 ). A proton may be removed 
from the guandinium ion in the plane of the molecule, 
-152-
orthogonal to the pi electron system, thus perturbing, 
but not fundamentally altering the 6 pi electron system. 
The resulting orbitals for guanidine reflect the loss of 
symmetry of the molecule, but retain most of the Y 
aromaticity2 • 5 with a DE of 1.2op (82.8 kJ.mol- 1 ). This is 
a loss of delocalisation energy of -0.4P or 27.6 kJ.mol- 1 
on deprotonation of the guanidinium ion, in good 
agreement with Pauling's estimate of 25-34 kJ.mol- 1 • 
However, Y-delocalised systems with more or less than 6 
pi electrons are decidedly less stable. BO/-, C0 3-, and 





The corresponding 4 pi electron systems are generally 
even less stable, being present as postulated 
intermediates or being stable only at extremely low 
temperatures. 
This then explains the reluctance of the substituted 
guanidinium ion to undergo additional protonation and 
move away from the highly stable 6 pi electron system. 
-153-




6.2 GU Tautomerism 
Whilst the guanidinium ion has three equivalent resonance 
forms, the free base exhibits three non-equivalent 
resonance structures, two of which are energetically, 
unfavoured as they involve separate charges. 
N monosubstituted and N,N' disubstituted amidines and 
guanidines display prototropic tautomerism: 
R - N = C - R' 
NH2 
R - NH - C - R' 
11 
NH 
(where R' is a substituted amino group in guanidines) 
The tautomeric equilibrium depends on the effects of the 
substituents at the nitrogen atoms 8 • 9 • 
The monoalkyl amidines and guanidines and N,N dialkyl 
amidines and guanidines should be weaker bases than the 
parent compound, as the replacement of one or two 
hydrogens of a primary amine group by alkyl groups tends 
to prevent double bond character from accumulating on 
this group. This is because, as carbon is more electro-
negative than hydrogen, it resists the build up of a 
positive charge on the adjacent nitrogen. In consequence, 
the double bond resonance is restricted to the two other 
nitrogen atoms. This causes a decrease in basic strength 
toward that found in an imidine group, the decrease 
being twice as great for the N,N dialkyl guanidines as 
for the monoalkyl guanidines. A very much larger effect 
would be expected for the N,N' dialkyl guanidines and 
indeed was observed for GU (pKa 8.6). The alkyl groups on 
two of the nitrogens would tend to force the double bond 








(where R' is a substituted amino group in guanidines) 
1s more important than the other two forms. This would 
have little tendency to add a proton and the substance 
would be a weak base3 • 
Prevorsek10 ' 11 investigating the IR spectra of N mono-
substituted and N,N' disubstituted amidines showed that 
alkyl groups tend to prefer attachment to the amino 
nitrogen of the amidine group, confirming Pauling's 
theories. However they found that the reverse was true 
for aryl groups: these conclusions were in agreement with 
earlier work on N aryl amidines by Pyman12 • 13 and was 
supported later by Moritz14 • 
CH3NH R' 
'-........ / c 
11 
NH 
For N aryl amidines, Prevorsek found two N-H bands at 
3500 and 3400cm-1 , in close agreement with those found 1n 
formamide 15 at 3533 and 3411cm-1 , indicating a terminal 
am1no group. 
Whereas the introduction of a phenyl moiety on the amino 
group reduces the basicity by a factor of ea 10, 
introduction of a phenyl on the imino group reduces 
basicity by ea 1000. The explanation for the drastic 
effects on basicity is that the imino phenyl is not 
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interacting with the pi system of the amidine, since it 
is twisted out of plane. Consequently the phenyl p1 
system is orientated so that it may overlap with the lone 
pair of the sp2 hybridised imino nitrogen9 • 
Charlton's 16 pioneering paper on the tautomeric 
preference among substituted guanidines argued 
qualitatively that protonation would be expected on the 
nitrogen most able to support a positive charge. The 
tautomeric ratio in 4-methylthiazol-2-yl guanidine, a 
model guanidine heterocyclic was studied by Button et 
a1 17 • 
They concluded that the aryl imino tautomer, RN=C(NH 2 ) 2 
was very dominant and evidence was produced arguing that 
this conclusion may be general for the guanidine 
heterocyclics. X-Ray diffraction studies on the crystal 
structure of 2-(phenylimino) thiazolidine thiazine and 
its 2,6-dimethyl substituted analogues also showed the 
preference for these compounds to adopt the aryl imino 
structure. 
In the free base structures of GU studied, the hydrate 
(GUFBHY) 18 and the isomorphous alcohol solvates (GUFBIP 
and GUFBIB) 19 ; all showed unambigously, the aryl imino 
tautomer, PhN=C(-NH2 )NR'. In all cases, the two hydrogen 
atoms were located and refined on the central nitrogen, 
N(2) and C(l)-N(3} was significantly shorter than C(l}-
N(2), 0.072(8) A and 0.066(9)A for GUFBHY and GUFBIP 
respectively. In GUFBIB the difference of 0.024(9)A is 
not significant, this may be related to the greater 
degree of disorder in this structure or may indicate the 
presence of the energetically unfavoured resonance 
structure, (PhN:..·c ("-=NH2 ) -NR2 ). 
b- 0~ 
The relevant crystallographic data are summarised in 
Table 6.2.1. 
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Table 6.2.1 Guanidine Bond Lengths, Tautomeric Preference and Dihedral Angle 
between Guanidine and Dichlorophenyl Ring in Free Base Structures of GU 
Structures Bond Lengths (A) Tau tom er Dihedral 
C(l)-N(3) C(l)-N(2) C(l)-N(ll) xC-N Angle(~0) 
GUFBHY 1.308(6) 1.380(7) 1.372(6) 1.353(39) Imino 55.5 
GUFBIP 1.298(9) 1.364(9) 1.375(9) 1.346(42) Imino 61.8 
GUFBIB 1.313(8) 1.337(9) 1.377(8) 1.342(32) Imino 62.2 
xC-N 1.306(8) 1.360(22) 1.375(3) x60(3) 
It may be seen from Table 6.2.1, that the dichlorophenyl 
groups are twisted by a mean value of 60(3) 0 , out of the 
plane of the guanidine group. Thus allowing efficient 
overlap of the phenyl pi system, with that of the lone 
pair of N(3), the imino nitrogen. 
The ionisation constant for GU (pka3 ) provides good 
supportive evidence for the tautomeric preference. The 
pka value of 8.6 for GU 1s in good agreement with other 
N imino phenyl structures, such as Mifentidine, pKa = 
8 0 88 20 0 
That this tautomer is also prevalent in solution is 
confirmed by Jackman and Jen21 • They used 1H and 13C NMR on 
some cyclic amidines, guanidines and related structures. 
The authors confirmed that in all tautomeric systems 
studied, the predominant tautomer was the imino form 
[PhN = C (NHR) R'] rather than the amino form 
[PhNH-C(=NR) R']. Clement and Kampchen22 studied the 
tautomeric equilibria of N monosubstituted amidines and 
N,N' diphenyl guanidines using 15N NMR. They concluded 
that in all compounds studied, the C=N double bond is 
'conjugated' with the phenyl group. In another recent 
study, Oszczapowicz23 using substituent induced chemical 
shifts in 13C NMR spectra of N2 -phenyl formamidines, 
acetamidines and guanidines; confirmed that in the 65 
compounds studied, all exist with an imino (N2 ) 
nitrogen adjacent to the phenyl group. 
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In a series of papers on unsymmetrically and symmetric-
ally substituted amidines 24 and N aryl amidines 25 ; the 
authors demonstrated using pKa measurements that 
N aryl amidines exist predominantly as the imino tautomer 
and that levels of the amino tautomer were negligible. 
The 1H NMR spectrum in d 6 dimethyl sulphoxide solution of 
GUFBHY18 shows a single broad resonance at 8 = 5.8ppm. 
That this single resonance is not the result of rapid 
exchange of the two NH protons of the alternative 
tautomer is suggested by the fact that other exchangeable 
protons present (phenolic OH, solvent water) glve 
separate discrete signals, implying slow proton exchange. 
The 5.8 ppm peak is thus most likely due to the NH2 
protons of the aryl imino tautomer. 
6.3 Guanidinhim Cation 
Protonation of the tautomerising amidine or guanidine 
yields only one cation, the conjugate acid (BH+) of both 
tautomeric bases (Bl and B2) 25 • Considering specifically 
the guanidinium ion, some of the structural consequences 
of its 6 pi-electron, pseudo-aromatic character are three 
essentially equivalent C-N bonds and the strictly planar 
geometry of the cation26 • 
The C-N bond length, inter-planar angle (0) of the phenyl 
and guanidinium groups and the root mean square deviation 
(a) of the guanidinium groups, from planarity, for all GU 
cations studied are summarised in Table 6.3.1. 
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Table 6.3.1 Guanidinium Bond Lengths2 Planarity {a} and Dihedral Angle between Guanidinium 
and DichloroQhenyl Ring in Protonated Structures of GU 
Structures Planarity Dihedral 
C(l)-N(3) C(l)-N(2) C(l)-N(ll) x C-N (a,A) Angle (0,0 ) 
Monoprotonated 
GUHFUMET 1.364(13) 1.328(13) 1.329(13) 1.340(21) 0.0008 66.3 
GUMASCHY 1.364(9) 1.314(9) 1.331(9) 1.336(25) 0.0023 68.3 
1.374(9) 1.281(9) 1.312(8) 1.322(46) 0.0012 71.8 
GUMACEHY 1.348(6) 1.321(7) 1.340(6) 1.336(14) 0.0027 45.2 
GUMHCLHYIP 1.334(10) 1.318(10) 1.361(10) 1.338(22) 0.0008 51.6 
Diprotonated 
GUDMES 1.345(10) 1.308(10) 1.331(9) 1.328(19) 0.0028 66.2 
GUDHCLHY 1.339(13) 1.329(13) 1.334(12) 1.331(13) 0.0012 73.8 
xl.352(15) x1.314(16) x1.334(15) xl.333(19) 64(10) 
The guanidinum groups are essentially planar in all 
structures. Although individual C-N bond lengths 
demonstrate some diverg@nce; the mean C-N bond lengths 
are equivalent, with a mean value of 1.333(19)A. The 
dihedral (inter-planar) angles, range from 45.2 to 
73.8°, but the mean value of 64°, is similar to that 
observed for the free base structures18 ' 19 [ 60 ( 3) 0 ] and 
demonstrates that 0 is essentially independent of the 
ionisation state. 
6.4 GU Conformation 
GU can exist 1n either an extended or folded 
conformation and with respect to the position of the 
amino and methoxy moieties, be either cis or trans. In 
the extended conformation the torsion angles, N(ll)-
C(l)-N(3)-C(21) are ea 160°, but in the folded 
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conformation the absolute values are nearer 40°. When 
GU exists in the cis conformation, the absolute values 
of the torsion angles N(2)-N(11)-N(14)-0(32) and N(2)-
C(1)-C(31)-0(32) are in the region of 0-90° and for the 
trans conformation this increases to between 90°-180°. 
These values are summarised in Table 6.4.1. 




























20.01(6) - 46.54(9) 
GUMACEHY 174.07(2) 159.33(3) 
40.27(6) 
37.05(7) 
158.07(7) GUMHCLHYIP 25.12(8) 
Diprotonated 
GUDMES 51.60(9) 50.96(7) 159.77(7) 












The majority of the structures studied exist ln the 
extended cis conformation, the exceptions being 
GUHFUMET (extended trans), GUMASCHY (folded cis) and 
GUMACEHY (folded trans). 
All phenyl rings are planar within experimental error. 
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Table 6.4.2 GU Puckering Parameters and In-ring Piperazine Torsion Angles 
Structure Puckering Parameters Torsion Angles 
Q q2 q3 00 eo x N (11) x N (14) 
Free Base 
GUFBHY 0.578 0.122 0.565 8.8 32.4 48.3 64.8 
GUFBIP 0.577 0.053 0.574 33.0 5.2 54.8 60.0 
GUFBIB 0.580 0.044 0.579 24.5 4.4 55.4 60.5 
X 53(4) x62(3) 
MonoQrotonated 
GUHFUMET 0.584 0.064 0.581 75.1 6.3 57.2 59.1 
GUMASCHY 0.571 0.156 -0.549 23.3 15.9 45.2 65.4 
0.552 0.107 0.541 29.9 11.2 47.4 62.2 
GUMACEHY 0.577 0.066 -0.574 -46.0 6.6 54.2 60.5 
GUMHCLHYIP 0.580 0.098 0.571 17.2 9.7 50.6 63.6 
x 51(5) x62(2) 
DiQrotonated 
GUDMES 0.565 0.017 0.565 75.6 1.7 58.2 55.6 
GUDHCLHY 0.583 0.050 0.581 17.5 4.9 63.1 53.2 
x 61(3) x54(2) 
The piperazine ring exists in a half-chair conformation 
significantly flattened towards N(ll) in the free base 
and monoprotonated structures, and toward N(l4) in the 
diprotonated structures. This is illustrated using the 
absolute in-ring torsion angles about N(ll) [but 
excluding N(l4)] and about N(l4), [but excluding N(ll)], 
these values are summarised in Table 6.4.2, together with 
the puckering parameters of Cremer and Pople27 (starting 
from either nitrogen atom and reducing 0 and e to first 
quadrant angles). The mean torsion angles (for structures 
of a particular protonation state), illustrate that there 
1s no significant difference, between the free base and 
monoprotonated structures. This can be explained in that 
the 'aromatic', planar guanidinium cation, extensively 
-162-
delocalises the positive charge over the whole of the 
cation. This results in marginal positive charge being 
present on the piperazine nitrogen, N(ll}. Thus the 
monoprotonated structures closely resemble the free base 
structures in terms of flattening of the piperazine ring 
towards N(ll}. In the diprotonated structures, the 
presence of a second positive charge on the other 
piperazine nitrogen, N(14), results in a flattening 
towards N(14}, as the ring tries to maximise the 
separation of the two positive charges. This flattening 
of the ring is accompanied by significant lengthening of 
both the in-ring and out-ring C-N(14} bond lengths, as 
shown in Table 6.4.3. 
Table 6.4.3 GU In-ring and Out-ring PiQerazine Bond Lengths 
Structure Out-Ring In-Ring Bond Lengths CA) 
Bond Lengths (A) C(12)-C(13) 
N(14)-C(31) xN(11)-C(12)/C(l6) XN(14)-C(13)/C(15) xC(l5)-C(16) 
Free Base 
GUFBHY 1.443 1.476 1.473 1.526 
GUFBIP 1.428 1.460 1.472 1.518 
GUFBIB 1.440 1.461 1.465 1.522 
xl.437 x1.466 xl.470 xl.522 
MonoQrotonated 
GUHFUMET 1.443 1.466 1.472 1.511 
GUMASCHY 1.436 1.472 1.468 1.514 
1.393 1.472 1.466 1.500 
GUMACEHY 1.445 1.472 1.468 1.519 
GUMHCLHYIP 1.434 1.480 1.470 1.528 
x1.430 x1.472 x1.469 x1.514 
DiQrotonated 
GUDMES 1.474 1.454 1.506 1.520 
GUDHCLHY 1.503 1.458 1.517 1.524 
x1.489 x1.456 xl.512 x1.522 
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In order to determine whether the tautomers found in 
solution correspond to those in the crystal structures, 
the 1H NMR spectra of a free base (GUFBHY), and selected 
monoprotonated (GUMHCLHYIP) and diprotonated (GUDHCLHY) 
salts were measured in d 6 dimethyl sulphoxide solution. 
The assignments for hydrogen atoms bonded to carbon are 
shown in Table 6.4.4. 
In the spectrum of GUFBHY, a single broad resonance at 8 
5.8 ppm could be attributed to two protons attached to 
N(2), and ruled out protons on N(2) and N(3). In the 
salts, the positions of the resonances due to the 
replaceable protons were less well defined, but the 
effects on others were clear. 
Conversion of GUFBHY into GUMHCLHYIP gives major shifts 
at centres near N(3) [H(22), H(24) and H(26)] and 
negligible effects on the resonances of other protons. 
In GUDHCLHY, these resonances change very little, while 
there are major shifts to the protons bonded to C(l3), 
C(15) and C(36). It thus appears that the tautomeric 
forms of the ions in dimethyl sulphoxide solution are the 
same as those in the crystal28 , and confirms the order of 
protonation. 
Table 6.4.4 1H NMR Spectra for the Free Base (GUFBHY) Monoprotonated (GUMHCLHYIP) and 
Diprotonated (GUDHCLHY) Salts in d6 dimethyl sulphoxide solution. (Values given are o in ppm 
relative to tetramethylsilane} 
Protons GUFBHY GUMHCLHYIP GUDHCLHY 
H(l2A),H(12B),H(16A),H(16B) 3.46 3.69 3.72 
H(13A),H(l3B),H(15A),H(15B) 2.84 2.96 4.08 
H(22),H(26) 6.69 7.39 7.43 
H(24) 6.89 7.37 7.38 
H(33) 6.39 6.45 6.68 
H(35) 6.28 6.32 6.50 
H(36) 6.71 6.71 7.61 
H(3M 1 ),H(3M2),H(3M3) 3.73 3.73 3.87 
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6.5 GU Pharmacological Profile 
A number of cyclic amidines possess interesting 
pharmacological properties29 ' 1 • 
Previous investigations have shown that slight changes in 
the structure of cyclic amidines could have profound 
consequences with respect to their pharmacological 
activityL 30 • Several physicochemical properties of these 
compounds have been considered to be related to this 
phenomenon. In particular, steric and electronic 
requirements have been suggested as being of prime 
importance3L 32 ' 30 • r:I'here is strong evidence that some 
cyclic amidines interact with a-adrenergic receptors 33 
and, in particular, the antihypertensive effect of 
Clonidine is thought to be mediated by stimulation of 
central a-adrenergic receptor si tes 34 ' 35 • The a-adrenergic 
receptor appears to pose very strict structural demands 
on those interacting compounds, which ultimately elicit a 
pharmalogical response. With the advanced receptor 
labelling techniques available36 it is now possible to 
assess these structural requirements at the receptor 
level·. These can be expressed in terms of their 
equilibrium affinity or dissociation constants (pki) 
based on their ability to displace 3H Clonidine from its 
a-adrenergic receptor sites in rat brain homogenate. 
Structural differences between molecules should be 
reflected in their affinity for these receptors and hence 
comparisons of these receptor affinities should g1ve 
insight into the structural features required for 
efficient receptor- complex formation 37 • In current 
representations of the interaction of Clonidine, related 
phenyl imidazoles and phenyl guanidines with the a-
adrenergic receptor(s), it is generally accepted that the 
phenyl ring and the heterocyclic or open chain derivative 
are not co-planar38 ' 39 • The inter-planar torsion angle (<f>) 
is assumed to be either 60°, 75° or 90°. The knowledge of 
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the conformational characteristics of the phenyl 
imidazoles is important for the considerations of a 
topological analogy of these class of compounds with the 
phenylethylamine type drugs. This includes the natural 
andrenergic ligands and, in consequence, of whether both 
types of drug interact with the same receptor site or 
not 40 ' 41 • Moreover, the assumed conformation of the phenyl 
imidazoles is important for HOMO and LUMO energies, since 
the calculated orbital energies are strongly dependent on 
The evidence for the conformation of the phenyl 
imidazoles stems from x-ray diffraction studies, 
conformational energy calculations, UV photoelectron 
spectroscopy and NMR work. In Xylometazoline42 , the 
methyl substituents at the ortho position of the phenyl 
ring, lead to the stabilisation of the nearly mutually 
perpendicular arrangement of the two ring systems ($ = 
85°) . A similar ring conformation has been found in other 
ortho di-substituted compounds of this series eg 
Clonidine Hydrochloride43 and Clonidine Phosphate44 • But 
in To1onidine Nitrate45 which has only one ortho 
substituent, ~ is close to 60°. Carpy et a1 39 using 
crystallographic and quantum mechanical calculations and 
Jackman et a1 21 using NMR techniques, both predicted that 
the solution state conformation would have a nearly 
perpendicular arrangement of the two ring systems (or two 
planar moieties in the case of the open ring guanidines 
and thioguanidines). The driving force for this, was 
postulated to be steric; in which compounds with large 
di-ortho substituents would be forced to adopt non-planar 
conformations to avoid mesomeric interactions within the 
molecule30 • 
However, UV photoelectron spectroscopic measurements in 
combination with CNDO/S quantum mechanical calculations 
suggest that di-ortho, mono-ortho and unsubstituted 
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phenyl imidizoles all prefer a perpendicular conformation 
of their ring systems 38 • That steric requirements only 
are not selective enough to explain observed differences 
was amply demonstrated by Leger et a1 46 • The authors 
determined the crystal structure of 1-[(3-methyl-4-
isothiazolyl)methyl] guanidinium hemisulphate and found 
that the two crystallographically independent molecules 
adopted two different conformations with the inter-planar 
angles being 83° for molecule 1 and 65° for molecule 2. 
Carpy et a1 39 postulated a model for the interaction of 
phenyl imidazole-like compounds with the a-adrenoreceptor 
sites. 
The model proposed the following requirements for 
efficient ligand-receptor interaction. 
(a) electrostatic attraction between the positively 
charged amidine function and a negatively charged site on 
the a-adrenoreceptor. 
(b) hydrophobic interaction between the aromatic nucleus 
and an electron deficient area of the a-adrenoreceptor 
and 
(c) the possible additional formation of a hydrogen bond 
between the receptor and the exocyclic NH. The distance 
(D) of the nitrogen (furthest from the phenyl ring) and 
the centre of the phenyl ring and the height (H) of this 
nitrogen atom above the phenyl ring are thought to be of 
considerable significance for the a-adrenergic 
agents 47 • 48 • 49 • The available data have been summarised for 
all of the structures of GU (Table 6.5.1) and for the 
phenyl imidazole type compounds (Table 6.5.2). 
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Table 6.5.1 Summ~ of C!}:stallograQhic Data for all GU structures on the basis of the 
PharmacoQhore Model of Cmpy et aP9 
Structure Pharmacophore Model Parameters 
D(A) H(A) <I> 
Free Base 
GUFBHY 4.93 0.43 55.5 
GUFBIP 4.90 -0.43 61.8 
GUFBIB 4.92 -0.36 62.2 
MonoQrotonated 
GUHFUMET 4.93 -0.37 66.3 
GUMASCHY* 4.80 -0.02 68.3 
4.75 0.01 71.8 
GUMACEHY* 4.86 0.08 45.2 
GUMHCLHYIP 4.97 0.03 51.6 
DiQrotonated 
GUDMES 4.92 -0.42 66.2 
GUDHCLHY 4.85 -0.82 73.8 
* folded confonnation, ~ = dihedral angle between phenyl and guanidine groups 
Structures exhibiting the folded conformation, (GUMASCHY 
and GUMACEHY) will be omitted from the subsequent 
discussions; as the most common conformation, occurring 
in 70% of the structures studied, is the extended one. 
The values of D obtained for the various structures of GU 
are very similar, with a mean value of 4.92(4)A and a 
range of 4.85A to 4.97A. 
The value of D is also independent of the protonation 
state of GU; free base (4.92A), monoprotonated (4.95A) 
and diprotonated (4.88A). These values compare favourably 
with those cited in Table 6.5.2, for other a-adrenergic 
compounds. Where the structures studied do deviate 
markedly from this model is in the value of H. Typical 
absolute values of H obtained were 0.4(2)A with a range 
of 0.43A to -0.82A, this is significantly less than the 
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typical value of l.OA for other a.-adrenergic compounds. 
Table 6.5.2 Summary of Crystallographic Data for a-Adrenergic Compounds of the Basis of the 
Pharmacophore Model of Carpy et aP9 • Key ot1 p. l7l 
Structure 










































































































The validity of this model has been questioned by several 
researchers in this field. Diamont et a1 57 studied the 
conformation and pharmacological activity of the specific 
a.-adrenergic agonist drug, Guanabenz. They observed that 
in the crystal state, the dihedral angle between the two 
planar moieties was only 39.7°, as compared with about 
7 6° in Clonidine50 ' 43 • Using PCILO calculations they were 
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able to show that Clonidine is rotationally restricted as 
compared with Guanabenz and that the dihedral angle is 
about 60° in the former, but 0° in the latter. Similarly 
using MNDO calculations they were able to calculate the 
charge distribution for the two molecules. 
At physiological pH (7.4), both molecules exist 
predominantly in the protonated form, Guanabenz (pKa 8.1, 
83.4% protonated) and Clonidine (pKa 8.05, 82.9% 
protonated) . The authors found that on protonation the 
additional positive charge is distributed in Clonidine, 
over the aromatic nucleus (+0.243), imino spacer group 
(+0.590) and the remainder of the imidazole ring (+0.165), 
In contrast, the charge distribution in Guanabenz shows a 
small fraction over the aromatic nucleus (+0.094), the 
majority residing on the guanidinium (+0.814) with the 
remainder being present in the imino spacer group 
(+0. 095). 
Interestingly the 1,2,4-triazole-4-amine analogue 
(Nebidrazine, 56 ) of Guanabenz also gave an almost planar 
arrangement of the two rings (8°), in agreement with the 
PCILO calculations for Guanabenz. CNDO charge distribution 
calculations were performed on the triazole ring only, so 
that comparison with Guanabenz are not possible. 
Charge distribution and its effect on binding affinity to 
receptor sites has been the subject of previous reports 42 • 
When considered as a class, the imidazolines have higher 
affinities for the a-adrenergic receptor than the 
phenylethylamines 65 • 
Ghose et a1 42 postulated that one of the reasons for this 
observation may be that the dispersed charge arrangement 
within the imidazole moiety helps it to achieve better 
interaction with the a-adrenergic receptor. This may not 
be possible in the phenylethylamines since the positive 
charge is concentrated at the nitrogen atom in the 
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protonated forms of these molecules. The a-adrenergic 
receptor-ligand model of Carpy et a1 39 appears not to 
model the phenylethylamines very effectively as can be 
seen from the values obtained for COR-3441 62 , BE-2254 63 , 
and Oxypertine64 in Table 6.5.2. 
Kaliszan et al 66 suggested that an additional parameter 
that should be considered for this model, was that of 
breadth (B) of the anchoring fragment of aromatic ring. 
They studied a series of pyrazine imidazolines and 
concluded that the general steric features of D - SA and 
the angle between the planes of the hydrophobic and 
imidazoline fragment of about 75°, were in accord with 
those suggested by Carpy et a1 39 • However, pyrazine, as 
compared to benzene, was not lipophilic enough to provide 
sufficient hydrophobic binding of the ligand to the 
receptor. 
Introduction of hydrophobic substituents to the pyrazine 
system can result in compounds with sufficient affinity 
for the ligand, provided the steric requirements are 
fulfilled. It is the substituent rather than the pyrazole 
that"provides binding affinity for the receptor. Whereas 
the total molecular hydrophobicity influences the 
affinity of the ligand for the receptor, the specificity 
could be related to the breadth of the hydrophobic 
'anchoring' moiety. Substances having anchoring fragments 
below 7.23A show antagonist properties if their geometry 
and lipophilicity are appropriate. Analogously, compounds 
having anchoring fragments above 6.03A behave as partial 
agonists. 
Thus far the discussion relating to the pharmacology of 
GU have centred around its a-adrenergic receptor 
affinity, which is closely linked with the dichlorophenyl 
guanidine moiety. The remainder of the molecule is also 
pharmacologically active, 2-methoxyphenyl piperazine has 
been shown to have potent hypotensive effects in man67 • 
&.•••••d•"• 
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Like other phenyl piperazine derivatives 68 • 69 it enhances 
central 5-hydroxytryptaminergic (5-HT) transmission70 and 
recent ligand binding studies show that it behaves as a 
selective 5-HT agonist, displaying affinity for the 5-HT, 
binding site comparable with that of the recognised 5-HT 
agonist, 1-(3-trifluoromethylphenyl) piperazine71 • 
Indeed, the 2-methoxyphenyl piperazine moiety has been 
incorporated into the structure of many pharmacologically 
unrelated compounds, which can form 2-methoxyphenyl 
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SECTION 7 : PREPARATION AND 
CHARACTERISATION OF SALTS AND 
MODIFICATIONS OF IM 
-179-
7.1 Introduction 
In this section, a similar coding system to that used 
in Section 3, is adopted. 
The first two letters of IM refer to the imidazole 
moiety, which is one of the salt forming groups of the 
molecule. The next letter(s) indicated the protonation 
state of the compound; FB - Free Base, M = Monoproton-
ated, H = Hemiprotonated, S = Sesquiprotonated, 
D = Diprotonated and T = Triprotonated. 
This is followed, in the case of the protonated 
compounds, by the code designating the anion; 
FUM - Fumarate, CIT - Citrate, ACE - Acetate, 
HCL - Chloride, ASC - Ascorbate, MAL - Maleate, 
MALN - Malonate, MES = Mesylate, NIT - Nitrate, 
SULF - Sulphate, PHOS = Phosphate, LAC = Lactate, 
TAR = Tartrate, OXA = oxalate and sue = succinate. 
The presence of solvation (or hydration) is indicated 
by; HY = Hydrate, Et = Ethanol, IP = Isopropanol, 
IB = Isobutanol, AC = Acetone and TOL = Toluene. 
Finally, a series of polymorphic modifications of a 
particular compound are designated by the suffixed 
letters A, B, c. 
Some examples are: 
IMFBA, IMFBB and IMFBC = A, B and C polymorphic 
modifications of the free base 
IMFBTOL = toluene solvate of the free base 
IMMHCLAC = acetone solvate of the monochloride salt 
IMDMES = dimesylate salt 
IMTHCLHYA, IMTHCLHYB, IMTHCLHYC = A, B and C 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SECTION 8 : PHYSICOCHEMICAL INVESTIGATIONS 
INTO SALTS AND MODIFICATIONS OF IM 
-191-
8.1 Hygroscopicity/Efflorescence Studies on Salts and 
Modifications of IM 
All modifications of the free base were non-hygroscopic 
under all humidity conditions studied. The data are 
summarised in Figures 8.1.1 to 8.1.3. 
The two polymorphic phases of the free base studied 
(IMFBA and IMFBB), both exhibited Type I adsorptionl. 2 
characteristics and the typically closed hysteresis 
loop for the moisture adsorption-desorption isotherms. 
The metastable IMFBB adsorbs about 4 times the level of 
water compared to the stable IMFBA. The data are 
summarised in Figure 8.1.10. 
In contrast, the toluene solvate (IMFBTOL) exhibited 
Type II adsorption characteristics, with a negative 
inflection point and a closed hysteresis loop for the 
moisture adsorption-desorption isotherms. 
All of the chloride salts were hygroscopic. IMMHCLHY, 
rapidly adsorbs water under all humidity conditions and 
achieves equilibrium moisture levels after about 24 
hours (Figure 8.1.4). At ambient and elevated relative 
humidities the salt is hygroscopic and only when stored 
at 20% relative humidity is the water uptake < 5% w/w. 
IMMHCLHY exhibits Type II adsorption characteristics 
and the atypical open hysteresis loop for moisture 
adsorption-desorption isotherms (Figure 8.1.11). 
The trichloride salts (IMTHCLHYA, IMTHCLHYC and 
IMTHCLHYE) were all extensively hygroscopic at ambient 
and elevated relative humidities (Figures 8.1.7-8.1.9). 
The monohydrated IMTHCLHYA was the least hygroscopic, 
equilibrating to 11.45% w/w (= 3.59 moles water) and 
the pentahydrated IMTHCLHYC was the most hygroscopic, 
equilibrating to 20.66% w/w (= 7.30 moles water). 
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However, even at these elevated levels of water uptake, 
there was no indication of deliquescent behaviour. 
Both IMTHCLHYA and IMTHCLHYC exhibited Type II 
behaviour (Figure 8.1.12). All three phases, in common 
with the monoprotonated chloride salt, exhibited the 
atypical open hysteresis loop for the moisture 
adsorption-desorption isotherms. 
The remaining mesylate (IMMMES) and .fumarate (IMSFUM) 
salts were non-hygroscopic (Figures 8.1.5 and 8.1.6) 
under all humidity conditions studied. Both salts 
exhibited Type II adsorption and the typical closed 
hysteresis loops for moisture adsorption-desorption 
(Figure 8.1.11). 
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Figure 8.1.1 Hygroscopicity/Efflorescence Studies on IMFBA 
Hygroscopicity Studies 
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Figure 8.1.2 Hygroscopicity /Efflorescence 
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Figure 8.1.3 Hygroscopicity/Efflorescence Studies on IMFBTOL 
Hygroscopicity Studies 
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Figure 8.1.4 Hygroscopicity/Efflorescence Studies on IMMHCLHY 
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Figure 8.1.5 Hygroscopicity/Efflorescence Studies on IMMMES 
Hygroscopicity Studies 
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Figure 8.1.6 Hygroscopicity/Efflorescence Studies on IMSFUM 
Hygroscopicity Studies 
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Figure 8.1. 7 Hygroscopicity/Efflorescence Studies on IMTHCLHYA 
.HVOAOSCOPIOTY STUDIES 
-6-- 1 -+- 2 -- 3 -9- • 






8 1'- RH 
2 76'- RH 







~A -+-s --c -9-0 
-2L---~~~~~~----~~~~~~ 
10 








81'- RH -. 76'- RH 
7 6'- RH - 62'- RH 
62'- RH - 20'- RH 
20'- RH - 0'- RH 






-6-- 1 -+- 2 -- 3 -9- • 
10 
Time (Houra) 
Identifier Condlt Ion 
8 1'- RH 
2 76, RH 
3 
EFFLORESCENCE STUDIES 














624J. RH - 204J. RH 
1000 
-197-





























87% RH - -75% RH 
75% RH - 52% RH 
52% RH - 20% RH 
20% RH - 0% RH 
1000 
-198-
Figure 8.1.10 Adsorption/Desorption Isotherms of Modifications of IM 
'1. w/w 
H'I"GA()SCCPtaTY 
8T'I.RH 7&'1.RH 152"/.RH 20'1.RH 
0.70 0.71 0.68 0.38 
Woleelf 0 0.17 0.17 0.1.C O.OSI 
EFFLORESCENCE 
T&'I.RH 152'1.RH 20'IoRH 
o..cse 0.68 o.A8 
0.1.C O.t.C 0.11 
- ADeofii'TIOtc -f- Hao«PTIOII 
... 
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Figure 8.1.11 Adsorption/Desorption Isothenns of Salts of IM 
- AOeOtWTtOtl -+- 0CeotlP1tON 
IMMHCLHY 
HYGROSCOPICITY 
87'1.RH 76't.RH 62-r.RH 20'1.RH 
"..,,.., 8.80 
Moles !4 0 2.67 
7.68 6.66 2.54 





87'1.RH 76-r.RH 62-r.RH 20-r.RH 
'- w/w 2.00 1.-46 1.-48 0.715 
MoiH ~ 0 0.158 0.-43 0.44 0.22 
HYGAOSCOPICITY 
87'1.RH 715-r.RH 62-r.RH 20"1.RH 
'- w/w 3.CI7 
t.Cole• ~ 0 1.215 
2.40 2.12 0.815 
0.81 0.72 0.28 
EFFLORESCENCE 









715-r.RH 62-r.RH 20-r.RH 
1.80 0.80 0.815 
0.47 0.18 0.28 
EFFLORESCENCE 






Figure 8.1.12 Adsorption/Desorption Isotherms of Salts of IM 
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8.2 Stability Studies on Salts and Modifications of IM 
8.2.1 Appearance of Stability Samples for Salts and 
Modifications of IM 
As with the stability samples of GU (see Section 
4.2.1}, considerable changes in appearance and 
especially colour, were observed throughout the course 
of these studies. These findings are summarised in 
Table 8.2.1. Although subjective in nature, the 
appearance of the samples are classified into various 
categories and intensities of colour, descriptive notes 
relating to textural changes, such as aggregation and 
melting are also included, if appropriate. 
Table 8.2.1 Appearance of Stability Samples for Salts and Modifications of IM 
Condition (Appearance) 
Salt/ 
Modification 25°C 40°C 50°C 70°C 100°C RH Lt Hv 
IMFBA NC F(2) F(3) F(4) 0(4) NC Y(4) 0(4) 
IMFBB NC F( 1) F{2) F{3) 0(3) NC Y{3) 0(3) 
IMFBC NC NC F{1) F(2) 0(2) NC Y{2) 0{3) 
IMFBTOL NC NC F{1) F{2) M,0(5) NC Y(1) Y(4) 
IMMHCLHY NC NC NC F(1) 0(5) A,F(1) Y(2) 0(4) 
IMMMES NC NC NC F( 1) 0(4) NC Y(4) 0(4) 
IMTHCLHYA NC NC NC NC Y(2) A,NC NC Y(4) 
IMTHCLHYC NC Y(1) Y(2) Y(4) M,0(5) A,NC Y(5) 0(4) 
IMTHCLHYE NC NC NC Y(1) Y(3) A,NC NC Y(4) 
NC - No change in colour M - Melted y - Yellow 
A - Aggregated F - Fawn 0 - Orange 
Intensity of colour is given in brackets, with 5 being the most intense and 1, the 
least intense. 
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8.2.2 Kinetic Modelling of Stability Data 
Samples that showed appreciable levels of decomposition 
were analysed using the six solid-state kinetic models, 
previously described in Section 4.2.2. Linear 
regression analyses, using least-squares fit, were 
performed and the data are summarised in Table 8.2.2. 
Table 8.2.2 Linear Regression Analyses (R2 ) of the Kinetic Data for the Various 
Kinetic Models Studied 
Linear Regression Analysis (R2 ) 
T opochemical Nucleation Diffusion 
Salt/ 
Modification Condition 1D 2D 3D PT 1D 3D 
IMFBA 100 0.921 0.896 0.887 0.886 0.958 0.901 
Hv 0.948 0.915 0.901 0.867 0.989 0.921 
Lt 0.884 0.807 0.779 0.721 0.967 0.816 
IMFBB 100 0.993 0.956 0.940 0.889 0.978 0.966 
Hv 0.976 0.926 0.901 0.841 0.968 0.938 
Lt 0.760 0.752 0.734 0.680 0.680 0.754 
IMFBC 100 0.991 0.985 0.963 0.928 0.992 
Hv 0.998 0.976 0.958 0.896 0.949 0.982 
Lt 0.873 0.843 0.793 0.784 0.700 0.871 
IMFBTOL 100 0.921 0.934 0.823 0.848 0.800 0.954 
Hv 0.741 0.662 0.635 0.584 0.833 0.671 
IMMHCLHY 100 0.997 0.953 0.916 0.795 0.967 0.964 
Hv 0.920 0.571 0.380 0.591 0.914 0.653 
Lt 0.975 0.780 0.605 0.758 0.923 0.936 
IMMMES Hv 0.957 0.615 0.425 0.910 0.922 0.713 
IMTHCLHYA Hv 0.893 0.541 0.736 0.647 0.980 
IMTHCLHYC 100 0.921 0.906 0.897 0.872 0.910 0.910 
Hv 0.837 0.815 0.807 0.790 0.873 0.819 
IMTHCLHYE Hv 0.655 0.721 0.664 0.467 0.852 0.875 
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All samples stored at 25°C to 50°C and at elevated 
humidities, demonstrated excellent stability after 24 
weeks storage, with no loss in potency or degradation 
observed. This demonstrates that slight changes in 
colour are not always accompanied by chemical 
decomposition. 
At elevated temperatures, the four different phases of 
IM free base gave quite different stability profiles. 
These data are summarised in Figures 8.2.1 to 8.2.4. 
At 70°C, IMFBB and IMFBTOL gave quantitative 
recoveries, whilst IMFBA and IMFBC gave slight drops in 
potency, 96.2% and 97.0% label, respectively. These 
drops in potency were accompanied by quite complex 
degradation profiles. For IMFBA, there were several 
very polar degradation products eluting on the solvent 
front and four partially retained degradation products 
at RRt 0.45 (1.41%), RRt 0.51 (0.91%), RRt 0.64 (1.47%) 
and RRt 0.79 {0.48%). For IMFBC, there were no non-
retained degradation products, three more polar 
degradation products at RRt 0.53 {1.04%), RRt 0.61 
(0.69~) and RRt 0.74 (0.61%). In addition, one less 
polar degradation product at RRt 1.20 {0.1%) was 
observed. 
At 100°C, IMFBB and IMFBC have half-lives of about 24 
weeks and similar kinetic profiles. Both phases gave 
good correlation coefficients for all of the models 
studied {Table 8.2.2) and similar degradation profiles 
{Table 8.2.3). 
IMFBA and IMFBTOL showed markedly different degradation 
profiles from one another and from the other phases. 
IMFBA has a half-life of about 10 weeksj after this 
stage there is a marked change in the reaction rate. 
This could be indicative of a phase change, but the 
level of decomposition in the sample precluded any 
investigations. The data gave good fits for both of 
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the diffusion models and for the 1D advancement of a 
phase boundary (zero order kinetics). 
IMFBTOL has a half-life of about 16 weeks and at the 
completion of the studies at 24 weeks, had a similar 
potency (6.0%) to that of IMFBA (9.4%). Despite the 
fact that IMFBTOL melts at a considerably higher 
temperature than the storage temperature of 100°C, the 
sample had, in fact, partially melted. The DSC heating 
curve (Figure 8.3.4) gives no indication of a 
desolvation endotherm at about 100°C, however, crimping 
of the DSC pan often leads to these endotherms either 
being masked or occurr~ng at very much higher 
temperatures. Loss of solvent followed by partial 
melting would seem to be a logical explanation and is 
substantiated by the high correlation coefficient for 
the 3D diffusion model, which gave the best fit of all 
of the models studied. 
A comparison of the degradation profiles at or about 
the half-life, shows, in all cases, a very complex 
pattern which is summarised in Table 8.2.3. 
It is interesting to note that the relative chemical 
stabilities at 100°C: IMFBB = IMFBC > IMFBA > IMFBTOL 
are not the same as the thermodynamic stabilities (see 
Section 8.3). 
All four phases of IM free base showed evidence of 
light instability. The most stable phase is IMFBTOL, 
which is additional evidence for the destabilising role 
of desolvation. IMFBTOL showed a slight drop in 
potency to 97.4% label and several more polar 
degradation products. IMFBB and IMFBC showed similar 
recoveries of 92.1 and 93.4% label, respectively. None 
of the kinetic models gave a good correlation for the 
data. The degradation profiles were, in both cases, 
very complex and are summarised in Table 8.2.4. The 
-205-
least stable of the phases was IMFBA which gave a 
recovery of 83.4% label and again, a very complex 
degradation profile which was very similar to that of 
IMFBB. The only kinetic model which gave a high 
correlation for the data was the lD diffusion model. 
The photolytic instability was even more pronounced 
when stored under UV light and the comparative 
stability was in the order IMFBTOL > IMFBC > IMFBA > 
IMFBB. The stability profile of IMFBB when stored 
under uv light was very similar to that of the 100°C 
sample, with a half-life of 24 weeks. As with the 
100°C sample, the kinetic data gave a good correlation 
for all of the kinetic models. The degradation 
profiles are, however, different, but equally complex. 
The UV light samples gave a major, less polar 
degradation product at RRt 1.48 and several non-
retained peaks at RRt <0.4 (Table 8.2.5). IMFBA and 
IMFBC showed similar recoveries with potencies of 60.7 
and 63.9% label, respectively and both gave good fits 
for all of the kinetic models studied. Degradation 
profi~es were similar, although IMFBC showed a higher 
percentage of less polar degradation products. 
The significance of desolvation to salt stability is 
again demonstrated for the monoprotonated salts. Both 
I~rnlliCLHY (175.0-177.8°C) and IMMMES (203.0-204.0°C) have 
similar melting points, but whereas IMMMES demonstrates 
excellent thermal stability, IMMHCLHY shows a much 
reduced shelf-life, with a half-life of about 25 weeks 
(Figures 8.2.5 and 8.2.6). Dehydration, followed by 
degradation of the anhydrous phase, appears to be a 
likely explanation. 
IMMMES shows only a small drop in potency (97.9% label) 
at 100°C accompanied by three more polar degradation 
products with a total value of 0.8%. 
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Both the light and UV light samples for IMMMES gave 
similar degradation profiles, several more polar 
degradation products were observed in the latter 
sample, but all were at low levels (~ 0.2%). The data 
for the UV light samples gave good correlations for the 
nucleation, 1D diffusion and 1D phase boundary 
advancement (zero order) models. 
The monochloride salt gave good correlations for the 
100°C kinetic data with all models, except the Prout 
Tompkins nucleation model. This salt showed light 
instability when stored under window light or UV light 
and the kinetic profiles were similar, giving highest 
correlation for either 1D diffusion or 1D phase 
advancement models. In both cases, there were major 
degradation products observed at RRt 0.70 and 1.15, in 
addition to a number of other products at smaller 
levels. The profiles for thermal and light degradation 
were very similar. 
The various phases of the trichloride were stable when 
stored between 25°C and 70°C and at high relative 
humidities (Figures 8.2.7-8.2.9}. Despite small colour 
changes, no degradation was observed in any of these 
samples. 
Storage at 100°C resulted in an apparent increase in 
potency for the IMTHCLHYA. This occurred after the 4 
week timepoint and remains constant at this level for 
the whole duration of the study. This may be explained 
by dehydration of the sample {Theory 103.3%, Found 
104.7% label) which is accompanied by small levels of 
degradation {Table 8.2.3). 
A similar process occurs for IMTHCLHYE samples which 
lose one mole of water after 4 weeks. The process of 
dehydration continues in a gradual fashion until at the 
end of the study an additional two moles of water have 
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been removed (Theory 109.9%, Found 110.6%); this is 
again accompanied by small levels of degradation. 
For the IMTHCLHYC samples, the rate of decomposition at 
100°C is far in excess of the rate of desolvation. The 
recovery after the 4 week timepoint decreased to 93.6% 
of label with evidence of degradation. The 70°C data 
for IMTHCLHYC does show an increase in potency, 
commensurate with the loss of one mole of water. 
There is an obvious change in the rate of decomposition 
after 8 weeks, accompanied by a phase change, which 
manifests itself as partial melting of the sample. 
This phase change is presumably formation of the 
anhydrate followed by its immediate melting, IMTHCLHYC 
has a half-life of 14 weeks at 100°C. Despite the fact 
that there are two competing reactions taking place 
simultaneously, the data fit several of the kinetic 
models satisfactorily, giving the highest correlation 
for the diffusion models and the 10 phase advancement 
model. The degradation profile at about the half-life 
is ve~y complex (Table 8.2.3}, with major degradation 
products at RRt 0.46, 0.60, 0.76 and 0.85. 
The trichloride phases show good light stability. Only 
IMTHCLHYA shows a slight drop in potency (97.6% label) 
with evidence of three more polar degradation products 
at RRt 0.42, 0.46 and 0.70. 
IMTHCLHYC and IMTHCLHYE samples gave slightly elevated 
recoveries (100.5 and 102.5% label) which, together, 
with the presence of several degradation products 
indicates that partial desolvation is occurring. 
The trichloride salts were slightly less stable towards 
UV light than towards window light. IMTHCLHYA samples 
show recoveries of 89.1% label with a large number of 
more polar degradation products. 
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IMTHCLHYE samples show recoveries of 93.5% label, with 
a very similar degradation profile, to that observed 
for IMTHCLHYA. The least photolytically stable phase 
is IMTHCLHYC with a recovery of 62.5% label. A very 
complex degradation profile was observed with 
degradation products eluting at RRt 0.46, 0.51, 0.60 
and 0.70, the major degradation product is less polar 
eluting at RRt 1.15. 
The UV light data for the three phases of the 
trichloride salt, do not fit any of the kinetic models 
particularly well. The best correlations in all cases 
are for either the 1 or 3D diffusion models. ~his is 
again supporting evidence for the role of the water 
molecules in stabilising this compound. 
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IMTHCLHYE samples show recoveries of 93.5% label, with 
a very similar degradation profile, to that observed 
for IMTHCLHYA. The least photolytically stable phase 
is IMTHCLHYC with a recovery of 62.5% label. A very 
complex degradation profile was observed with 
degradation products eluting at RRt 0.46, 0.51, 0.60 
and 0.70, the major degradation product is less polar 
eluting at RRt 1.15. 
The UV light data for the three phases of the 
trichloride salt, do not fit any of the kinetic models 
particularly well. The best correlations in all cases 
are for either the 1 or 3D diffusion models. ~his is 
again supporting evidence for the role of the water 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fi~ure 8.2.1 Stability Data for IMFBA 
- 21'C -f- 40'C _._ IO'C -G- 70'C 
~ 100'C + 21'C/17UH -A- WINDOW liOHT -H- UV liOHT 







0 12 11 20 24 
TIWE (WEEKS) 
TIMEPOINT CONDITION (% Label) 
(Weeks) 25 40 50 70 100 RH Lt H11 
4 99.8 99.8 99.6 98.6 74.0 100.2 96.4 85.2 
8 99.8 99.6 100.2 100.0 61.5 97.8 90.2 76.6 
13 100.8 100.4 100.2 98.4 27.1 100.2 87.0 69.0 
16 100.4 100.7 101.0 98.6 23.0 100.4 86.9 66.8 
20 100.6 98.7 98.6 97.4 16.6 99.8 85.2 64.3 
24 100.0 100.2 99.4 96.2 9.4 101.0 83.4 60.7 
Figure 8.2.2 Stability Data for IMFBB 
- ze·c -+- 40'C ...._ IO'C -G- 70'C 
'"*' 100'C + 21'C/17UH -A- WINDOW liOHT -H- UV liOHT 








1:1 1e 20 24 
TlloCE (WEEKII 
TIME POINT CONDITION ("" label) 
(Weeks) 25 40 50 70 100 RH Lt H11 
4 100.2 101.2 99.3 101.2 90.0 100.4 98.6 91.8 
8 99.8 99.2 99.6 99.6 79.3 101.9 96.0 78.4 
13 99.9 98.6 99.7 99.4 68.2 99.3 93.0 68.2 
16 99.7 99.2 99.0 99.4 63.8 100.4 91.4 66.0 
20 100.1 98.2 99.6 99.8 56.3 99.6 89.4 58.6 
24 99.7 99.7 99.8 100.4 48.2 100.4 92.1 49.6 
Figure 8.2.3 Stability Data for IMFBC 
- 21'C 
-K- IOO'C 







'*' IO'C -9- 70'C 
...[!,. WINDOW liOHT -B- UV LIOHT 
0~-------L-------J--------~------~--------L-------~ 
12 20 24 
TI..CE (WEEKII 
TIMEPOINT CONDITION (% Label) 
{Weeks) 25 40 50 70 100 RH Lt Hv 
4 100.0 99.8 100.4 101.4 g1.7 100.4 99.7 95.6 
8 99.9 100.4 100.2 101.0 86.8 101.0 99.9 90.3 
12 99.6 99.5 99.6 98.2 76.9 99.2 97.2 82.4 
16 100.0 99.8 101.6 98.4 69.6 100.7 97.0 76.8 
20 101.0 100.4 98.6 98.4 57.0 100.5 96.6 70.5 
24 99.9 99.6 99.5 97.0 50.2 99.4 93.4 63.9 
Figure 8.2.4 Stability Data for IMFBTOL 
- u·c -+- 40'C "*" IO'C -9- 70'C 
-K- IOO'C + 21'C/17UH ...[!,. WINDOW liOHT -B- UV liOHT 








0 12 HI 20 24 
Tllol[ (WEEKII 
TIMEPOINT CONDITION (% Label) 
(Weeks) 25 40 50 70 100 RH Lt Hv 
4 101.1 101.1 101.2 102.2 99.0 101.2 102.2 96.6 
8 100.2 100.2 101.1 100.2 88.2 99.4 
96.8 85.8 
12 99.1 98.8 98.7 99.6 70.6 100.9 
95.2 83.5 
16 99.3 99.4 99.4 102.8 53.6 99.6 
96.6 83.4 
20 98.9 100.7 101.4 102.0 11.2 99.6 
97.6 83.3 
2-4 100.2 99.8 100.3 102.6 6.0 99.6 
97.4 78.6 
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Figure 8.2.5 Stability Data for IMMMES 
- 2G'C 
"'*" 100"C 










-+- 40'C _..._ IO'C -e- 10'C 
+ 21'C/11'1.RH -A- WINDOW LIOHT -B- UV LIOHT 
12 141 20 24 
TIWE (WEEKS) 
CONDITION (, Label) 
40 50 70 100 RH Lt 
21 
Hv 
99.8 99.3 98.8 99.-4 99.0 97.-4 99.9 101.6 
2 101.0 102.2 101.8 100.6 98.7 98.5 99.3 
3 99.5 100.4 99.8 99.-4 98.9 99A 98.8 
.. 99.8 100.7 99.4 99.6 98.2 98.6 99.2 
13 99.6 99.2 98.4 99.0 97.-4 99.2 ~n.o 
28 100.0 101.3 101.0 100.0 97.9 98.-4 94.6 
Figure 8.2.6 Stability Data for IMMHCLHY 
- 21'C 
"'*" 100'C 














-+- 40'C -*" IO"C -€1- TO'C 
+ 21'C/11'1.RH -&- WINDOW LIOHT -B- UV LIOHT 
12 11 20 24 21 
TIWE IW((ICSI 
CONDITION (, Label) 
40 50 70 100 RH Lt 
100.8 100.-4 100.-4 97.6 99.0 102.2 
99.6 98.9 99.0 9-4.1 98.-4 98.9 
101.6 100.5 100.6 92.3 98.8 98.0 
101.0 99.6 101.4 92.2 98.5 98.2 
101.9 101.4 99.8 72.7 97.4 93.3 



















_.... IO"C -6- 70"C 
-8.- WINDOW LIGHT -H- UV LIGHT 





12 11 20 
TI .. E (WEEKS! 
TIME POINT CONDITION (% label) 
(Weeks) 25 40 50 70 100 RH lt 
4 101.0 100.8 100.7 102.4 104.2 101.0 98.4 
8 100.2 100.0 99.9 101.6 103.8 100.0 98.6 
12 99.6 99.9 100.2 103.1 103.8 99.9 99.0 
16 99.0 99.7 99.9 101.0 104.2 99.2 97.5 
20 100.2 99.4 100.0 102.4 106.8 100.7 96.8 
24 100.1 100.3 99.8 102.8 104.7 100.2 97.6 
Figure 8.2.8 Stability Data for IMTH CLHY C 
- 21'C --+- 40"C ..._ IO"C -6- 70"C 
"""*- 100"C + 211"CII7'LRH -&- WINDOW LIGHT -H- UV LIGHT 







12 11 20 
TI .. E (W[(ICI) 
TIME POINT CONDITION ("J. label) 
(Weeks) 25 40 50 70 100 RH lt 
... 100.-4 100.0 100.-4 100.3 93.6 100.2 100.0 
8 99.2 99.4 99.4 100.4 89.5 99.6 100.0 
12 100.7 100.6 100.6 101.4 61.0 100.6 99.7 
17 99.8 100.5 100.3 102.6 29.0 100.4 101.1 
20 99.4 99.5 99.8 102.7 22.0 99.9 100.4 


















FiS!ure 8.2. 9 Stability Data for IMTHCLHYE 
~ 21"C 
-x- tao·c 
+ .co·c + •o·c -G- 1o·c 
+ 21.C/17t.AH -A- WINDOW LIOHT -H- UY LIOHT 






0 12 Ill 20 24 
TIS.CE (WEEKII 
TIME POINT CONDITION (% Label) 
(Weeks) 25 40 50 70 100 ~H Lt Hv 
4 101.0 100.4 99.4 100.6 102.4 99.3 101.4 99.7 
8 100.4 100.4 100.2 102.0 103.5 100.0 103.5 100.0 
12 99.6 100.0 100.5 101.7 106.4 100.4 104.7 101.6 
16 100.8 100.0 99.8 101.0 105.6 99.8 102.5 96.4 
22 100.0 100.0 99.9 100.9 109.4 100.1 101.0 93.1 
24 100.3 101.9 101.6 100.7 110.6 101.0 102.6 93.5 
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Figure 8.2. 10 Comparison of Thermal Stability (100°C) of Salts and Modifications 
of IM 
-- IIAFBA -+- IIAFBB ..;t(-ruFBC -8· IIAFBTOL 





0 12 16 20 24 
TIIAE (WEEKS) 
--IIAUIAES + IIAIAHCLHY --*"- IUTHCLHYA -8-IIATHCLHYC ~ IIATHCLHYE 
'llo LABEL STRENGTH 
120 
oL-----~------~------~------~------~------~------~--
0 8 12 1«1 20 24 28 
TIUE (WEEKS) 
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Figure 8.2.11 Comparison of Window Light Stability of Salts and Modifications of IM 
-IMF BA +IMF BB 4(- IMF BC -8- IMFBTOL 






0 12 111 20 
TIME (WEEKS) 
-eMMMES 4-IMMHCLHY + IMTHCLHYA -8-IMTHCLHYC ~IMTHCLHYE 








0 12 111 20 2~ 211 
TIME (WEEKS) 
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Figure 8.2.12 Comparison of UV Light Stability of Salts and Modifications of IM 
-IMF BA -f- IMFBB --*""IMF BC -B·tMFBTOL 
'I. LABEL STRENGTH 
0 8 12 16 20 24 
TIME (WEEKS) 
--tMMMES -f-tMMHCLHY "*-tMTHCLHYA -8- IMTHCLHYC "*-tMTHCLHYE 








0 8 12 18 20 24 28 
TIME (WEEKS) 
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8.3 Van't Hoff Solubility Investigations on Salts and 
Modifications of IM 
The data and Van't Hoff solubility plots are summarised 
in Figures 8.3.1 to 8.3.3 respectively for the neutral, 
mono and triprotonated species. Linear regression 
analys~s (using least squares fit) were performed on 
the data and are summarised together with the heat of 
solution (~Hs) values, in Table 8.3.1. 
Table 8.3.1 Summary of Linear Regression and Heat of Solution (6HJ Data for Salts 
and Modifications of IM 
Linear Regression Analysis 6H5 
Salts/ 
Modifications R2 a b KJ mor1 
IMFBA 0.974 0.646 -1139.5 9.47 
IMFBC 0.967 -0.221 -852.0 7.08 
IMMMES 0.995 6.340 -2671.7 22.21 
IMTHCLHYC 0.994 -11.064 2532.9 -21.06 
a = intercept, b = slope 
The free energy change (~GT) associated with the 
transitions between the various phases of the free base 
and trichloride salt of IM, were calculated directly 
from the molar solubility (Cs) measurements at 25°C, 
via equation (1) . 
= RT tn Cs (A) 
Cs(B) 
( 1) 
where R = Universal Gas Constant, T = Absolute 
Temperature and Cs(A) and Cs(B) are the respective 
molar solubilities of the two phases A and B. 
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Aguiar and Zelmer3 , postulated that when the free 
energy differences between polymorphs or solvates are 
small then it is unlikely that there will be 
differences in the bioavailability of the drug as it 1s 
probable that the forms will interconvert ~0~. 
A difference in biological activity between solid oral 
preparations of their polymorphs was demonstrated for 
Chloramphenicol palmitate, but not Mefanamic acid. The 
respective free energy differences are 3.24 and 
1 . 0 5 KJ . mo 1 -1 • 
Subsequent work 4• 5 has tended to confirm the hypothesi.:: 
of Aguiar and Zelmer. 
For the polymorphs and solvates of the free base, the 
data are summarised in Scheme 1. 
Scheme 1 Gibbs Free Energy Differences Between Polymorphs of IMFB (KJ mor1) at 







The toluene solvate (IMFBTOL) converted directly into 
Phase C (IMFBC), following suspension and agitation in 
ethanol at 4°C and thus could not be directly studied. 
The free energy differences at 25°C between Phases A, B 
and C are minimal, with the largest difference (1.075 
KJ.mol- 1 , Phase B to Phase A) being of the same order 
as found between the various polymorphs of Mefanamic 
acid. Bioavailability differences between the various 
polymorphs of IMFB are thus unlikely. 
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The relative thermodynamic stabilities of the 
polymorphic forms at 25°C are Form A > c > B, these 
findings are supported by the DSC data (Figure 2.1.2) 
which indicates that the metastable Form B converts 
into the more stable Form A when heated above 188°C. 
It should be noted from the Van•t Hoff solubility plot 
(Figure 8.3.1) that at 4°C the relative thermodynamic 
stabilities are Forms B > A > C. This plot also 
confirms the metastable nature of Form B, the change in 
the slope at 25°C being indicative of a phase change 
into the more stable Form A. 
Form A (~s = 9. 4 7 KJ. mol-1 ) subsequently converts into 
the thermodynamically more stable Form c 
(~s = 7. 08 KJ. mol-1 ) , the transition temperature is 
about 56°C. 
Behme etaf advocated the classification of polymorphs 
as monotropic or enantiotropic, as an aid to the 
understanding of polymorphic systems. For monotropic 
solids, the higher melting form has the lower free 
energy at all temperatures and is, therefore, more 
stable at every temperature. The relative stabilities 
of enantiotropic solids depends on the temperature of 
the system relative to the transition temperature. 
All three polymorphs of IMFB were characterised as 
enantiotropic on the basis of Burger and Rambergers7 
heat of transition rule. This rule states in part that 
if an endothermal transition, resultant upon a solid-
solid phase transition, is observed at some 
temperature, then it may be assumed that there is a 
transition point below it and that the two forms are 
related enantiotropically. Endothermic phase 
transitions were observed for Phases B to A (see Figure 
2.1.2) and Phases c to A (see Figure 8.3.4). In 
addition, the Van't Hoff solubility plot shows a 
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transition between Phases A and C and Phases B and A. 
A very similar polymorphic system to IMFB was described 
by Behme etaf, in their investigations into the 
polymorphism of Gepirone Hydrochloride. In an exactly 
analogous fashion, the DSC investigations showed a low 
melting form (Form I) converting into a high melting 
form (Form II) via a solid-solid phase transition. All 
forms characterised during these investigations were 
enantiotropic. 
Due to the exceptionally high solubility 
(250.3 mg.ml- 1 ), of the monochloride salt (IMMHCLHY) at 
4°C, additional solubility readings at 25°C, 40°C and 
48°C could not be determined due to lack of solute. 
The monomesylate salt (IMMMES) demonstrated the highest 
~Hs (22.21 KJ.mol- 1 ) of all the salts and modifications 
of IM studied. 
The Van't Hoff solubility plot of sesquifumarate salt 
(IMSF~), shows evidence of a transition from a 
thermodynamically less stable to a more stable form. 
The transition temperature is about 25°C. 
The free energy differences at 25°C for the solvates of 
the trichloride are summarised in Scheme 2. 
Scheme 2 Gibbs Free Energy Differences Between Solvates of IMTHCI (KJ.mol"1) at 





IMTHCLHYD g a ~ IMTHCLHYE 
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From the crystallographic investigations (Table 7.1) it 
was found that Phases A and E, converted into Phase D 
on standing•. This data coupled with the Van't Hoff 
solubility data suggests that the relative 
thermodynamic stabilities are Phase D > E > A > C at 
25°C. 
Although the hypothesis of Aguiar and Zelmer3 would 
suggest that there will be no differences in the 
bioavailability of Phases A and E, due to free energy 
differences of < 1 KJ. mol-1 • It would also indicate 
that Phase C will not be bioequivalent with either 
Phase A or E. However, it must be noted that this 
thermodynamic data was generated in ethanol, due to the 
freely soluble (> 10 mg .ml-1) nature of these phases in 
water. Kaplan8 suggested that provided the solubility 
of the drug is in excess of 10 mg. ml-1 at <pH 7, then no 
bioavailability problems were to be expected. This is 
because the kinetics of absorption for freely soluble 
drugs (see Section 1) are trans-membrane rate limited. 
Dissolution rate limited kinetics only apply for poorly 
soluble drugs (< 1 mg.ml-1). 
The change of slope observed at 25°C for Phases A and E 
is probably indicative of a phase change, possiblf to 
the more stable Phase D. 
As observed previously for GUMASCHY and GUDMES (see 
Section 4.3), Phase c demonstrates an inverse 
relationship between temperature and molar solubility 
and a resultant exothermic heat of solution. As stated 
previously, this could be indicative of the molecule 
adopting a conformation corresponding to an isolated, 
rather than a solvated molecule. As the temperature 
decreases, the intramolecular hydrogen bonds weaken and 
the solubility increases. 
Figure 8.3.1 
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3 3.2 3.4 3.11 3.1 
1/T x 10a-3 Ka-1 
to3 lnvene of Absolute Temperature ( K · ') 
SALT 3.61 3.36 3.H~ 3.12 
IMF BA -3.·U -3.2~ -2.9g -2.88 
IMF BB -3_go -2.80 -2.go -2.86 
JMFBTOL -3.28 -3.11 -2.g7 -2.8~ 
(flguraa quo!Ad ••• ll\ of Wolar concei\Uatlonl 
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Figure 8.3.2 Van't Hoff Solubility Plots for the Monoprotonated Salts of IM 
-IWWHClHY -f- IWWW(I ""*-IWWfUW 
lnCe (W) 
3.2 3.4 3.1 a.a 
1/T x 10e·3 Ke·1 
lD3 lnver .. of Abaolute Temperature ( K.') 
SALT 3.61 3.36 3.1G 3.12 
IMMHCLHY -0.66 NA NA NA 
IMMMES -3.30 -2.63 -2.24 -1.G6 
IMMFUM -7.68 -4.83 -4.30 -4.,. 
Figure 8.3.3 
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Van 't Hoff Solubility Plots for the Various Phases of the Trichloride Salt 
ofiM 







3.Z 3.4 3.1 1.1 
1/T a 10.·3 Ke-1 
\DJ lnwree of Abeolute Temperature ( K"') 
SALT 3.81 3.36 3.1i 3.12 
IMTHCLHYA -3.1i -3.68 -3.26 -3.26 
IMTHCLHYC -1.i3 -2.66 -2.g3 -3.21 
IMTHCLHYE -3.g-4 -3.8g -3.-46 -3.23 
Figure 8.3.4 DSC Heating Curves for (i) IMFBB and (ii) IMFBC, Showing in Both 
Cases Evidence of Solid-Solid Phase Transitions and Subsequent 
Melting as Phase A 
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8.4 Physicochemical Properties of Salts and 
Modifications of IM 
The physicochemical properties of the salts and 
modifications of IM are summarised in Table 8.4.1. 
The very low aqueous solubility of all of the 
modifications of the free base of IM would restrict 
their use in conventional solid oral dosage forms. 
However, their potential use should not be totally 
discounted, as at a later stage in product development 
a sustained release formulation may be deemed 
desirable. In this case, the low aqu~ous solubility 
may be considered advantageous. This approach of 
utilising the slow release characteristics of slightly 
soluble salts of a drug substance has previously been 
used successfully for Methadone9 and Amitryptyline10 • 
With chloride salts there is frequently an 'overkill' 
on acid strength which leads to a very low pH for an 
aqueous solution. These problems can be particularly 
acute for di- and trichlorides (or the sulphate 
analogues). Other problems arise as a result of the 
polar nature of chloride salts. Their hydrophilic 
nature leads to hygroscopicity problems. This was 
encountered for both the mono- and trichlorides of IM. 
This can often result in processing difficulties, 
eg powder flowrand reduce the stability of compounds 
prone to hydrolysis~ the latter effect can be 
exacerbated by the very low pH of the surface bound 
water. 
The low aqueous solubility of the fumarate salt and the 
isolation problems associated with the sulphate and 
oxalate salts (plus the toxicity of the latter salt) 
would be major impedtments to their further use. 
Therefore, based on the good solubility, non-hygroscopic 
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nature and excellent stability, the monomesylate salt 
would be a prime candidate for future development. 
Again, as with GU, the salts and modifications of IM 
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Small coloured plates from toluene, 0.25 x 0.25 x 
0.04 mm. 
c29H32N4 . C7H8 I Mr = 52 9 . 8 I orthorhornbi c I Pbca (No . 61) I 
a= 27.054 (7), b = 22.701 (6), c = 9.580 (3) A, 
V= 5833.4 A3, z = 8, V/Z = 729 A3 • 
Lattice parameters refined from accurately measured 2e 
values (30.6-32.0°) for 40 reflections. 
De = 1. 19 g. cm- 3 , Jl = 0. 3 7 cm- 1 , F ( 0 0 0) = 2 2 7 2 . 0, 
T = 290 K. 
Data Collection and Processing 
stoe STADI-4 diffractometer, MoKa, 'A = 0.71073 A. 5120 
independent data (2 :::;; e :::;; 22 ° I -29 :::;; h :::;; 2 91 -24 :::;; k :::;; 
24, 0 :::;; 1 :::;; 10) yielding 2146 data with I ~ 2.5 a (I) . 
No measurable crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86). 
ur 1 = a2 ( F ) + o . o o o 218 F2 , R = o . o 8 55 , wR = o . o 9 3 2 , 
S = 1.273 based on 332 parameters. Maximum and minimum 
ripple in difference electron density map : 0.53 and 
-0 . 2 6 e. A -3 • 
The disordered toluene solvent is located on an 
inversion centre and is modelled as two inter-
penetrating ring systems. The toluene was refined 
isotropically, the methyl group and all of the ring 
hydrogens could not be located. Ten low angle 
reflections were omitted from the refinement. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. A drawing of the 
molecular structure and molecular packing as viewed 
along the c-ax1s is given in Figure 9.1. The packing 
may be described as interpenetrating bilayers of IM 
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running parallel to the a-axis, separated by a 
monolayer of solvent molecules. The imidazole 
'pyrrole' nitrogen, N(J) forms a bifurcated hydrogen 
bond, giving closest contact with N{l) and a very long 
contact with N(7) of the same molecule. These 
distances, together with some of the close 
intermolecular contacts are summarised in Table 9.1. 
Table 9.1 Hydrogen Bonding and Other Close Intermolecular Contacts 





x, 1 %-y,% +z 
X, 1 %-y,% + Z 
b) C ... C Contacts Closer than 3. 75A 
C(4') ...... C(4S) 
C(17) ...... C(21) 
C(4M) ...... C(9) 
C(17') ..... C(2M) 
C(6) ....... C(6S) 
C(16') ..... C(2M) 
1-x,% +y, %-z 
-% +x,y, %-z 
x,y,-1 +z 
-% + x, 1 % -y, 1-z 
1-x,%+y,%-z 
-% +x, 1 %-y, 1-z 
c) C ... N Contacts Closer than 3. 75A 
C(21 ) ...... N(3) 
C(25) ...... N(1) 
C(4M) ...... N(1) 
C(4) ....... N(1) 
C(2) ....... N(3) 
C(5) ....... N(3) 
x, 1 %-y,% +z 
x, 1 %-y,-% +z 
x, 1 %-y,-% +z 
x,1%-y,-%+z 
x, 1 %-y,% +z 




H ... A 
2.02(5) 
2.85(5) 
















Figure 9 .I Molecular Structure and Molecular Packing (as viewed along the c-axis) of 
IMFBTOL 
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9. 2 IMMMES 
Crystal Data 
Large colourless plates from a 50:50 v/v mixture of 
methanol and ethyl acetate, 0.80 x 0.74 x 0.07 mm. 
C29H33N4 ... CH3S03-, Mr = 548.7, monoclinic, P2 1 /n 
alternative setting of P2 1 /c (No.14), a= 9.498 (7), 
b = 31.647 (2), c = 10.1o3 (9) A, p = 106.23 (6) 0 , 
V= 2916.0 A3 , z = 4, VIZ= 729 A3 • 
Lattice parameters refined from accurately measured 2e 
values (25.3° - 29.2°) for 12 reflections. 
De= 1.25 g.cm- 3 , Jl = 12.22 cm-1 , F(OOO) = 1168, 
T = 290 K. 
Data Collection and Refinement 
Stoe STADI-4 diffractometer, CuKa, A = 1.5418 A. 4591 
independent data (2 ~ e ~ 66.8°, -11 ~ h ~ 11, 0 ~ k ~ 
37, 0 ~ 1 ~ 12) yielding 2080 data with I~ 2.5 a (I). 
No measurable crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86). 
ur 1 = cr2 (F) + o . o o 0 2 53 F2 , R = o . o 4 7 9 , wR = o . o 53 4 , 
S = 0.933 based on 374 parameters. Maximum shift/esd 
in last cycle = -0.102. Maximum and minimum ripple in 
difference electron density map : 0.18 and -0.24 e.A- 3 • 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. A drawing of the 
molecular structure and molecular packing as viewed 
along the a-axls is given in Figure 9.2. The packing 
may be described as corrugated monolayers of IM, 
packing along the b-axis, the direction of the IM 
molecules alternating from one layer to the next. The 
mesylate anions are located near the piperazine ring of 
each IM molecule and alternate from one side of the 
layer to the other. 
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The salt hydrogen bond is formed between the mesylate 
oxygen, 0(28) and the piperazine nitrogen, N(7), and 
an additional hydrogen bond is formed between the 
imidazole nitrogen, N(3) and the mesylate oxygen, O{lS) 
of a second anion. These distances, together with some 
of the close intermolecular contacts are summarised in 
Table 9.2. 
Table 9.2 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor 
0(2S)-H(7) .. N(7)* 
N(3)-H(3)... 0(1 S) 
* salt H-bond 
Symmetry 
x,y,z 




b) C ... C Contacts Shorter than 3.75A 
C(19') ..... C(20) 
C(18) ...... C(2M) 
C(21 ) ...... C(1 S) 
C(22) ...... C(22) 
C(17) ...... C(2M) 
C(19') ..... C(21) 
C(19) ...... C(2M) 
% + X, % -y,-% + Z 
%-x,% +y, %-z 
x,y,z 
-x,-y, 1-z 
%-x,% + y, %-z 
% +x, %-y,-% +z 
%-x,% + y, %-z 
c) C ... N Contacts Shorter than 3. 75A 
C(1S). ..... N(1) 
C(12) ...... N(3) 
C(19) ...... N(1) 
x,y,z 
% + X, % -y, % + Z 
% +x, %-y,-% +z 
d) C ... 0 Contacts Shorter than 3. 75A 
C(9) ....... 0(3S) -% +x,%-y,-% +z 
C(12) ...... 0(3S) x,y,z 
C(4M) ...... 0(2S) -% +x, %-y,% +z 
C(8) ....... 0(2S) x,y,z 
C(6) ....... 0(1 S) -% + X, % -y, % + Z 
C(25) ...... 0(1 S) -1 +x,y,z 
H ... A 
1.93(5) 
1.96(5) 




















d) C ... O Contacts Shorter than 3. 75A (cont'd) 
C(12) ...... 0(2S) x,y,z 
C(4M) ...... 0(1 S) -% +x, %-y,% +z 
C(4M) ...... 0(3S) -1 +x,y,z 
C(6) ....... 0(2S) x,y,z 
C(9) ....... 0(2S) x,y,z 
C( 11) ...... 0(25) x,y,z 
C(4) ....... 0(1S) -1 +x,y,z 
C(5) ....... 0(2S) x,y,z 
C(11 ) ...... 0(35) x,y,z 












Figure 9.2 Molecular Structure and Molecular Packing (as viewed along the a-axis) of 
IMMMES 
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9 . 3 IMMHCLAC 
Crystal Data 
Large colourless plates from a 50% aqueous acetone, 
0.80 X 0.76 X 0.08 mm. 
C29H33N4 +.cl-. C3H60, 
a = 9.062 ( 5) 1 b 
a = 71.24 ( 2 ) 1 ~ 
1503.8 A3 I z = 2 1 
Mr = 532.2, triclinic, Pl(No.2) 
= 11.968 (6) I c = 15.781 (7) I A, 
= 77.96 (2) I 'Y = 69.23 (2) 0 , V = 
V /Z = 7 52 A3 • 
Lattice parameters refined from accurately measured 2e 
values (7.79°- 11.01°) for 23 reflections. 
De = 1 . 19 g . cm- 3 , Jl = 1 . 19 cm -1 1 F ( 0 0 0 ) = 52 4 . 0 , T = 2 9 0 
K. 
Data Collection and Refinement 
Stoe STADI-4 diffractometer, MoKa 1 A= 0.71069 A. 4573 
independent data (2 ~ e ~ 22° 1 -9 ~ h ~ 9, -11 ~ k ~ 
12, 0 ~ 1 ~ 16) yielding 2821 data with I ~ 2.5 a (I). 
No measurable crystal decay or movement. 
Structure Solution and Refinement 
Soluti?n by direct methods (SHELX 86) . 
rn- 1 = cr2 ( F) + 0 . 0 0 0 50 F2 , R = 0 . 0 4 9 9 , wR = 0 . 0 6 55 , 
S = 1.253 based on 377 parameters. Maximum shift/esd 
in last cycle= 0.803. Maximum and m1n1mum ripple in 
difference electron density map : 0.20 and -0.27 e.A-3 • 
Disorder was apparent in the tolyl methyl group and was 
modelled as two alternative positions for the three 
hydrogens. All of the major shifts associated with the 
structure were attributable to the disordered methyl 
group. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. A drawing of the 
molecular structure and molecular packing as viewed 
along the a-axis is given in Figure 9.3. It is 
dominated by hydrogen bonding and ring stacking. 
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Conformationally, the molecule is quite dissimilar from 
other IM structures, mainly involving rotations about 
the single non-ring bond at C(5)-C(6). The molecular 
packing may be described as parallel bilayers of IM 
cations, stacking in a head-tail fashion along each 
layer and with each layer being aligned in opposite 
directions. Each bilayer is separated by a channel 
occupied by the anions and solvent molecules. The 
chloride anion is central to the hydrogen bonding being 
joined to two different cation molecules. These 
distances are summarised in Table 9.3, together with 
some close intermolecular contacts. The main 
hydrophobic contacts are between phenyl and tolyl ring 
systems through an inversion centre. 
Table 9.3 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry D-H H ... A D ... A 
N(3)-H(3) ... Cl(1) x,y,z 0.83 2.34(4) 3.167(3) 
Cl(1 )-H(7) .. N(7)* -x, 1-y,-z 0.90 2.17(4) 3.067(3) 
* salt H-bond 
b) C ... C Contacts Shorter than 3.75A 
C(9) ....... C(1A) -1 + x,y,z 3.426(7) 
C(17') ..... C(25) x,1 +y,-1 + z 3.470(7) 
C(2) ....... C(15) -1-x,2-y,-z 3.580(5) 
C(24) ...... C(3A) -x, 1-y,-z 3.595(7) 
C(9) ....... C(3A) -1 +x,y,z 3.635(7) 
C(4M) ...... C(22) 1 + x,y,z 3.642(6) 
C(15') ..... C(23) -1-x,2-y,-z 3.695(6) 
C(17') ..... C(24) x,1 +y,-1 +z 3.704(7) 
C(4M) ...... C(1 A) x,y,z 3. 719(7) 
C(15) ...... C(20) -1-x,2-y,-z 3.741(5) 
C(16'). .... C(23) -1-x,2-y,-z 3.742(6) 
c) C ... N Contacts Shorter than 3. 75A 
C(8) ....... N( 1) -1-x,2-y,-z 
C(15) ...... N(1) -1-x,2-y ,-z 
d) C ... 0 Contacts Shorter than 3. 75A 
C(6) ....... 0(1 A) -x,2-y,-z 
C(9) ....... 0(1A) -1 +x,y,z 
C(4M) ...... 0(1 A) x,y,z 
C(8) ....... 0(1A) -1 + x,y,z 















9 . 4 IMTHCLHYA 
Crystal Data 
Colourless prisms from 50% methanolic ethyl acetate, 
0.52 X 0.40 X 0.26 mm. 
C29H3sN/+. 3cl- .H20, Mr = 565.0, monoclinic, P2 1 /n (No .14), 
a= 14.491 (8), b = 13.070 (8), c = 15.269 (8) A, p = 
99.72 (4) 0 , V= 2850.3 A3 , z = 4, V/Z = 713 A3. 
Lattice parameters refined from accurately measured 2e 
values (12.4° - 16.3°) for 20 reflections. 
De= 1.31 g.cm- 3 , Jl = 30.11 cm- 1 , F(OOO) = 1184, 
T = 290 K. 
Data Collection and Refinement 
Stoe STADI-4 diffractometer, CuKa, A = 1.5418 A. 3418 
independent data (2 < e < 56°, 0 ~ h ~ 15, 0 ~ k ~ 
14, -16 ~ 1 ~ 16) yielding 2508 data with I~ 2.5 a 
(I). No measurable crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods (SHELX 84) . 
m- 1 = a_2 (F) + o . o 0 0 31F2 , R = o . o 3 8 5, wR = 0 . 0 51 o, 
S = 1.217 based on 368 parameters. Maximum shift/esd 
on last cycle = -0.109. Maximum and minimum ripple in 
difference electron density map : 0.24 and -0.26 e.A- 3 • 
Disorder was apparent in solvent molecule. The water 
oxygen was refined with a site occupancy of one third. 
No hydrogens located for disordered water molecule. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. A drawing of the 
molecular structure and molecular packing as viewed 
along the a-axis is given in Figure 9.4. The molecular 
packing may be described as off-set, parallel bilayers 
of cations running diagonally across the projected unit 
cell. The anions straddle the resulting channel 
between these bilayers. The hydrogen bonding and other 
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close intermolecular contacts are summarised in Table 
9.4. The principal hydrophobic contacts are between 
phenyl and tolyl ring systems through an inversion 
centre. 
Table 9.4 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry D-H 
N(3)-H(3) ... Cl(1) -x,-y,-z 1.08 
Cl(1 )-H(1 0). N(1 0) * %-x,% + y, %-z 0.96 
0(1 )-H(1 W) .. Cl(2) x,y,z 
CI(2)-H(1 ) .. N(1 )* x,y,z 0.86 
0(1 )-H(2W) .. Cl(3) % +x,-%-y,% +z 
CI(3)-H(7) .. N(7)* % +x,-%-y,% +z 0.92 
* salt H-bonds 
b) C ... C Contacts Shorter than 3. 75A 
C(18) ...... C(25) -x,-y, 1-z 
C(4) ....... C(25) -x,-y, 1-z 
C(4M) ...... C(24) -x,-y,-z 
C(19') ..... C(21) -x,-y, 1-z 
C(19) ...... C(25) -x,-y, 1-z 
C(18) ...... C(24) -x,-y, 1-z 
C(4M) ...... C(25) -x,-y,-z 
C(19') ..... C(22) -x,-y, 1-z 
C(18') ..... C(22) -x,-y,1-z 
C(19) ...... C(20) -x,-y, 1-z 
C(18') ..... C(21) -x,-y, 1-z 
C{4) ....... C{24) -x,-y,-z 
C(14') ..... C(22) -x,-y, 1-z 
C(1 7') ..... C(22) -x,-y, 1-z 
C(17) ...... C{24) -x,-y,1-z 
C{9) ....... C{17) -% +x,-Yz-y,-Yz +z 
c) C ... N Contacts Shorter than 3. 75A 
C{25) ...... N(3) -x,-y,-z 






























d) C ... O Contacts Shorter than 3. 75A 
C(11 ) ...... 0(1) x,y,z 
C(19') ..... 0(1) -x,-y, 1-z 
C(2M) ...... 0(1) -% +x, %-y,-% +z 
C(12) ...... 0(1) x,y,z 
C(17) ...... 0(1) %-x,-% + y, 1 %-z 
C(16) ...... 0(1) %-x,-% + y, 1 %-z 
C(24) ...... 0(1) -% +x,%-y,-% +z 















Colourless needles from isopropanol, 0.58 x 0.09 x 
0.06 mm. 
c29H3sN/+. 3Cl-. 2H20 I Mr = 583. 0 I triclinic I Pl (No. 2) I 
a= 6.970 (5), b = 15.000 {18), c = 16.340 {36) A, 
a = 118.01 (3), {3 = 91.64 {13), 'Y = 101.40 (8) 0 , 
V = 1512 . 7 A3 I z = 2 I V I z = 7 56 A3 • 
Lattice parameters refined from accurately measured 28 
values (18.2° - 24.2°) for 14 reflections. 
De= 1.28 g.cm-3 , p. = 2.86 cm-1 , F(OOO) = 592, 
T = 290 K. 
Data Collection and Refinement 
Stoe STADI-4 diffractometer, MoKa, A= 0.71073 A. 3932 
independent data {2 < e < 22°, -7 ~ h ~ 7, -16 ~ k ~ 
16, 0 ~ 1 ~ 17) yielding 1970 data with I~ 2.5 a (I). 
No measur~ble crystal decay or movement. 
Structure Solution and Refinement 
Solution by direct methods {SHELX 86). 
?a>-1 = a2 (F) + 0.000243F2 , R = 0.0683, wR = 0.0691, 
S = 1.252 based on 374 parameters. Maximum shiftjesd 
on last cycle = -0.136. Maximum and minimum ripple in 
difference electron density map : 0.33 and -0.28 e.A-3 • 
Disorder was apparent in solvent molecules. No 
hydrogens located for either disordered water molecule. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. A drawing of the 
molecular structure and molecular packing as viewed 
along the a-axis is given in Figure 9.5. The molecular 
packing may be described as parallel monolayers of IM 
cations, stacking in a head to tail fashion along each 
layer and with each layer being aligned in opposite 
directions. The channels between layers are occupied 
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by anions and solvent molecules. The packing is 
similar to that previously described in Section 9.3 for 
IMMHCLAC. The chloride anions are central to the 
packing being hydrogen bonded to two different cation 
molecules. The hydrogen bonding and other close inter-
molecular contacts are summarised in Table 9.5. The 
principal hydrophobic contacts are imidazole-phenyl 
along the a-axis, phenyl-phenyl and phenyl-tolyl 
through an inversion centre. 
Table 9.5 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
N(1 )-H(1 ) ... Cl(2) -x,2-y,1-z 1.01 2.29(9) 3.070(9) 
CI(2)-H(7) .. N(7)* -x,2-y,1-z 1.01 2.13(8) 3.098(8) 
Cl(1 )-H(1 0). N(1 0) * 1 + x,y,z 0.97 2.09(8) 3.058{7) 
CI(3)-H(3) .. N(3)* x,y,z 0.88 2.04(8) 3.017(9) 
0(1) Cl(2) 1 +x,y,z 3.208(9) 
* salt H-bonds 
b) C ... C Contacts Shorter than 3. 75A 
C(4) ...... C(22) -1 + x,y,z 3.394(14) 
C(5) ...... C(22) -1 +x,y,z 3.428(14) 
C(17') .... C(17') -1-x, 1-y, 1-z 3.469(20) 
C(17') .... C(21) -x,2-y,1-z 3.592(17) 
C(4) ...... C(23) -1 + x,y,z 3.593(15) 
C(17) ..... C(24) -1 +x,-1 +y,z 3.631(17) 
C( 16) ..... C(24) -1 +x,-1 +y,z 3.657(17) 
C(16') .... C(21) -x,2-y,1-z 3.671 (17) 
c) C ... N Contacts Shorter than 3. 75A 
C(2M) ..... N(3) 1 + x,y,z 3.546(14) 
C(23) ..... N(3) 1 + x,y,z 3.601 (14) 
d) C ... O Contacts Shorter than 3. 75A 
C(6) ...... 0(1) -x,2-y,1-z 
C(8) ...... 0(1) -x,2-y,1-z 
C(19') .... 0(1) x,y,z 
C(6) ...... 0(2) x,y,z 
C(12) ..... 0(2) x,y,z 
C(4M) ..... 0(2) x,y,z 
C(15') .... 0(1) -1+x,y,z 



















Colourless plates from 50% aqueous acetone, 0.85 x 0.70 
x 0.10 mm. 
C29H3sN4
3
+ .3cl- .5H20, M = 637 .0, monoclinic, C2/c (No.15), 
a= 23.580 (3), b = 17.176 (2), c = 17.164 (2) A, p = 
105.88 (1) 0 , V = 6686.4 A3 , z = 8, V/z = 833 A3 • 
Lattice parameters refined from accurately measured 2e 
values (10.0° - 11.3°) for 30 reflections. 
De = 1. 2 5 g. cm- 3 , Jl = 2. 6 0 cm-1 , F ( 0 0 0) = 2 3 6 8, 
T = 290 k. 
Data Collection and Processing 
Stoe STADI-4 diffractometer, MoKu, A = 0.71073 A. 3167 
independent data (2 < e < 22°, -25 ~ h ~ 25, 0 ~ k ~ 
18, 0 ~ 1 ~ 18) yielding 1355 data with I~ 2.5 a (I). 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86) after incorpor-
ating the positions of Cl(1) and Cl(2) into the matrix. 
No weighting scheme employed, R = 0.0848, wR = 0.1035, 
S = 9.513 based on 376 parameters. Maximum shift/esd 
on last cycle = 1.514. Maximum and minimum ripple in 
difference electron density map : 0.47 and -0.30 e.A- 3 • 
Refinement not completed, anions and water molecules 
all disordered. High thermal parameters for Cl(2) and 
0(3), 0(4) and 0(5). Cl(1) badly disordered and 
modelled in three segments, about a special position, 
with partial site occupancies of 0.5, 0.18 and 0.32, 
the two smaller fragments were refined isotropically. 
Water oxygens 0(3), 0(4) and 0(5) all modelled with 
partial site occupancy of 0.5. No hydrogens were 
located on any of the water oxygens. 
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Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. Molecular structure and 
molecular packing diagram (as viewed along the b-axis) 
are shown in Figure 9.6. The hydrogen bonding and 
other close intermolecular contacts are summarised in 
Table 9.6. The principal hydrophobic contacts are 
phenyl-tolyl and imidazole-tolyl through an inversion 
centre. 
Table 9.6 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry D-H H ... A D ... A 
N(1 )-H(1 ) ... 0(1) x,y,z 1.08 2.83(2) 3.29(2) 
Cl(1 )-H(3) .. N(3)* Y:z +X, Y:z -y ,Z 1.08 2.08(5) 3.11(2) 
CI(2)-H(1 0). N(1 0) * Y:z-x, Y:z-y,-z 1.08 1.98(1) 3.03(2) 
N(7)-H(7) ... 0(1) x,y,z 1.08 1.66(2) 2.73(2) 
CI(5)-H(7) .. N(7)* x,y,z 1.08 3.34(3) 3.65(3) 
0(3) ........ 0(5) x,y,z 2.48(6) 
0(3) ........ 0(4) Y:z -x,- Y:z + y, Y:z -z 2.78(5) 
0(1 ) ........ 0(5) x,y,z 3.27(5) 
+ salt H-bonds 
b) C ... C Contacts Shorter than 3. 75A 
C(19) ..... C(21) Y:z-x, Y:z-y,-z 3.42(4) 
C(20) ..... C(20) 1-x, 1-y,-z 3.44(3) 
C(2) ...... C(20) 1-x, 1-y,-z 3.47(3) 
C(19) ..... C(22) Y:z-x, Y:z-y,-z 3.49(4) 
C(2) ...... C(21) 1-x, 1-y,-z 3.55(3) 
C(4) ...... C(22) 1-x, 1-y,-z 3.56(3) 
C(4) ...... C(23) 1-x, 1-y,-z 3.56(3) 
C(18') .... C(24) Y:z-x, Y:z-y,-z 3.57(4) 
C(5) ...... C(23) 1-x, 1-y,-z 3.58(3) 
C(15) ..... C(2M) x,-1 + y,z 3.62(4) 
C(l9') .... C(23) Y:z -x, Y:z -y,-z 3.63{4) 
-257-
b) C ... C Contacts Shorter than 3. 75A continued 
C(18) ..... C(25) %-x,-% + y,- %-z 
C(5) ...... C(24) 1-x,1-y,-z 
C(18') .... C(23) %-x, %-y,-z 
C(2) ...... C(25) 1-x, 1-y,-z 
C(19') .... C(24) %-x, %-y,-z 
C( 18) ..... C(22) %-x, %-y,-z 
C(18) ..... C(21) %-x, %-y,-z 
c) C ... N Contacts Shorter than 3. 75A 
C(21 ) ..... N(3) 
C(22) ..... N(3) 
C(25) ..... N(1) 





d) C ... O Contacts Shorter than 3. 75A 
C(8) ...... 0(2) %-x, %-y,-z 
C(4) ...... 0(2) %-x, %-y,-z 
C(11 ) ..... 0(3) x,y,z 
C(16') .... 0(2) %-x,-% + y, %-z 
C(8) ...... 0(1) x,y,z 
C(11 ) ..... 0(5) x,y,z 
C(9) ...... 0(1) x,y,z 
C(4) ...... 0(4) %-x, %-y,-z 
C(12) ..... 0(1) x,y,z 
C(2M) ..... 0(5) X, 1-y,-% + Z 
C(12) ..... 0(4) % +x,-% +y,z 
C(6) ...... 0(1) · x,y,z 



































Colourless plates from water, also formed from aqueous 
suspensions of Phases A or E, 1.12 x 0.60 x 0.20 mm. 
c29H35N4 3+ .3cl- .5H20, M= 637 .0, lW'V,:'J.Clinic, C2/c (No.15) I 
a = 26.624 (3), b = 9.412 (1), c = 28.890 (5), A, 
P = 112.355 (8) 0 , V= 6695.8 A3 , Z = 8, V/Z = 840 A3 • 
Lattice parameters refined from accurately measured 2e 
values (23.0°- 26.2°) for 26 reflections. 
De= 1.26 g.cm-3, Jl = 2.67 cm- 1 , F(OOO) = 2648, 
T = 258 K. 
Data Collection and Processing 
StOe STADI-4 diffractometer, MoKa, A= 0.71073 A. 3599 
independent data (2 < e < 22°, 0 < h ~ 28, 0 ~ k ~ 10, 
0 ~ 1 ~ 31) yielding 2506 data with I~ 3.0 a (I). 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86) . 
m- 1 = a2 ( F) + 0 . o o 0 15 4 F2 , R = o . 11 o 7 , wR = 0 . 12 7 3 , 
S = 1.153 based on 434 parameters. Maximum shift/esd 
on last cycle = 0.946. Maximum and minimum ripple in 
difference electron density map : 0.49 and -0.59 e.A-3 • 
Refinement not completed, anlons and water molecules 
disordered and all show high thermal parameters. Two 
partial fragments of a water molecule refined with 
partial site occupancy of 0.25 each (0(6) and 0(6A)). 
The 0(6A) fragment was also refined isotropically. 
Hydrogen on N(1) was located and refined, but was 
removed when distance contracted to <0.5 A. Hydrogen 
on remaining imidazole nitrogen is also contracting, 
N(3)-H(3) = 0.72 A and all major shifts/esd in last 
cycle were associated with these two atoms. No 
hydrogens were located on any of the water oxygens. 
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6 low angle reflections were omitted from the 
refinement, a DIFABS absorption correction was applied 
to the data, but made no significant difference. A new 
data set was collected from another crystal, but this 
showed no improvement on the existing data and was 
rejected. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. Molecular structure and 
molecular packing diagram (as viewed along the b-axis) 
are shown in Figure 9.7. The molecular packing may be 
described as interleaved layers of tolyl and phenyl 
rings running parallel to c. The anions and water 
molecules occupy the remaining channels. The hydrogen 
bonding and other close intermolecular contacts are 
summarised in Table 9.7. The principal hydrophobic 
contacts are imidazole-tolyl and phenyl-phenyl through 
an inversion centre. 
Table 9. 7 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydrogen Bonding 
Donor Acceptor Symmetry 
Cl(1 )-H(7) ... N(7)* x,y,z 
CI(2)-H(3) ... N(3)* x,y,z 
CI(3)-H(1 0) .. N(1 0)* %-x,-% +y, %-z 
N(1 )-H(1 ).... 0(1) 
* salt H-bonds 
b) C ... C Contacts Shorter than 3.75A 
C(4M) ..... C(22) 
C(4M) ..... C(23) 
C(15) ..... C(17) 
C(16) ..... C(16) 
C(15) ..... C(16) 
%-x, %-y, 1-z 























c) C ... N Contacts Shorter than 3. 75A 
C(20) ..... N(3) 
C(21 ) ..... N(3) 
%-x, %-y, 1-z 
%-x, %-y, 1-z 
d) C ... O Contacts Shorter than 3.75A 
C(12) ..... 0(3) 1-x,y, 1 %-z 
C(4M) ..... 0(3) -%+x,%+y,z 
C(4M) ..... 0(5) %-x,% +y,1 %-z 
C(1.8') .... 0(1) X, 1-y, Y:z + Z 
C(17') .... 0(6A) 1-x,1-y,1-z 
C(5) ...... 0(1) 1-x,-y, 1-z 
C(9) ...... 0(6A) x,1-y,% +z 
C(16') .... 0(6A) X, 1 -y I Y:z + z 
C(16') .... 0(6A) 1-x,1-y,1-z 
C(8) ...... 0(4) 1-x, 1-y, 1-z 
C(4M) ..... 0(1) 1-x, 1-y, 1-z 
C(21) ..... 0(1) 1-x,-y, 1-z 
C(6) ...... 0(1) 1-x,-y, 1-z 













































Colourless plates from isopropanol (also from 50% v/v 
acetonitrile/hexane), 0.76 x 0.84 x 0.24 mm. 
C29 H35N4 
3
+. 3cl-. SH2o, Mr = 637.0, triclinic, P1 (No.2), 
a = 9.217 ( 1) 1 b = 14.146 ( 2) 1 c = 14.270 ( 2) A, 
a = 70.88 ( 1) 1 p = 87.54 ( 1) 1 'Y = 74.03 ( 1) O 1 V = 
1706.3 A\ z = 2 1 VIZ = 847 A3. 
Lattice parameters refined from accurately measured 2e 
values (31.0° - 31.9°) for 40 reflections. 
D c = 1 . 2 4 g . ern- 3 , Jl = 2 . 9 ern -l , F ( 0 0 0 ) = 5 9 2 , 
T = 290 K. 
Data Collection and Processing 
Stoe STADI-4 diffractorneter, MoKa, A= 0.71073 A. 5127 
independent data (2 < e < 23°, -9 ~ h ~ 10, -14 ~ k ~ 
15, 0 ~ 1 ~ 16) yielding 3849 data with I~ 3.0 cr (I). 
Structure Solution and Refinement 
Solution by direct methods (SHELX 86) . 
nr 1 = cr2 (F) + o . o o o 7 9 2 F2 , R = o . o 8 o 6 , wR = o . 12 3 8 , 
S = 0.989 based on 410 parameters. Maximum shift/esd 
on last cycle = 0.035. Maximum and minimum ripple in 
difference electron density map : 0.70 and -0.61 e.A-3 • 
Anions and water molecules were all disordered, Cl(3), 
0(4) and 0(5) were refined isotropically and these 
oxygens had high thermal parameters. Cl(3) was badly 
disordered and in an analogous fashion to Phase C was 
modelled in three parts with partial site occupancies 
of 0.4, 0.1 and 0.4. The water oxygen 0(5) was 
modelled in a similar fashion with each of the parts 
having one third site occupancy. The remaining 
disordered water oxygen, 0(4), was modelled in two 
parts with site occupancies of 0.75 and 0.25. No 
hydrogens were located on any of the water oxygens. 
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24 low angle reflections were omitted from the 
refinement. A DIFABS absorption correction was applied 
to the data, but made no significant difference. A new 
data set was collected from another crystal, but this 
showed no improvement on the existing data and was 
rejected. 
Structure Discussion 
Selected bond lengths, angles and torsion angles are 
given in Tables 9.9.1-9.9.3. Molecular structure and 
molecular packing diagram (as viewed along the a-axis) 
are shown 1n Figure 9.8. The cations form dimeric 
units around an inversion centre, with large channels 
parallel to b being occupied with anions and water 
molecules. The hydrogen bonding and other close 
intermolecular contacts are summarised in Table 9.8. 
The principal hydrophobic contacts are phenyl-tolyl and 
imidazole-tolyl through an inversion centre. 
Table 9.8 Hydrogen Bonding and Other Close Intermolecular Contacts 
a) Hydr~gen Bonding 
Donor Acceptor Symmetry 0-H H ... A D ... A 
Cl(1 )-H(3) ... N(3)* x,y,z 0.72 2.39(15) 3.092(4) 
N(1 )-H(1 ) .... 0(1) 2-x,-y, 1-z 0.94 1.65 2.756(8) 
CI(3)-H(7) ... N(7)* 2-x,-y,1-z 0.96 2.04(5) 2.993(7) 
CI(2)-H(1 0) .. N(1 0)* x,y,z 0.68 2.36(5) 3.019(4) 
0(42) ........ 0(52) x,y,z 2.83(4) 
0(41) ........ 0(51) x,y,z 2.88(3) 
0(2) ......... 0(3) x,y,-1+z 2.89(1) 
0(3) ......... 0(3) 1-x,-y,2-z 2.90(1) 
0(1 ) ......... 0(41) 1-x,-y, 1-z 3.03(2) 
* salt H-bonds 
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b) C ... C Contacts Shorter than 3. 75A 
C(19) ..... C(21) 2-x,-y, 1-z 3.396(7) 
C(2) ...... C(21) 1-x, 1-y, 1-z 3.446(6) 
C(20) ..... C(20) 1-x, 1-y, 1-z 3.506(6) 
C(19) ..... C(22) 2-x,-y, 1-z 3.540(7) 
C(5) ...... C(23) 1-x, 1-y, 1-z 3.550(6) 
C(4) ...... C(22) 1-x, 1-y, 1-z 3.555(7) 
C(2) ...... C(20) 1-x, 1-y, 1-z 3.604(6) 
C(20) ..... C(21) 1-x, 1-y, 1-z 3.626(6) 
C(2) ...... C(22) 1-x, 1-y, 1-z 3.633(6) 
C(18') .... C(24) 2-x,-y, 1-z 3.648(9) 
C(18) ..... C(22) 2-x,-y, 1-z 3.650(8) 
C(15) ..... C(2M) 1+x.-1+y,1+z 3.677(8) 
c) C ... N Contacts Shorter than 3. 75A 
C(22) ..... N(3) 1-x, 1-y, 1-z 3.431 (6) 
C(21 ) ..... N(3) 1-x,1-y,1-z 3.549(6) 
C(24) ..... N(1) 1-x,1-y,1-z 3.608(6) 
C(23) ..... N(1) 1-x, 1-y, 1-z 3.709(6) 
C(25) ..... N(1) 1-x, 1-y, 1-z 3.735(6) 
d) C ... O Contacts Shorter than 3. 75A 
C(12) ..... 0(5) x,y,z 3.236(24) 
C(4M) ..... 0(5) x,y,z 3.252(24) 
C(9) ...... 0(5) 1 + x,y,z 3.267(24) 
C(4) ...... 0(5) x,y,z 3.400(24) 
C(9) ...... 0(4) 1 + x,y,z 3.400(25) 
C(4M) ..... 0(3) x,y,z 3.438(1 0) 
C(4M) ..... 0(3) 1-x,-y,2-z 3.506(10) 
C(9) ...... 0(4) 1 + x,y,z 3.520(17) 
C(16') .... 0(2) 2-x,-y, 1-z 3.525(9) 
C(18') .... 0(5) 1 + x,y,z 3.532(25) 
C(19') .... 0(5) 1 + x,y,z 3.535(24) 
C(6) ...... 0(1) 2-x,-y, 1-z 3.549(8) 
C(19) ..... 0(1) x,y,z 3.556(9) 
C(5) ...... 0(1) 2-x,-y, 1-z 3.566(8) 
C(18) ..... 0(1) x,y,z 3.574(9) 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9.9.3 Selected Torsion Angles for All IM Structures 
r l~ T OL MHCL MME$ THCLA THCLB THCLC THCLD THCLO 
N ( 1) C(2) N(3) 0.7(7) 0. 1 ( 4) 0. 1 ( 5) -1.1(4) 1.0(11) -1.4(23) -1.5(12) -0.1(4) 
)) N ( 1) c ( 2) c (20) 179.9(6) 179.4(3) 178.9(5) 177.1(3) -179.2(9) -179.1(20) 178.0(10)-179.3(4) 
)) N( 1) C(S) c ( 4) -0.1(7). 0.4(4) ·-0.2(5) 0.7(4) -.0. 6•( 11) 1.6(24) 2. 4 ( 11) -0.3(5) 
I) N ( 1 ) C(5) C(6) 177.7(6) -17~.6(3) -179.7(4) -172.3(3) -175.0(8) 177.3(19) 179.5(9) -177.8(4) 
I) c ( 2) N(3) C(4) - 1. 1 (7) -0.4(4) 0. 1 ( 6) 1.0(4) -1.0(11) 0.7(23) 0. 1 ( 12) 0.3(5) 
1) c ( 2) N(3) ((4) 179.6(6) -179.8(3) -178.8(5) -177.2(3) 179.2(10) 178.4(20)-179.4(10) 179.6(4) 
10) - c ( 2) C(20) - c ( 2 1) -4.6(10) 22.9(5) 14.8(8) -5.7(5) 7.2(16) 0(3) 2.3(17) -4.4(6) 
1) C(2) C(20) - C(25) 176.2(6) -155.8(4) -166.5(5) 178.0(3) -170.8(10)-177.4(20)-177.6(11) 175.6(4) -1) c ( 2) C(20) - c (21) 174.5(6) -157 .9(3) -166.6(5) 172.1(3) -173.0(10)-176.6(21)-178.3(11) 176.4(4) 
) c (2) C(20) - c (25) -4.6(10) 23.4(5) 12.2(8) -4.2(6) 9.0(16) 5(3) 1.8(18) -3.6(7) -) 
N(3) C(4) c ( 4. ) -179.6(6) -176.2(3) -179.8(4) 178.5(3) -179.1(9) 177.5(19)-179.5(9) 177.7(4) 
) -
N(3) C(4) C(5) 1 . 1 (7) 0.6(4) -0.2(5) -0.5(4) 0. 6 ( 11) 0.3(23) 1.3(12) -0.4(5) 
ll - C(4) C(5) N ( 1) -0.6(7) -0.6(4) 0.2(5). -0.1(4) -0.1(10) -1.1(23) -2.2(11) 0.4(5) 
) - C(4) c ( 5) C(6) -178.1(6) 179.4(3) 179.7(5) 171.7(3) 173.5(9) -176.2(21)-179.1(10) 177.6(4) 
) - C(4) C(5) N ( 1) -179.8(7) 175.8(4) 179.8(5) -179.0(4) 179.6(10)-177.9(21) 178.7(10)-177.5(5) 4')-
C(4) C(5) C(6) 2.6(13) -4.2(6) -0.7(9) -7 .3(7) -6.9(18) 6(4) 1.8(19) -0.3(8) n-
1) - C(S) C(6) N (7) -67.6(7) -79.6(4) 86.5(5) 85.0(4) -75.8(10) 79.7(23) 88.3(11) -80.0(5) ., - C(S) C(6) N(7) 109.7(8) 100.4(4) -93.0(6) -85.9(4) 111.4(11)-105(3) -95.2(13) 103.1(5) 
5) - C(6) N (7) C(8) 
157.0(5) 70.6(4) 65.0(5) 89.4(3) 165.1(7) 67.6(20) 67.1(10) 166.1(3) 
) - C(6) N (7) c ( 12) -79.8(6) -165.8(3) -171.2(4) -147.4(3) -72.8(9) -172.9(16)-170.5(8) -72.3(4) 
6) - N(7) C(8) C(9) -179.9(5) -177.7(3) 177.4(4) -175.4(3) -177 .8(7) 178.6(16) 177 .9(8) -178.8(3) 
12) - N (7) C(8) C(9) 56.4(7) 56.8(4) 52.8(5) 59.3(4) 59.4(9) 57.5(20) 55.0(10) 57.9(4) 
N(7) c ( 12) - c ( 11) -179.6(5) 177 .3(3) -178.4(4) 176.2(3) 179.4(7) 178.3(16)-178.2(8) -179.3(3) 6) -
N(7) c ( 12) - c ( 11) -54.7(7) -57.1(4) -53.4(5) -59.6(3) -58.0(9) -60.3(20) -54.5(11) -57.6(4) I) -
) - C(8) C(9) N ( 1 0) -61.0(7) -58.9(4) -58.8(5) -56.9(4) -61.0(9) -57.9(21) -59.1(10) -57.8(5) 
I) - C(9) N ( 1 0) - c ( 11) 60.9(7) 59.0(4) 63.0(5) 52.6(4) 58.7(9) 55.4(21) 59.0(10) 55.7(5) 
I) - C(9) N ( 1 0) - c ( 13) -175.5(6) -178.2(3) -172.7(4) 174.2(3) -179.4(7) 176.6(17)-179.3(8) 178.9(3) 
!) - N(10) - c ( 11) - c ( 12) -59.6(7) -58.4(4) -62.4(5) -53.2(4) -56.8(9) -54.5(20) -57.1(10) -54.8(4) 
13) - N ( 10) - c ( 11) - c ( 12) 176.9(5) -179.7(3) 176.2(4) -175.3(3) -179.4(7) -177.7(16)-179.6(8) -177 .4(3) 
!) - N ( 10) - c ( .13) - c ( 14) -179.3(6) 64.5(4) -166.6(4) 175.6(3) -178.8(7) 53.9(22)-175.3(8) -173.9(3) 
9) - N ( 10) - c ( 13) - C(14') 57.4(7) -172.9(3) 70.1(5) 46.5(3) 53.1(9) -175.7(17) 59.0(11) 57.0(4) 
11) - N ( 10) - c ( 13) - c ( 14) -59.1 (7) -174.4(3) -45.9(5) -62.8(3) -57.9(9) 174.4(18) -55.5(11) -52.0(4) 
11) - N ( 10) - c ( 13) - C(14') 1 i7. 6 ( 6) -51.8(4) -169.2(4) 168.1(3) 174.0(7) -55.2(23) 178.8(8) 179.0(3) 
10) - c ( 11) - c ( 12) - N(7) 58.3(7) 58.8(4) 58.9(5) 57.4(4) 57.0(9) 60.1(21) 57.3(11) 57.3(5) 
10) - c ( 13) - c ( 14) - c ( 15) -45.3(9) 30.3(5) -63.6(6) -58.7(4) -69.9(11) 67(3) -66.1(13) -77.9(5) 
10) - C(13) - c ( 14) - c ( 19) 135.2(7) -151.8(4) 115.6(5) 124.4(3) 114.2(9) -109.6(24) 118.1(11) 107.7(4) 
n- c ( 13) - c ( 14) - c ( 15) 78.3(9) -93.0(4) 58.9(7) 68.1(4) 57.6(12) -62(3) 59.6(14) 49.8(6) 
n - c ( 13) - c ( 14) - c ( 19) -101.3(8) 84.8(4)-121.9(5) -108.8(4) -118.3(9) 120.6(25)-116.2(11)-124.6(4) 
10) - c ( 13) - C(14') - C(15') 40.4(10) -63.3(4) 31.4(6) 73.0(4) 50.6(12) -57(3) 35.9(14) 50.7(6) 
10) - c ( 13) - C(14') - C(19') -140.8(8) 118.4(4) -150.1 (5) -106.3(4) -129.2(9) 125.9(22)-144.2(10)-132.4(4) 
14) - c ( 13) - C(14') - C(15') -82.7(9) 59"8(4) -92.1(6) -54.1(5) -75.7(11) 69(3) -89.9(12) -77.6(5) 
14) - c ( 13) - C(14') - C(19') 96.1(9) -118.5(4) 86.4(6) 126.6(4) 104.5(10)-106(3) 90.0(11) 99.4(5) 
13) - c ( 14) - c ( 15) - c ( 16) 178.5(8) 178.2(4) 179.8(6) -174.4(4) -176.3(9) -178(3) -179.3(11)-173.8(5) 
19) - c ( 14) - c ( 15) - c ( 16) -2.0(13) 0.4(6) 0.6(9) 2.4(6) -0.4(15) -1 ( 4) -3.5(18) 0.7(7) 
13) - c ( 14) - c ( 19) - c ( 18) -178.7(8) -178.0(4)-179.4(6) 174.9(4) 176.2(9) -179.1(25) 177.2(11) 173.3(5) 
IS) - C(14) - c ( 19) - c ( 18) 1.8(13) -0.1(6) -0.2(9) -2.1(6) 0.2(15) 3(4) 1.1(17) -1.4(7) 
I~) - c ( 15) - c ( 16) - C(17) 1 . 7 ( 14) -0.7 (7) -1.1(10) -0.6(6) 1.0(17) -3(5) 3.9(20) 0.6(9) 
15) - c ( 16) - c ( 17) c ( 18) -1.1(15) 0.8(8) 1.2(12) -1.5(7) -1.3(18) 5(5) -1.9(22) -1.3(9) 
16) - c ( 17) - C(18) - c ( 19) 0.9(16) -0.5(8) -0.8(12) 1.8(7) 1 . 1 ( 18) -3(5) -0.4(22) 0. 6 (9) 
17) - c ( 18) - c ( 19) - c ( 14) -1.3(15) 0.2(8) 0.3(11) 0.0(6) -0.5(17) 0(4) 0.8(21) 0.7(9) 
13) - c ( 14 . ) - C(15') - C(16') -179.7(9) -179.2(4) 178.3(5) -179.2(4) 179.9(10)-176.5(23) 179.9(10) 177.3(5) 
')-C(14') - c ( 1 5.) - C(16') 1.5(13) -0.9(6) -0.2(8) 0. 1 ( 6) -0.2(16) 0(4) 0. 1 ( 17) 0.4(8) 
13) - c ( 14 . ) - C(19') - C(18') 179.3(10) 179.4(4)-179.0(5) 178.2(4) -179.1(10) 176.2(24)-178.3(11)-177.5(5) 
S')- C(14') - C(19') - C(18') -1.9(14) 1 . 0 ( 6) -0.5(9) - 1 . 1 ( 6) 1.1(16) 0(4) 1.5(17) -0.4(8) 
C') - c ( 15.) - C(16') - C(17') -0.6(18) 0. 0 (7) 0.8(10) 0.8(7) -1.2(18) 0(4) -1.1(18) 0.1(9) 
S')-C(16') - ((17') - C(18') 0.2(22) 0.8(8) 
6')- C(17') - c ( 1 8.) - C(19') -0.6(23) -0.7(8) -0.7(10) -0.6(8) 1.7(20) - 1 ( 4) 0.6(19) -0.5(10) 
1')- C(18') - C(19') - C(14') i.5(20) -0.2(8~ 0.1(10) -0.4(8) -0.8(20) 1 ( 4) 1.0(20) 0. 5 ( 11) 
IJ - C(20) - c ( 21) - c (22) 179.7(6) -179.9(3; 0.6(10) 1. 3 (7) -0.6(19) 0(4) -2.1(19) 0. 1 ( 10) 
5) - c (20). - c (21) - C(?L) .• 1 . 1 ( 1 0) -1.2(5~179.5(5) -176.6(3) 179.7(10)-174.3(22)-179.0(10) 178.4(4) 
) - c (20) - c (25) - C(/4) -179.6(7). 179.8(3~. 1 . 6 ( 8) -0.3(6) -2.2(15) 3(4) 0.9(16) -1.6(7) 
I) - ((20) - C(25) - c (2.c) 1 . 3 ( 1 0) 1.1 (5} 09.9(5) 176.3(4) 1 7 9. 9·( 1 0) 175.8(21) 178.6(11)-179.0(4) 
0) - c ( 2 1) - c (2 2) - C(!?.; 0. 1 ( 1 1) 0. 2 ( 6) -1.3(8) -0.1(6) 1 . 8 ( 16) -2(3) -1.3(18) 1.0(7) 
1) - ((22) - C(23) - C(23.) -178.7(7) -176.8(./l) 0.2(9) 1.0(6) 2.0(16) -3(4) 0.5(18) -0.1(7) 
!) - C(22) - C(23) - c ([.C) o e < 1 1 > 0.9(6) 179.0(6) 177.9(4) -179.4(10) 177.5(24) 176.5(12)-175.5(5) 
1) - C(23) - C(24) - C{:'5) -0.6(12) -1 .0(6) -2.3(9) -1 .4(6) -1.3(17) 1 ( 4) -1.5(19) 2.4(8) 
) - C(23) - C(24) - CC:.'S) 178.9(7) 1 7 6 . 7 ( .ll) 2.6(9) 1 . 1 ( 6) 0.9(17) 0(4) 1 . 1 ( 19) -3.2(8) 
3) - C(24) - c (25) - C(2G) -0.4(12) 0.1 (6)-178.6(6) -178.2(4) 179.0(10)-176.2(23)-176.9(12) 174.8(5) 
-0.9(8) -0.4(6) -1.2(17) 0(4) 0.2(19) 1 . 5 ( 8) 
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IM is a tribasic piperazinyl imidazole which can 
theoreticaly exist as a monoanion, neutral species (pKa 3 
7.16), monocation (pKa 2 3.93), dication (pKa 1 2.68) and a 
trication. Two of the ionisation constants are assumed to 
be associated with the piperazine ring (pKa 1 and pKa 3 ) 
and the third with the substituted imidazole group 
'(pKa2 ). Only the neutral and cationic species were 
studied during these investigations. In solution IM can 
exist as an equilibrium mixture of all of these species, 
but in practice the relative proportions depend on the 
ionisation constants and the pH of the medium under 
consideration. The species composition as a function of 
pH are shown in Figure 10.1.1 and the sites and order of 
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10.2 IM Tautomerism 
Unsymmetrically substituted imidazoles exhibit annular 
tautomerism, between nitrogen atoms, where both tautomers 
are aromatic 1 • 
In the recent past annular tautomerism has been 
considered to require some special explanations, distinct 
from common prototropy. The chief reason being the very 
fast rate of proton transfer 1n annular tautomerism 
relative to many other types of prototropy. This is due 
to several factors; firstly, hetero atom-hydrogen bonds 
are easier to break and form than carbon-hydrogen bonds 
which are involved in some of the other types of 
tautomerism. Secondly, the partial or total charges 
resulting from proton gain or loss are delocalised 1n an 
aromatic ring. Thirdly, there are intermolecular 
associations, which facilitate proton transfer in these 
systems, as shown in Figure 10.2.1. 
Figure 10.2.1 Imidazole inter-molecular associations 
I \ A I \ 
H-N N-----H-N N---- H-N /.N 
~ ~ ~ 
F\ A f==J\ 
N_, _N-H ---- N N-H-- -- N N-H 
~ ~ ~ 
The two tautomers are referred to as the Nx-H (proximal) 
and N~-H (distal) forms, with reference to the largest of 
the substituents, on the 4 or 5 position of the imidazole 
ring. 13C NMR is probably the method of choice to study 
-275-
the position of the tautomeric equilibria in imidazole 
compounds, when derivatives representing the frozen forms 
of the two tautomeric possibilities are not available. 
Reynold et al 2 using these techniques concluded for the 
first time that the tautomeric equilibria of histidine 
and its l-and 3-methyl analogues is shifted towards the 
distal (T) form. 
Figure 10.2.2 Structure of Histidine 
The same technique has been applied to several peptides 
and proteins, in most cases it has been found that the 
W-H tautomer is predominant 3 • 4 with the occasional 
meaningful exception5 • 
Charlton6 • 7 qualitatively suggested that when considering 
4 {5)-substituted imidazoles, that electron donating 
groups·will favour the 5-substituted tautomer and 
electron withdrawing groups the 4-substituted tautomer. 












Confirmation of this hypothesis was produced by Pedroso et 
al 8 , who demonstrated that the tautomeric equilibria in 
Nf-acetyl-5-nitrohistidine methyl ester was 98% in favour 
of the Nr-H tautomer. The same group of workers confirmed 
these findings during investigations of [5-nitro-L-
histidine]a-thyroliberin9, showing without ambiguity that 
the tautomeric equilibrium in the peptide is strongly 
shifted to the Nr-tautomer. They also postulated that the 
·position of the tautomeric equilibrium determines the 
extent of biological activity, and that the Nx-H tautomer 
shows much reduced biological activity. This confirmed the 
earlier work of Deslauriers et a1 10 on the unsubstituted 
peptide, thyroliberin, which showed the 1r-H tautomer to 
be the predominant tautomeric form. Staabe and 
Mannschreck11 used isotopic studies to confirm the site of 
deuterium uptake by 4(5)-bromoimidazole and its 2-methyl 
analogues. They concluded that the 4-bromo structure was 
the predominant structure for these compounds, again 
confirming Charlton's hypothesis. 
X-ray crystallographic studies have produced conflicting 
findings. The structure of the imidazole-containing am1no 
acid L-histidine was determined by Madden 12 • 13 • The 
tautomeric preference was found to be for the N~-H form. 
By contrast, histamine (the product of enzymatic 
decarboxylation of histidine) was found to exist in the 
Nr-form14 • Interestingly when histamine acts as a bidentate 
ligand, with a metal, then these complexes are derivatives 
of the 4-substituted imidazole ie the N~-H form. 15 • 16 • 17 and 18 
Worth et al 19 have shown the importance of hydration 
energy on the position of the tautomeric equilibrium. A 
combination of quantum mechanical and molecular dynamics 
simulations on 4(5)-methyl imidazole have shown that the 
aqueous phase favours the Nx-H tautorner more than the gas 
phase. 
-277-
In the present work, both the neutral and the 
monocationic species of IM may demonstrate annular 
tautomerism of the type previously described. (see Figure 
10.2.4) 
In the free base (IMFBTOL) and monocation (IMMMES and 
IMMHCLAC) structures of IM studied; all showed 
unambigously the N~-H tautomer, with reference to the 
largest substituent (R 3 ) 






methyl <liphenyl piperazine 
In all cases a single hydrogen was located on N(3) and 
N(l)-C(2) is shorter than N(3)-C(2), in most cases 
significantly so. A summary of the relevant 































































































































































































































































































































































































































































10.3 Imidazolium Cation 
Protonation of the tautomerisable imidazole yields only 
one cation and as with the guanidinium ion (see Section 
6.3), it is the conjugate acid (BH+) of both of the 
tautomeric bases (B1 and B2). Some of the structural 
implications of its aromatic character are the two 
essentially equivalent C-N bonds and the strictly planar 
·geometry of the cation. The C-N bond lengths, inter-
planar angle (0) between the imidazolium cation and tolyl 
ring and the root mean square deviation (cr) of the cation 
from planarity, for all of the imidazolium cations are 
summarised in Table 10.3.1. 
An interesting feature of the molecular geometry is the 
observed co-planarity of the imidazolium and t~lyl rlngs. 
This may arise from the combination of a hyper-
conjugation effect of the 4-methyl group (located on the 
tolyl ring) , linked to the powerful electron sink 
capabilities of the imidazoliurn ion, causing significant 
double bond character of the inter-ring bond (C(2)-
C(20)), resulting co-planarity and charge stabilisation. 

























































































































































































































































































































































































































































Figure 10.3.1 Potential Resonance Hybrids for Imidazolium Cations 
+ 
H 
By reference to Table 10.3.1 it can be seen that the mean 
C{1)-N(1) and C{1)-N(2) bond lengths are equivalent and 
there is significant double bond character on the inter-
ring bond, 1.452(3)A; as compared with a typical phenyl-
carbon, out of ring bond, in toluene of 1.53(1)A20 • In 
the free base and monoprotonated structures this hyper-
conjugation effect may still occur, but it is 
energetically less favoured, as the resonance hybrids 
require two separate charges and not one as in the 
triprotonated forms. In the free base (IMFBTOL) co-
planarity (0=4.54°) and the consequent shortening of the 
inter-ring bond (1.454{9)A) was observed. This structure 
is potentially stabilised by the type of inter-molecular 
association shown in Figure 10.2.1. This was observed ln 
the H-bonding scheme for IMFBTOL (see Table 9.1). 
This inter-molecular association was not observed for the 
monomesylate {Table 9.2) or the monochloride (Table 9.3) 
and as such the degree of coplanarity (0~5=13.42°, 
0HcL=23. 27°) and consequ~nt shortening of the inter-ring 
bond (MES=1.464(7) and HCL=l.469(5) A) is reduced. 
-282-
10.4 IM Conformation 
The conformation of salts and modifications of IM rema1ns 
essentially the same, irrespective of the state of 
ionisation. Only the monoprotonated chloride (IMMHCLAC) 
showed any evidence of conformational changes (see Figure 
9.3) and these involved rotations about the non-ring 
bonds, C(5)-C(6) and C(6)-N(7) and a slight twisting 
·about C(2)-C(20). All phenyl rings are planar within 
experimental error. The piperazine ring exists in a half 
chair conformation significantly flattened towards N(7) 
in the free base and monoprotonated structures and 
towards N(10), but not significantly so, in the 
triprotonated structures. 
This may be illustrated using the absolute in-ring 
torsion angles about N(10) (but excluding N(7)). and about 
N(7) (but excluding N(10)). These values are summarised 
in Table 10.4.1, together with the puckering parameters 
of Cremer and Pople21 (starting from either nitrogen atom 
and reducing 0 and e to first quadrant angles). 
-283-
Table 10.4.1 IM Puckering Parameters and In-ring Piperazine Torsion Angles 
Salt/ Puckering Parameters Torsion Angles (0 ) 
Modification Q q2 q3 e x N(7) X: N(10) 
Free Base 
IMFBTOL 0.585 0.044 -0.583 26.9 -4.3 55.56 60.24 
MonoQrotonated 
IMMMES 0.590 0.060 -0.587 -0.4 -5.8 53.10 62.69 
IMMHCLAC 0.585 0.003 -0.585 29.5 -0.35 58.71 57.00 
x55.90 x59.84 
TriQrotonated 
IMTHCLHYA 0.572 0.047 0.570 -7.5 4.7 59.49 52.90 
IMTHCLHYB 0.595 0.023 0.595 -81.2 2.2 58.70 57.74 
IMTHCLHYC 0.575 0.035 0.573 29.2 3.5 58.32 54.47 
IMTHCLHYD 0.574 0.018 -0.574 2.5 -1.8 57.76 55.24 
IMTHCLHYE 0.577 0.038 0.575 16.7 3.7 54.71 58.01 
x57.80 x55.67 
(1.84) (2.18) 
Interestingly, there appears to be no difference between 
the free base torsion angles and the mean torsion angles 
for the monoprotonated structures; both are flattened 
towards N(7). This is in agreement with the findings for 
the GU structures (Section 6.4). 
As explained previously, in the GU structures the 
positive charge is extensively delocalised over the whole 
guanidinium cation. This results in marginal build up of 
charge on the appropriate piperazine nitrogen, N(ll) and 
only small differences in the levels of charge, between 
the free base and monoprotonated structures. 
However, in the case of the corresponding IM structures, 
there is again no charge present in the free base 
structure, but 1n the monoprotonated structures the 
charge is located on the appropriate piperazine nitrogen, 
N(7). To circumvent this localisation of charge, the in-
-284-
ring and out-ring C-N bond lengths significantly lengthen 
(see Table 10.4.2) in the monoprotonated structures, to 
spread the charge over four atoms. 
Table 10.4.2 IM In-ring and Out-ring Piperazine Bond Lengths 
Structure Out-ring Bond Lengths (A) In-ring Bond Lengths (A) 
N(7)-C(6) N(l0)-C(13) XN(7)-C(8) XN(10)-C(9) C(8)-C(9) 
/C{12) /C{ll) xC( 11)-C( 12) 
Free Base 
IMFBTOL 1.461 1.466 1.453 1.469 1.505 
MonoQrotonated 
IMMMES 1.524 1.481 1.498 1.466 1.513 
IMMHCLAC 1.514 1.476 1.489 1.465 1.506 
x1.519 x1.479 x1.494 x1.466 xl.510 
TriQrotonated 
IMTHCLHYA 1.521 1.540 1.490 1.500 1.515 
IMTHCLHYB 1.518 1.533 1.491 1.501 1.515 
IMTHCLHYC 1.52 1.522 1.498 1.498 1.498 
IMTHCLHYD 1.495 1.485 1.477 1.502 1.520 
IMTHCLHYE 1.508 1.524 1.490 1.492 1.518 
xl.512 x1.521 x1.489 xl.499 xl.513 
In the triprotonated structures, the presence of a second 
charge on the piperazine nitrogen, N(10), results 1n a 
small flattening towards N(10), as the ring tries to 
maximise the separation of the two positive charges. 
However the flattening is not significant and in the case 
of IMTHCLHY£ (one of the more disordered structures, see 
Section 9.7) the ring is actually flattened towards N(7). 
Again, as was the case for GU structures, the flattening 
of the ring is accompanied by significant lengthening of 
both the in-ring and out-ring C-N bond lengths at the 
appropriate side of the ring, as shown in Table 10.4.2. 
-285-
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